Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3034860	s-iglck-v	mg/l (mg/l)	11701	37135	0.00%
3034860	s-iglck-v	— (—)	2873	8746	100.00%	Distribution not available
3034860	s-iglck-v	mg/l______ (mg/l)	334	1580	0.00%
3034860	s-iglck-v	MG/L (mg/l)	55	191	0.00%
3034860	s-iglck-v	mg/L (mg/l)	39	136	0.00%
3034860	s-immunoglob,kevyetketjut,vapaat,kappaosatutk	mg/l (mg/l)	9	12	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other heart diseases, wide

2560

6566

2.42

321.22

3.4

54.27

57.32

mg/l

0.10

2130

5664

Hypertensive heart and/or renal disease

1257

2737

3.58

321.08

2.5

4.0

67.09

51.57

mg/l

2.12

1069

2353

Oedema, not elsewhere classified

1367

4392

3.20

320.34

3.2

55.74

61.50

mg/l

0.35

1182

3738

Asthma, unspecified (mode), excluding more controls

1599

3950

2.99

314.35

2.9

2.7

84.64

53.29

mg/l

0.41

1348

3412

GASTRO-related operations

1911

3431

2.86

313.06

3.4

2.6

81.29

55.23

mg/l

0.41

1587

3062

Any gastric operation

1911

3431

2.86

313.06

3.4

2.6

81.29

55.23

mg/l

0.41

1587

3062

Erysipelas

2127

7559

2.52

312.64

2.9

3.0

62.82

65.07

mg/l

0.08

1793

6431

L04AA Selective immunosuppressants

1002

2790

3.86

310.45

2.4

3.5

102.47

67.30

mg/l

0.33

804

2372

Heart failure and bmi 25plus

1624

3811

3.03

308.79

2.9

3.9

64.33

64.77

mg/l

0.01

1327

3192

Hypercalcemia

451

660

8.89

308.44

4.9

3.8

69.43

63.68

mg/l

0.15

379

577

Implicit Sepsis, including avohilmo

3588

8414

3.20

307.65

3.5

3.2

86.58

52.96

mg/l

1.03

3022

7209

Glomerular diseases

1576

2498

7.55

307.65

3.4

3.5

116.51

51.65

mg/l

1.15

1285

2149

Bacterial infection, other or unspecified, including avohilmo

3107

7389

3.69

307.65

4.4

3.0

65.40

72.05

mg/l

0.23

2663

6294

Acute renal failure

1947

3122

7.37

307.65

3.8

3.3

144.97

42.56

mg/l

2.08

1630

2641

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3184

7289

2.64

307.65

4.6

2.6

70.28

60.94

mg/l

0.24

2688

6268

Nephropathy related operations

1090

1649

8.08

307.65

4.1

3.6

102.04

49.30

mg/l

10.46

897

1405

Glomerular disorders in diseases classified elsewhere

1078

1557

8.51

307.65

3.7

3.6

130.02

53.18

mg/l

0.87

895

1342

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3484

8014

3.06

307.65

3.4

3.3

85.50

52.07

mg/l

0.97

2921

6861

Chronic kidney disease

3616

4635

9.31

307.65

2.8

3.2

78.13

44.64

mg/l

18.53

2979

3926

Explicit Sepsis

2198

6347

3.36

307.65

4.3

3.1

73.40

51.63

mg/l

6.04

1804

5417

3184

7289

2.64

307.65

4.6

2.6

70.28

60.94

mg/l

0.24

2688

6268

Nutritional anaemias

2337

8168

2.88

307.65

2.6

3.4

103.01

59.09

mg/l

0.78

1955

6942

Multiple myeloma

805

379

72.48

307.65

23.8

1.5

228.68

46.27

mg/l

1.98

748

322

Acute tubulo-interstitial nephritis

2367

6671

3.13

307.65

2.9

3.5

87.52

47.90

mg/l

0.96

1941

5746

Malaise and fatigue

2180

5488

3.28

307.65

3.1

100.49

67.18

mg/l

0.50

1824

4682

All chronic kidney diseases

4731

5534

7.83

307.65

3.0

3.5

92.93

40.10

mg/l

3.98

3939

4764

All kidney diseases

5175

7314

5.07

307.65

3.2

3.6

82.82

44.20

mg/l

1.98

4301

6317

Other disorders of fluid, electrolyte and acid-base balance

1565

4742

3.32

307.65

2.9

3.3

102.11

56.74

mg/l

0.67

1280

3984

Anaemias

1024

336

20.99

307.65

3.1

1.5

53.23

28.60

mg/l

9.00

852

291

Condition for Implicit Sepsis (Organ dysfunction codes)

3538

8315

3.08

307.65

3.5

3.2

86.91

52.62

mg/l

1.03

2963

7129

Bacterial Sepsis

2671

6530

3.64

307.65

4.0

3.1

84.28

51.41

mg/l

1.39

2255

5566

Heart failure, not strict

3845

6903

4.02

307.65

3.5

76.52

57.05

mg/l

0.60

3236

5935

All pneumoniae

3610

9272

2.62

307.65

4.7

2.9

68.64

58.29

mg/l

0.33

3054

7924

Dialysis, with operation codes

1170

1332

10.86

307.65

4.2

3.6

102.05

41.85

mg/l

14.30

976

1140

Pneumonias (Asthma/COPD co-morbidities)

3607

9249

2.64

307.65

4.7

2.8

68.53

58.71

mg/l

0.31

3051

7900

Aplastic and other anaemias

3683

6877

5.56

307.65

3.2

3.3

100.42

60.13

mg/l

1.07

3091

5853

Other anaemias

3498

6582

5.67

307.65

3.2

3.3

101.55

60.65

mg/l

1.02

2952

5588

Disorders of calcium metabolism

586

785

9.16

307.65

4.9

3.6

67.98

59.73

mg/l

0.28

492

667

Polyarthropathies

2906

5701

3.44

307.65

3.4

3.7

58.29

79.04

mg/l

0.79

2438

4876

Other bacterial diseases, including avohilmo

4023

8406

3.12

307.65

3.9

3.1

59.49

65.89

mg/l

0.26

3396

7151

Gout, FINNGEN

1660

5297

3.38

307.65

4.4

3.3

62.92

69.18

mg/l

0.25

1404

4496

Persons encountering health services for specific procedures and health care

3366

8966

2.27

307.65

3.9

3.0

73.47

53.74

mg/l

0.60

2865

7607

Renal tubulo-interstitial diseases

5249

7685

5.43

307.65

3.2

3.6

85.38

45.69

mg/l

2.15

4387

6625

Hypertension

2205

4659

2.75

307.65

2.9

4.0

76.78

62.13

mg/l

0.22

1839

4002

Other heart diseases

1294

1892

4.60

307.65

3.7

3.6

59.05

58.74

mg/l

0.00

1079

1660

Care involving dialysis

833

990

10.81

307.65

3.3

103.74

51.19

mg/l

11.23

687

850

Other bacterial diseases

4160

8828

3.28

307.65

4.1

3.0

59.13

66.18

mg/l

0.31

3507

7520

Influenza and pneumonia

3637

9024

2.57

307.65

4.8

2.7

68.16

58.46

mg/l

0.31

3082

7706

Septicaemia

2157

6209

3.38

307.65

4.4

3.0

73.70

64.91

mg/l

0.38

1768

5261

Autoimmune diseases excluding thyroid diseases

3429

8138

2.35

307.65

2.8

3.7

53.11

66.25

mg/l

0.86

2874

6965

Bacterial infection, other or unspecified

2940

7171

3.72

307.65

4.5

3.0

65.76

73.68

mg/l

0.27

2516

6095

L04AX Other immunosuppressants

2487

7969

3.30

307.65

9.6

2.1

54.31

61.89

mg/l

0.37

2124

6783

Implicit bacterial Sepsis

2387

6139

3.60

307.65

3.7

3.1

87.45

52.33

mg/l

1.29

2015

5226

Osteopathies and chondropathies

2688

8076

3.23

307.65

4.1

3.2

53.42

66.76

mg/l

0.71

2208

6923

Abnormal findings on examination of blood, without diagnosis

2420

7429

3.15

307.65

3.4

70.78

64.99

mg/l

0.12

2038

6278

Systemic connective tissue disorders

1684

5537

3.25

307.65

2.5

3.5

45.77

68.27

mg/l

1.32

1396

4696

Metabolic disorders

3336

7804

2.65

307.65

3.4

3.3

72.32

62.88

mg/l

0.21

2813

6587

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

969

1150

11.41

307.65

3.4

3.3

49.57

102.33

mg/l

0.58

765

980

General symptoms and signs

3218

6471

2.56

307.65

3.6

3.1

65.43

63.01

mg/l

0.05

2720

5514

Autoimmune diseases excluding thyroid diseases, strict definition

3321

7884

2.36

307.65

2.8

3.7

53.55

66.91

mg/l

0.84

2777

6743

Oral corticosteroids

3879

8965

2.63

307.65

3.0

3.6

65.31

65.23

mg/l

0.00

3157

7728

Implicit bacterial Sepsis, including avohilmo

2562

6455

3.55

307.65

3.6

3.1

106.35

51.44

mg/l

1.38

2164

5504

Multiple myeloma, including Hilmo

1205

599

56.92

307.65

21.8

1.5

247.62

46.41

mg/l

2.58

1133

506

Osteoporosis

1641

4130

4.03

307.65

2.9

3.2

48.74

70.53

mg/l

0.80

1302

3548

Other septicaemia, including avohilmo

1930

5852

3.30

307.65

3.9

2.9

76.06

65.65

mg/l

0.44

1571

4958

Hypertensive diseases

2206

4659

2.75

307.65

2.9

4.0

76.78

62.13

mg/l

0.22

1840

4002

Heart failure,strict

2723

5606

3.65

307.65

3.1

3.5

66.01

53.95

mg/l

0.85

2267

4810

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5719

7730

5.39

307.65

3.4

79.39

53.66

mg/l

1.03

4820

6606

Diabetic nephropathy, excluding more controls

994

1990

4.61

307.65

2.1

2.9

76.58

53.05

mg/l

5.24

838

1691

Tramadol

2679

6221

2.68

307.65

3.5

2.7

68.59

65.86

mg/l

0.05

2262

5303

Hypertensive diseases (excluding secondary)

1354

1911

4.26

307.65

2.9

3.6

51.89

58.41

mg/l

0.10

1125

1676

Explicit Sepsis, including avohilmo

2222

6436

3.33

307.65

4.3

3.1

73.35

51.25

mg/l

6.32

1822

5495

Other systemic involvement of connective tissue (FG)

1196

3195

3.93

307.65

2.4

3.8

44.18

69.41

mg/l

0.86

982

2741

Other and unspecified iron deficiency

1687

5516

3.26

307.65

2.4

3.4

120.66

60.00

mg/l

0.77

1403

4668

Implicit Sepsis

3513

8314

3.29

307.65

3.6

3.2

87.97

53.83

mg/l

1.02

2963

7122

Liquid cancers, including Hilmo

2880

4987

5.83

307.65

10.6

1.5

138.22

46.25

mg/l

2.75

2581

4206

Disorders of mineral metabolism

653

1023

7.48

307.65

4.6

3.6

65.92

55.81

mg/l

0.45

544

873

First line medication for Crohn's disease

3859

7472

2.87

307.65

4.9

1.8

66.41

55.32

mg/l

0.34

3202

6429

Dyspnoea

3144

10561

2.22

307.65

3.5

3.4

104.05

53.80

mg/l

1.17

2609

9032

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1336

612

66.36

307.65

8.2

1.3

68.40

43.39

mg/l

7.08

1156

517

Other and unspecified anaemias

3488

6542

5.71

307.65

3.2

3.3

101.57

60.75

mg/l

1.01

2943

5556

Erysipelas, including avohilmo

2727

7980

2.63

307.65

2.8

3.1

62.25

68.21

mg/l

0.22

2307

6810

Glomerulonephritis

724

1244

6.81

307.65

3.2

3.7

80.70

53.63

mg/l

1.93

568

1074

Heart failure, strict

2972

7452

2.96

307.65

3.0

3.6

67.06

67.08

mg/l

0.00

2482

6367

Secondary hypertension

524

539

10.95

307.65

2.3

3.3

77.98

42.61

mg/l

7.74

399

475

Unspecified kidney failure

986

1388

8.66

307.65

3.4

3.2

87.54

40.08

mg/l

7.27

846

1184

Transplanted organ and tissue status

738

1084

8.02

307.65

8.4

3.5

122.21

49.46

mg/l

0.69

620

934

Renal failure

4728

6205

7.72

307.65

3.2

3.3

106.93

43.20

mg/l

4.01

3939

5285

Hypertension, essential

2245

4643

2.82

307.65

3.1

4.0

75.69

62.23

mg/l

0.20

1887

3988

Extracorporeal dialysis

576

807

9.05

307.65

3.4

3.7

109.30

56.04

mg/l

5.52

464

683

Iron deficiency anaemia

2061

7053

3.04

307.65

2.5

3.4

109.13

59.36

mg/l

0.77

1715

5975

All-cause Heart Failure

2909

7336

2.94

307.65

3.0

3.6

67.28

67.56

mg/l

0.01

2422

6271

Primary_lymphoid and hematopoietic malignant neoplasms

2321

3839

7.33

307.65

12.7

1.5

159.93

47.42

mg/l

2.72

2095

3207

Multiple myeloma and malignant plasma cell neoplasms

1230

723

46.58

307.65

21.6

1.7

242.52

45.74

mg/l

2.57

1156

617

Implicit viral Sepsis, including avohilmo

1406

4633

3.22

307.65

4.4

3.0

58.38

52.27

mg/l

0.92

1180

3933

ILD medications

4201

7638

3.08

307.65

4.9

2.0

74.43

55.41

mg/l

0.57

3484

6562

Type 2 diabetes, wide definition

2900

7810

2.43

307.65

2.5

4.0

78.93

61.90

mg/l

0.38

2409

6695

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

805

379

72.48

307.65

23.8

1.5

228.68

46.27

mg/l

1.98

748

322

Second line medication for Crohn's disease

2519

8145

3.26

307.65

9.5

2.1

54.08

61.40

mg/l

0.36

2149

6922

Gout

1660

3934

3.95

307.65

4.4

3.7

62.92

85.24

mg/l

0.69

1404

3348

Disorders resulting from impaired renal tubular function

396

463

11.45

307.65

2.3

3.7

87.53

61.26

mg/l

1.19

327

390

Liquid cancers

2700

4427

6.81

307.65

11.2

1.6

144.15

46.71

mg/l

2.74

2433

3729

Diseases of arteries, arterioles and capillaries (FINNGEN)

941

1310

5.26

307.65

2.9

3.7

56.80

73.23

mg/l

0.19

789

1158

Pneumonia, organism unspecified

3391

8907

2.71

307.65

4.6

2.8

71.07

58.85

mg/l

0.38

2851

7610

Oxycodone

1703

5264

2.91

307.65

7.4

2.8

95.15

71.36

mg/l

0.32

1453

4480

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3546

9417

2.59

307.65

4.6

2.9

68.71

58.79

mg/l

0.31

3001

8046

ILD medications: immunosuppressive drugs

3228

6853

4.56

307.65

7.9

2.0

67.92

54.71

mg/l

0.47

2723

5918

ILD medications: prednisolone, methylprednisolone, prednisone

3952

7626

2.99

307.65

3.0

2.0

76.89

55.46

mg/l

0.61

3240

6550

Heart failure and antihypertensive medication

1218

1395

6.15

307.65

3.2

4.4

63.27

43.58

mg/l

2.66

1000

1213

Fever of other and unknown origin

2698

5977

4.15

307.65

5.4

3.1

59.92

65.20

mg/l

0.21

2245

5094

Inflammatory bowel disease treatment related agents

3925

8997

2.50

307.65

2.9

3.6

65.96

65.11

mg/l

0.02

3224

7756

Infections, IBD-co-morbidities

672

540

9.35

307.65

5.8

4.1

62.54

49.88

mg/l

1.26

571

480

L04AD Calcineurin inhibitors

653

1133

6.53

307.65

3.2

4.1

133.05

53.66

mg/l

0.61

520

975

Other septicaemia

1906

5751

3.34

307.65

4.0

2.9

76.15

65.92

mg/l

0.42

1553

4868

Heart failure and coronary heart disease

2036

5748

2.63

302.88

2.7

3.6

71.50

66.93

mg/l

0.18

1671

4915

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

194

75.21

302.86

8.4

1.3

110.19

44.48

mg/l

4.40

180

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3008

8957

2.18

298.59

3.9

3.2

70.93

63.51

mg/l

0.18

2473

7731

Nephrotic syndrome

315

305

13.57

297.73

3.0

4.1

89.85

63.05

mg/l

0.51

255

266

Finngen Rheumatological endpoints

2703

6837

2.30

297.71

3.0

3.7

51.80

74.57

mg/l

1.15

2246

5854

Other diseases of blood and blood-forming organs, wide

1089

3329

3.54

293.44

4.3

3.4

55.23

69.43

mg/l

0.38

900

2831

Kidney transplant status

394

519

9.10

290.46

2.1

4.5

79.97

56.29

mg/l

1.25

305

442

Cardiovascular diseases (excluding rheumatic etc)

1226

2060

3.48

287.82

3.3

3.4

55.12

55.71

mg/l

0.01

1027

1800

Viral Sepsis

1026

3053

3.61

287.56

4.9

3.0

62.50

51.48

mg/l

1.92

854

2609

Implicit viral Sepsis

1024

3049

3.61

286.71

4.9

3.0

62.60

51.53

mg/l

1.92

852

2605

Diabetes, varying definitions

3016

8320

2.15

285.71

2.6

3.9

74.40

60.48

mg/l

0.31

2516

7124

Diabetes mellitus

3024

8319

2.15

285.29

2.6

3.9

74.28

60.49

mg/l

0.31

2525

7120

Valvular heart disease excluding rheumatic fever

1759

4869

2.69

281.19

3.4

3.5

56.58

64.99

mg/l

0.25

1435

4213

Disorders of lipoprotein metabolism and other lipidaemias

2682

7512

2.23

279.80

3.1

3.4

72.06

64.14

mg/l

0.15

2333

6348

Non-rheumatic valve diseases

1750

4860

2.68

277.50

3.4

3.5

56.68

65.05

mg/l

0.24

1427

4206

Pain in limb

2633

7743

2.22

274.22

3.3

3.6

84.41

61.95

mg/l

0.40

2263

6496

Non-ischemic cardiomyopathy

1455

4188

2.93

274.21

3.3

3.6

63.38

57.45

mg/l

0.32

1221

3606

Covid-19 confirmed case

1629

6411

2.67

274.08

4.4

3.1

61.58

65.34

mg/l

0.15

1375

5399

Type 2 diabetes

2964

8264

2.13

272.35

2.5

3.9

74.80

60.73

mg/l

0.31

2473

7075

Dental caries

1078

3187

3.37

272.20

6.0

2.8

70.54

71.15

mg/l

0.01

963

2693

Amyloidosis

294

302

13.93

270.20

11.6

3.7

61.60

66.41

mg/l

0.07

261

265

Preparatory care for dialysis

406

620

8.31

265.94

2.6

4.0

100.45

55.50

mg/l

4.10

388

522

Atrial fibrillation and flutter

904

1515

4.00

265.28

3.6

3.7

57.30

67.19

mg/l

0.12

743

1342

Abnormalities of breathing

2559

6702

2.24

265.22

3.4

3.3

75.42

52.60

mg/l

0.52

2134

5727

Asthma, unspecified (mode)

1676

4713

2.65

263.63

2.9

2.7

90.13

55.27

mg/l

0.50

1407

4064

Certain infectious and parasitic diseases

2657

6115

2.22

262.65

3.6

2.7

52.69

74.69

mg/l

0.88

2244

5201

Insulin medication

2165

8035

2.31

261.99

2.7

3.8

71.31

58.51

mg/l

1.06

1787

6858

Gout, idiopatic and unspecified

1320

4820

2.96

261.88

2.5

3.4

62.74

70.38

mg/l

0.29

1100

4082

Amyloidosis, other/unspecified

264

245

16.35

261.78

12.5

3.6

63.52

73.71

mg/l

0.14

237

210

Osteoporosis with pathological fracture (FG)

508

965

6.08

261.60

2.4

3.5

59.62

118.44

mg/l

0.51

392

822

Codeine

2550

6299

2.24

261.04

3.2

2.7

71.87

65.33

mg/l

0.11

2143

5367

Diabetic nephropathy

1001

3118

3.55

260.20

2.1

2.8

76.56

77.65

mg/l

0.02

844

2618

Other systemic involvement of connective tissue

1218

4266

3.03

258.55

2.5

3.5

43.93

65.05

mg/l

0.99

1000

3624

Caries of dentine

974

2885

3.45

255.67

6.0

2.8

67.33

73.44

mg/l

0.12

869

2429

Provisional assignment of new diseases of uncertain etiology

1918

8311

2.37

254.29

4.3

3.1

59.08

63.52

mg/l

0.21

1644

7014

Codes for special purposes

1919

8324

2.37

253.74

4.3

3.1

59.20

63.58

mg/l

0.21

1645

7025

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

452

463

7.34

253.32

2.7

4.3

54.10

53.89

mg/l

0.01

348

408

Disorders of other endocrine glands

1568

6196

2.59

250.80

3.1

3.3

50.82

65.03

mg/l

0.76

1264

5303

Autoimmune diseases

3193

8166

2.03

250.74

3.0

3.7

72.82

66.10

mg/l

0.14

2687

6991

Other soft tissue disorders, not elsewhere classified

2820

7818

2.10

250.03

3.4

3.5

82.99

62.10

mg/l

0.40

2430

6555

Other arthritis (FG)

1136

3883

3.06

249.87

3.0

3.7

51.31

64.98

mg/l

0.48

922

3329

Malignant immunoproliferative diseases

205

143

31.01

248.40

7.9

3.5

104.80

98.57

mg/l

0.05

192

121

Gout, unspecified

1107

3802

3.16

246.38

2.6

3.2

64.07

72.73

mg/l

0.26

918

3237

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2480

10493

2.13

245.97

3.2

3.5

67.78

67.67

mg/l

0.00

2107

8911

Disorders of parathyroid gland

1035

3391

3.25

243.14

2.8

3.3

52.47

68.30

mg/l

0.48

851

2884

Gout, strict definition

1031

3433

3.29

243.10

2.5

3.5

65.02

74.27

mg/l

0.25

851

2932

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2785

8217

2.06

236.66

2.5

3.9

79.68

60.97

mg/l

0.41

2317

7036

Atrial fibrillation and flutter with reimbursement

808

1324

4.02

235.39

3.5

3.7

54.79

72.14

mg/l

0.20

666

1175

Opioids

2570

6320

2.14

234.74

3.6

2.7

69.82

65.29

mg/l

0.07

2180

5386

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2202

8121

2.22

234.60

2.7

3.8

72.41

65.48

mg/l

0.32

1834

6937

Cerebrovascular diseases (FINNGEN)

820

1571

3.79

230.86

2.9

3.7

102.97

65.35

mg/l

0.29

702

1390

Hypertensive Renal Disease

327

457

8.68

229.80

2.2

4.0

76.30

60.57

mg/l

0.60

264

405

Used for control exclusion in common control thyroid runs

2948

7511

2.02

229.26

3.0

3.7

71.40

60.79

mg/l

0.23

2476

6405

Pure hypercholesterolaemia

2410

7352

2.14

229.09

3.0

3.4

71.28

64.89

mg/l

0.11

2171

6217

Autoimmune diseases related-to ILD

2615

11068

2.02

227.52

2.6

3.6

53.35

66.73

mg/l

0.91

2184

9471

Complications of surgical and medical care, not elsewhere classified

3091

10945

1.93

224.51

3.2

3.4

74.98

62.34

mg/l

0.33

2611

9308

Other CVD (FINNGEN)

507

761

5.47

223.14

3.9

3.5

51.58

41.01

mg/l

1.84

431

684

Other disorders of kidney and ureter

722

2033

3.92

222.84

2.8

3.5

89.84

79.71

mg/l

0.14

600

1737

Asthma, excluding more controls

1844

4030

2.40

218.16

2.8

2.7

77.27

52.98

mg/l

0.35

1556

3484

Reimbursement for rheumatic diseases

1916

8861

2.22

217.99

2.1

3.6

46.85

66.36

mg/l

1.45

1560

7591

Dialysis

282

352

9.53

217.14

3.2

3.6

100.69

34.61

mg/l

18.12

225

300

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

952

1847

3.33

216.38

3.5

3.7

53.56

59.42

mg/l

0.09

782

1627

Other specified/unspecified arthritis

1003

3486

3.02

214.34

3.0

3.7

50.27

67.59

mg/l

0.57

811

2988

Low back pain

2315

7618

2.10

214.17

3.7

3.1

68.19

56.16

mg/l

0.29

1956

6449

Symptoms and signs involving the urinary system

2570

9951

2.00

212.32

2.9

3.6

56.47

69.23

mg/l

0.74

2179

8452

Bleeding

2757

10132

1.96

211.08

2.8

3.6

96.55

58.03

mg/l

0.81

2301

8679

Type 2 diabetes, definitions combined

2737

8193

1.99

210.70

2.6

3.9

74.28

61.02

mg/l

0.26

2288

7015

Myelodysplastic syndrome, including Hilmo

287

387

9.36

209.68

2.6

1.4

48.89

48.12

mg/l

0.05

249

323

Type 2 diabetes, strict (exclude DM1)

2749

8265

1.98

209.04

2.7

3.9

74.28

60.90

mg/l

0.27

2298

7072

Diseases of arteries, arterioles and capillaries

2479

9270

2.03

208.93

2.6

3.6

63.08

67.49

mg/l

0.21

2081

7890

Insulin, combination of fast acting with intermediate-acting or long-acting

2166

9691

2.09

207.93

2.7

3.4

71.31

64.85

mg/l

0.35

1787

8253

Ulcer of lower limb, not elsewhere classified

799

2514

3.47

206.88

2.7

3.3

71.16

78.58

mg/l

0.13

669

2151

Examination and observation for other reasons

1754

4288

2.37

206.27

3.4

3.2

77.98

60.14

mg/l

0.35

1643

3316

Cardiac arrhythmias

1373

3454

2.61

205.21

3.6

4.0

50.76

52.47

mg/l

0.04

1129

3016

Asthma (only as main-diagnosis), excluding more controls

1703

4030

2.39

203.68

2.8

2.7

82.88

52.98

mg/l

0.42

1434

3484

Diabetes, insulin treatment (Kela reimbursement)

3013

9682

1.89

202.26

2.5

3.8

77.88

60.29

mg/l

0.43

2508

8272

Non-Hodgkin lymphoma, all, including Hilmo

674

1936

3.80

201.13

3.3

1.5

60.16

47.75

mg/l

2.22

581

1613

Spondylopathies

2485

7449

2.02

200.91

3.7

3.2

90.77

56.88

mg/l

0.64

2079

6309

Polyneuropathies and other disorders of the peripheral nervous system

1031

3797

2.91

200.55

4.0

3.3

74.67

72.59

mg/l

0.02

904

3220

Diseases of oesophagus, stomach and duodenum

3088

9941

1.87

200.43

3.1

3.5

68.36

58.74

mg/l

0.22

2650

8381

Symptoms and signs concerning food and fluid intake

525

1265

4.49

199.14

2.4

3.2

39.81

61.52

mg/l

2.63

453

1098

Cardiovascular diseases

989

1680

3.18

198.34

3.3

57.09

31.98

mg/l

2.86

829

1457

Coagulation defects, purpura and other haemorrhagic conditions

832

2736

3.24

197.64

3.5

3.3

109.30

73.31

mg/l

0.25

690

2351

Codeine or tramadol medication

3211

9658

1.84

194.42

3.3

66.99

66.47

mg/l

0.01

2712

8220

Syncope and collapse

1452

5219

2.40

191.83

3.0

3.2

50.43

69.04

mg/l

1.02

1209

4461

Type 2 diabetes, definitions combined, including avohilmo

2669

8141

1.94

190.65

2.6

3.9

74.24

55.35

mg/l

0.42

2232

6966

Other and unspecified polyneuropathies, also in other diseases

933

3361

2.99

189.70

3.5

3.3

76.87

75.34

mg/l

0.02

818

2852

Insulin, intermediate and long-acting

1932

9190

2.10

188.25

2.6

3.5

71.21

62.64

mg/l

0.51

1607

7826

Other medical care

1771

7027

2.19

187.95

5.1

3.0

130.26

59.24

mg/l

0.97

1413

5968

Diverticular disease of intestine

2392

7678

1.99

187.30

3.3

3.5

77.52

54.62

mg/l

0.51

2076

6482

Polymyalgia rheumatica

749

2414

3.40

186.92

2.4

3.4

44.43

79.28

mg/l

0.90

605

2050

Other disorders of skin and subcutaneous tissue

2418

10806

1.94

186.43

3.0

3.5

57.89

68.81

mg/l

0.66

2064

9165

Hyperparathyroidism

867

2990

3.07

186.18

2.8

3.2

55.51

70.70

mg/l

0.38

727

2534

Hyperkalaemia

400

839

5.44

183.86

3.1

3.4

215.41

57.73

mg/l

0.58

326

707

Genitourinary diseases

1344

2665

2.58

183.70

3.1

3.7

58.57

39.71

mg/l

3.35

1134

2268

Rheumatoid arthritis

1122

3915

2.64

182.80

2.2

3.8

48.52

78.96

mg/l

1.00

948

3349

Other diseases of intestines

2782

8383

1.88

182.09

3.2

3.4

72.10

52.78

mg/l

0.48

2351

7072

COPD/asthma related infections

2729

7289

1.91

181.76

4.4

2.6

54.48

60.94

mg/l

0.27

2295

6268

COPD/asthma/ILD related infections

2729

7289

1.91

181.76

4.4

2.6

54.48

60.94

mg/l

0.27

2295

6268

Endocrine, nutritional and metabolic diseases

1701

3822

2.29

180.97

3.3

3.8

46.15

62.78

mg/l

0.67

1436

3284

Asthma

1957

4808

2.14

178.77

2.9

2.7

75.26

54.98

mg/l

0.31

1651

4148

Diabetes medication

2881

9331

1.84

176.70

2.4

3.8

78.46

60.19

mg/l

0.43

2414

7975

Any reimbursement code in KELA

1017

1768

2.93

175.58

3.7

1.8

54.81

33.86

mg/l

2.29

867

1529

Hypertensive Heart Disease

953

2637

2.88

174.88

2.6

3.9

64.82

52.24

mg/l

1.18

819

2271

Purpura and other haemorrhagic conditions

628

1882

3.60

174.77

3.4

3.5

130.16

85.00

mg/l

0.23

515

1616

Persons encountering health services in other circumstances, wide

3250

9559

1.78

174.22

3.2

3.4

66.91

66.68

mg/l

0.01

2762

8097

Asthma (mode)

1925

4850

2.13

173.74

3.0

2.7

79.15

54.82

mg/l

0.38

1641

4190

Certain disorders involving the immune mechanism

760

2575

3.14

171.44

3.8

3.3

63.97

70.86

mg/l

0.12

615

2195

Malignant neoplasm

2288

6979

1.96

170.38

6.2

1.5

79.09

43.84

mg/l

0.87

1972

5872

Complications of medical and surgical care

2314

11216

1.90

170.08

3.4

77.86

63.31

mg/l

0.30

1998

9499

Malignant neoplasm, including Hilmo

2294

6966

1.96

169.93

5.9

1.5

79.05

43.82

mg/l

0.88

1977

5856

Hypothyroidism (congenital or acquired)

376

344

6.23

168.99

4.3

1.5

40.99

28.42

mg/l

2.85

320

297

Pain in throat and chest

2192

6680

1.98

168.75

3.3

52.90

52.70

mg/l

0.01

1867

5709

Enlarged lymph nodes

587

1718

3.60

167.75

2.2

3.2

52.59

57.79

mg/l

0.40

499

1468

Anaemia in chronic diseases classified elsewhere

217

274

9.96

167.36

2.0

3.9

90.79

73.36

mg/l

0.34

155

238

Isolated proteinuria

225

296

9.27

166.81

5.1

3.8

79.19

68.51

mg/l

0.17

199

256

Malignant neoplasm

2279

6999

1.95

166.40

6.2

1.5

79.38

43.80

mg/l

0.88

1964

5890

Cardiomyopathy

707

2335

3.21

166.37

4.1

3.3

50.35

69.54

mg/l

0.40

610

2021

Percutaneous Coronary Intervention

2394

7805

1.91

165.95

2.9

3.7

76.21

63.07

mg/l

0.22

1986

6740

Other disorders involving the immune mechanism, not elsewhere classified

233

320

8.70

165.87

3.6

3.9

71.51

67.01

mg/l

0.08

189

267

Acquired haemolytic anaemia

225

303

9.44

164.88

3.3

3.9

51.57

69.90

mg/l

0.40

198

259

Pain, not elsewhere classified

866

3204

2.80

163.77

3.7

3.2

47.55

53.82

mg/l

0.76

759

2735

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3107

9521

1.77

163.48

3.2

3.4

65.73

66.70

mg/l

0.02

2752

8069

Chronic nephritic syndrome

272

448

7.17

163.39

2.8

4.0

86.69

57.62

mg/l

0.71

198

385

Malignant neoplasm, wide definition

2290

7040

1.93

163.33

5.9

1.5

79.34

43.76

mg/l

0.89

1972

5921

Asthma (only as main-diagnosis)

1789

4808

2.12

163.31

2.8

2.7

85.83

54.98

mg/l

0.47

1509

4148

Hypothyroidism and >3 levothyroxin purchases

368

343

6.12

162.99

4.2

1.5

40.07

28.42

mg/l

2.54

313

297

Hypothyroidism, levothyroxine purchases

368

343

6.12

162.99

4.2

1.5

40.07

28.42

mg/l

2.54

313

297

Diarrhoea and gastroenteritis of presumed infectious origin

2045

9634

1.94

160.10

4.1

3.0

55.46

60.74

mg/l

0.35

1714

8159

Intestinal infectious diseases

2690

11368

1.79

160.07

4.4

3.1

57.20

66.81

mg/l

0.61

2285

9646

ILD medications: azathioprine

473

1239

4.01

158.99

2.1

1.9

56.39

51.16

mg/l

0.34

397

1056

Coronary revascularization (ANGIO or CABG)

2368

7807

1.89

157.94

2.9

3.7

75.26

63.06

mg/l

0.20

1968

6742

Medical observation and evaluation for suspected diseases and conditions

1760

4318

2.13

157.60

3.4

3.2

50.11

60.11

mg/l

0.65

1607

3339

Antihypertensive medication - note that there are other indications

989

1903

2.76

155.99

3.1

3.9

58.47

38.50

mg/l

1.73

833

1648

Insulin, fast-acting

1233

5513

2.32

155.55

2.5

3.4

69.25

60.69

mg/l

0.39

1019

4678

Dorsalgia

2612

7696

1.83

154.94

3.6

3.1

52.81

56.11

mg/l

0.36

2214

6512

Hypo-osmolality and hyponatraemia

756

2681

2.97

154.56

3.1

3.2

63.52

62.23

mg/l

0.03

600

2258

Ischemic heart diseases

2420

7926

1.86

153.81

3.2

3.7

78.37

62.62

mg/l

0.28

1996

6841

Haemolytic anaemias

251

407

7.30

153.20

3.2

3.7

49.47

62.85

mg/l

0.37

220

349

Emergency coronary revascularization (for ACS)

2615

8922

1.81

152.90

2.9

3.7

77.35

64.22

mg/l

0.25

2172

7643

Hyperlipidaemia, other/unspecified

1393

5885

2.21

152.58

3.3

3.4

64.94

63.45

mg/l

0.05

1137

4958

Excluding asthma or asthma-COPD overlap

1927

4851

2.03

151.92

3.8

2.7

80.13

54.74

mg/l

0.40

1636

4182

Lower back pain or/and sciatica

3025

11102

1.72

151.81

3.6

3.3

72.00

62.73

mg/l

0.21

2582

9402

Hard cardiovascular diseases

2352

7615

1.87

150.96

3.2

3.8

78.18

57.43

mg/l

0.40

1951

6550

Other pulmonary diagnosis

1920

4851

2.02

149.88

3.8

2.7

81.18

54.74

mg/l

0.42

1625

4182

Paroxysmal tachycardia

542

1295

3.59

149.72

3.1

3.6

55.38

72.12

mg/l

0.18

441

1143

Other necrotizing vasculopathies (FG)

340

737

5.17

149.63

1.8

4.2

48.91

128.06

mg/l

0.56

280

635

Disorders of thyroid, IBD co-morbidities

386

555

4.89

149.34

2.7

4.0

42.00

48.63

mg/l

0.60

330

494

Presence of other functional implants

2027

7375

1.94

148.90

3.2

3.3

57.57

69.73

mg/l

0.56

1470

6383

Explicit bacterial Sepsis, including avohilmo

498

1424

3.76

148.80

6.1

3.1

70.31

56.38

mg/l

1.08

426

1241

Parasetamol

1597

3805

2.16

148.55

3.5

3.0

46.36

55.32

mg/l

2.01

1343

3264

Other abnormal findings of blood chemistry

285

534

6.06

148.51

4.2

3.9

46.32

57.02

mg/l

0.54

256

454

Explicit bacterial Sepsis

490

1394

3.78

147.58

6.0

3.1

69.69

56.59

mg/l

0.96

418

1212

Certain infectious and parasitic diseases, including avohilmo

1787

4430

2.06

146.82

3.5

2.6

52.68

85.65

mg/l

0.97

1516

3738

Cardiomyopathy in other diseases

108

35.92

146.73

12.8

2.5

37.20

51.09

mg/l

0.82

Other dialysis

236

380

7.54

145.93

2.8

4.2

97.01

68.58

mg/l

0.94

192

321

Exposure to unspecified factor

2833

11359

1.73

145.67

3.3

3.4

92.42

58.28

mg/l

0.72

2285

9758

Disorders of lens

2041

6735

1.93

145.62

3.6

3.5

100.77

56.94

mg/l

0.68

1683

5797

COPD differential diagnosis

1902

4853

2.00

144.56

3.8

2.7

80.29

54.83

mg/l

0.40

1612

4193

ILD differential diagnosis

1901

4850

2.00

144.49

3.8

2.7

80.33

54.82

mg/l

0.40

1611

4190

Major coronary heart disease event

2495

8462

1.80

143.99

2.9

3.7

77.75

63.09

mg/l

0.27

2070

7273

Fall on same level

2951

9284

1.72

143.01

3.0

3.6

70.12

60.61

mg/l

0.20

2500

7905

Continuous positive airway pressure

593

1564

3.29

142.03

2.9

4.1

70.69

41.17

mg/l

1.96

553

1377

Other necrotizing vasculopathies

412

1082

4.26

141.57

2.0

3.8

48.25

59.23

mg/l

0.85

347

925

Abnormal findings on diagnostic imaging of lung

1769

8859

1.96

141.13

3.0

3.5

77.87

62.88

mg/l

0.27

1506

7508

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

207

299

8.19

140.73

3.1

3.9

67.26

69.45

mg/l

0.04

169

248

Hypothyroidism, drug reimbursement

254

260

7.00

140.34

4.0

1.5

46.68

29.57

mg/l

2.58

208

226

Streptococcal septicaemia

434

1182

3.99

140.00

5.9

3.2

71.10

97.40

mg/l

0.25

366

1020

Complications of procedures, not elsewhere classified

2343

10776

1.79

139.78

3.0

3.5

82.44

62.73

mg/l

0.43

1984

9164

Fracture of lumbar spine and pelvis

956

4025

2.50

139.46

3.0

3.2

99.90

70.97

mg/l

0.27

796

3405

Streptococcal septicaemia, including avohilmo

441

1221

3.92

138.84

6.0

3.2

71.00

98.59

mg/l

0.27

373

1056

Haemorrhage from respiratory passages

1223

5012

2.24

138.46

2.8

3.3

107.52

57.95

mg/l

0.56

1018

4260

Insulin, fast-acting or short human

1235

5810

2.20

137.31

2.5

3.4

69.31

61.72

mg/l

0.35

1021

4929

Non-invasive ventilation

643

1886

3.03

137.04

3.7

4.3

50.46

64.09

mg/l

0.24

587

1664

Abnormal findings on examination of urine, without diagnosis

280

558

5.76

136.86

4.8

3.5

74.50

59.12

mg/l

0.44

241

488

Other (not insulin) diabetes medications

2685

9240

1.74

136.63

2.5

3.8

79.59

60.60

mg/l

0.42

2251

7895

Constipation

2628

10511

1.73

134.85

3.8

3.3

72.31

64.29

mg/l

0.14

2183

8983

Thrombocytopenia, unspecified

389

1014

4.25

134.51

3.0

3.5

180.60

55.38

mg/l

0.47

311

862

Depression medications

365

353

5.28

133.81

2.7

1.5

41.08

28.05

mg/l

2.68

303

306

Seropositive rheumatoid arthritis

811

3208

2.62

133.15

2.1

3.9

49.08

84.31

mg/l

0.92

704

2743

Postmenopausal osteoporosis with pathological fracture

392

1051

4.21

131.33

2.6

3.1

56.09

97.89

mg/l

0.38

304

917

Unspecified haematuria

1527

6354

2.02

131.01

2.9

3.5

66.95

70.83

mg/l

0.12

1278

5379

Other diseases of pleura

1681

7773

1.94

129.81

3.0

3.3

80.19

64.47

mg/l

0.37

1360

6607

Other arrhythmias

1588

6108

1.98

128.92

3.2

3.5

78.01

59.10

mg/l

0.28

1318

5285

Neoplasms

1502

3858

2.07

128.09

4.4

1.4

53.52

43.01

mg/l

1.38

1284

3174

Spinal stenosis

1716

6726

1.94

127.88

3.1

3.2

72.50

58.99

mg/l

0.24

1502

5693

Other autoimmune haemolytic anaemias

147

163

12.77

127.86

2.4

3.7

54.99

91.23

mg/l

0.44

130

137

Azathioprine

473

1435

3.46

127.64

2.1

3.9

56.39

52.57

mg/l

0.26

397

1230

Diseases of the digestive system

1575

8237

1.96

127.54

2.8

3.4

130.61

55.48

mg/l

0.95

1302

6982

Intestinal infectious diseases, including avohilmo, including avohilmo

3135

10823

1.64

127.54

4.2

3.1

54.48

68.21

mg/l

0.96

2681

9174

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

662

1090

3.10

125.43

3.4

3.2

65.40

42.13

mg/l

1.34

556

938

Abnormal weight loss

462

1420

3.54

124.35

2.4

3.4

40.14

92.94

mg/l

0.78

395

1209

Weight loss

483

1525

3.43

124.16

2.4

3.5

39.63

92.15

mg/l

0.85

414

1301

Viral pneumonia

511

1660

3.26

123.94

6.7

2.6

81.37

82.26

mg/l

0.01

418

1433

Disorders of choroid and retina

2494

10454

1.71

122.64

3.0

3.5

56.12

69.36

mg/l

0.87

2099

8929

Iron deficiency anaemia secondary to blood loss (chronic)

665

2515

2.80

122.41

2.6

3.4

146.16

55.99

mg/l

0.55

549

2157

Symptoms and signs involving the circulatory and respiratory systems

2329

6706

1.77

122.00

3.2

3.3

77.73

52.58

mg/l

0.54

1974

5730

Headache

1479

5866

1.98

121.74

2.9

3.1

42.13

63.71

mg/l

1.52

1283

4990

Other specific joint derangements/joint disorders

1714

5677

1.91

121.71

3.0

3.7

43.21

76.63

mg/l

1.64

1484

4862

STROKE

1462

4994

2.02

121.66

3.3

4.1

80.91

60.17

mg/l

0.31

1264

4317

Senile cataract

1910

6410

1.86

121.33

3.7

3.5

103.70

57.88

mg/l

0.66

1580

5518

3067

9688

1.63

119.62

4.8

2.9

74.41

64.46

mg/l

0.26

2565

8284

Type 1 diabetes

695

2695

2.66

119.44

2.1

3.6

68.72

49.84

mg/l

3.79

579

2284

Symptoms and signs involving cognition, perception, emotional state and behaviour

2629

10714

1.67

118.65

3.0

3.5

64.11

60.63

mg/l

0.08

2298

9023

Diseases of the skin and subcutaneous tissue

2507

7445

1.72

118.63

3.1

3.4

75.70

60.63

mg/l

0.29

2120

6311

Injuries to the abdomen, lower back, lumbar spine and pelvis

1334

6725

2.01

117.72

3.2

83.80

66.22

mg/l

0.23

1122

5682

Implicit fungal Sepsis, including avohilmo

347

915

4.14

117.53

3.9

3.2

69.83

54.01

mg/l

0.77

289

799

IgA nephropathy (IgA glomerulonephritis)

175

258

8.14

117.22

2.1

3.7

70.79

74.02

mg/l

0.05

143

216

All influenza

844

3624

2.41

117.19

7.3

2.6

66.23

65.18

mg/l

0.02

713

3077

Isolated proteinuria with specified morphological lesion

125

124

13.81

117.05

3.8

4.0

69.86

83.87

mg/l

0.11

107

Bacterial pneumoniae

1296

5733

2.04

116.82

4.8

2.7

91.25

61.50

mg/l

0.45

1161

4896

Primary hyperparathyroidism

511

1731

3.19

116.71

3.1

3.4

39.58

85.51

mg/l

0.85

439

1491

Benign neoplasm of colon, rectum, anus and anal canal

2108

10497

1.74

114.65

3.1

3.5

84.59

65.20

mg/l

0.39

1878

8852

Non-follicular lymphoma

472

1551

3.32

114.08

2.8

3.6

57.36

56.37

mg/l

0.05

401

1315

Biguanides

2597

9583

1.66

113.99

2.4

3.8

78.12

60.83

mg/l

0.36

2176

8176

Other dorsopathies, not elsewhere classified

2478

7698

1.70

113.75

3.5

3.1

52.76

56.10

mg/l

0.35

2139

6513

Hernia of abdominal wall, postoperative

531

1831

2.98

113.13

3.2

3.0

55.98

48.11

mg/l

0.89

457

1626

Other retinal disorders

2096

9351

1.74

112.94

2.8

3.5

61.89

68.61

mg/l

0.33

1746

7975

Other disorders of urethra and urinary system

1975

7888

1.78

112.59

3.2

3.4

50.28

71.06

mg/l

1.36

1653

6699

Volume depletion

434

1359

3.42

112.54

2.5

3.3

59.21

58.58

mg/l

0.03

328

1150

Asthma, hospital admission 2, infections

1694

9236

1.83

112.22

3.2

3.4

62.09

60.03

mg/l

0.08

1425

7829

Asthma-related infections

1694

9236

1.83

112.22

3.2

3.4

62.09

60.03

mg/l

0.08

1425

7829

Other bacterial intestinal infections

689

2763

2.62

112.13

5.0

2.9

66.87

75.92

mg/l

0.18

592

2346

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1840

10355

1.78

111.96

3.2

3.4

83.93

64.78

mg/l

0.32

1580

8775

Other nutritional deficiencies

1757

9071

1.80

110.86

2.4

3.6

55.16

58.22

mg/l

0.15

1430

7760

Diseases of liver

1139

5648

2.09

110.50

2.3

3.5

58.97

61.73

mg/l

0.10

938

4803

Conduction disorders

971

3569

2.25

110.33

2.8

3.3

56.98

60.47

mg/l

0.08

808

3093

Presence of cardiac and vascular implants and grafts

1547

6147

1.91

110.31

2.4

3.3

60.88

68.20

mg/l

0.29

1395

5301

Infections of the skin and subcutaneous tissue

1614

8803

1.84

110.24

3.4

60.68

60.97

mg/l

0.01

1383

7453

Type 1 diabetes, wide definition, subgroup 1

553

1992

2.87

109.99

2.1

3.8

67.22

48.58

mg/l

3.82

459

1696

Any event in cancer register

2204

7590

1.72

109.63

5.5

2.0

79.16

45.27

mg/l

0.78

1888

6419

Other diseases of urinary system

2605

9019

1.65

108.51

3.1

3.5

50.43

72.50

mg/l

1.56

2195

7670

Acute myeloid leukaemia and myelodysplastic syndromes

176

284

7.35

108.13

1.9

1.4

52.15

45.30

mg/l

0.41

155

241

Coxarthrosis [arthrosis of hip](FG)

1577

5897

1.88

107.84

3.0

3.8

47.20

81.01

mg/l

1.74

1338

5065

Hypokalaemia

477

1621

3.12

107.20

2.6

3.3

61.41

52.68

mg/l

0.35

401

1372

Bacterial pneumonia, not elsewhere classified

1220

5454

2.02

106.86

4.6

2.7

93.18

62.57

mg/l

0.44

1107

4650

Peripheral artery disease

1601

7019

1.86

106.55

2.3

3.5

66.00

69.32

mg/l

0.14

1352

5968

Other functional intestinal disorders

1353

6493

1.94

106.52

3.7

3.4

101.98

56.66

mg/l

0.58

1152

5477

AV-block

690

2392

2.58

105.76

2.9

3.2

61.36

70.35

mg/l

0.15

578

2064

Enterocolitis due to Clostridium difficile

482

1669

3.09

105.38

5.2

3.2

73.28

91.70

mg/l

0.23

409

1420

Asthma (diagnoses ohter than nonallergic)

2337

11631

1.65

104.90

2.6

3.5

83.00

61.49

mg/l

0.42

1983

9874

Adjustment and management of implanted device

738

3159

2.46

104.58

3.3

2.8

77.19

54.37

mg/l

0.87

576

2673

Ischaemic heart disease, wide definition

2256

8398

1.69

104.34

3.0

3.7

79.42

63.29

mg/l

0.27

1880

7215

Rheumatoid arthritis, including avohilmo

1209

6250

2.00

104.11

2.2

3.5

47.46

60.39

mg/l

0.81

1017

5292

Myelodysplastic syndrome

128

153

10.87

103.81

2.3

1.3

59.45

52.71

mg/l

0.27

114

127

Other bacterial intestinal infections, including avohilmo

796

3526

2.34

103.22

4.8

2.9

63.96

69.26

mg/l

0.13

689

2985

Coronary atherosclerosis

1936

7123

1.75

102.99

3.0

3.7

82.89

66.08

mg/l

0.24

1611

6142

Nausea and vomiting

885

3994

2.23

102.20

3.5

3.3

69.96

59.98

mg/l

0.33

746

3385

Neurological diseases, wide definition

429

607

3.60

101.77

3.1

3.8

43.47

47.10

mg/l

0.32

363

539

COPD (mode)

977

3611

2.18

101.74

2.1

2.7

101.71

47.57

mg/l

0.66

801

3107

Other diseases of the digestive system

1163

5992

2.01

101.52

2.7

3.3

157.42

57.31

mg/l

0.94

967

5066

Obesity due to excess calories

1227

6426

1.95

100.73

2.3

3.7

54.38

56.84

mg/l

0.11

991

5514

Dermatitis

1784

10233

1.74

100.25

3.1

3.5

54.74

68.42

mg/l

0.86

1468

8731

Venous thromboembolism

1737

9752

1.76

100.18

4.2

3.2

57.76

72.37

mg/l

0.85

1447

8310

Bacterial intestinal infections, IBD co-morbidities

689

2914

2.48

100.00

5.1

3.1

68.84

73.61

mg/l

0.09

591

2479

GI-bleeding

1160

6011

2.00

99.50

2.7

3.3

158.75

57.43

mg/l

0.95

962

5080

Non-Hodgkin lymphoma, all

252

599

4.70

99.08

3.6

1.6

68.36

48.51

mg/l

2.12

212

506

Polyarthrosis

709

2717

2.45

98.90

2.8

3.9

44.09

91.14

mg/l

1.11

591

2326

Disorders of gallbladder, biliary tract and pancreas

2692

10716

1.59

98.76

3.4

62.40

59.12

mg/l

0.16

2284

9110

Asthma-related pneumonia

1208

6343

1.95

98.10

3.3

62.90

54.30

mg/l

0.64

1022

5342

Other diseases of blood and blood-forming organs

327

939

3.80

98.01

4.5

3.7

50.88

60.48

mg/l

0.50

291

803

Asthma-related pneumonia or sepsis

1208

6348

1.95

97.85

3.3

62.90

54.28

mg/l

0.64

1022

5346

Asthma, hospital admissions 3, pneumonia

1208

6348

1.95

97.85

3.3

62.90

54.28

mg/l

0.64

1022

5346

Other diseases of pericardium

224

493

5.01

96.50

2.7

3.4

56.85

150.34

mg/l

0.41

184

424

Other acute lower respiratory infections

1534

8296

1.80

96.30

4.8

3.0

90.80

60.39

mg/l

0.53

1271

7010

Bronchitis

2846

11101

1.56

96.12

5.1

2.9

76.41

62.33

mg/l

0.38

2363

9493

Diabetic retinopathy, excluding more controls

926

2391

2.26

96.10

2.3

2.8

69.04

51.54

mg/l

1.92

755

2025

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2611

10565

1.59

95.75

3.4

52.08

69.32

mg/l

1.32

2171

9012

Spondylosis

1591

7092

1.79

95.30

2.9

3.2

132.51

56.70

mg/l

0.84

1268

6004

Care involving use of rehabilitation procedures

1643

8569

1.76

94.59

3.2

3.1

54.70

54.41

mg/l

0.01

1448

7277

Diseases of the musculoskeletal system and connective tissue

1012

2388

2.15

94.46

3.6

3.3

57.48

53.16

mg/l

0.24

868

2046

Other cataract

1361

5509

1.88

94.43

3.5

3.4

52.59

60.77

mg/l

0.43

1124

4739

Other and unspecified dermatitis

1505

8577

1.79

94.24

3.1

3.5

55.31

66.20

mg/l

0.57

1251

7321

Other special examinations and investigations of persons without complaint or reported diagnosis

1548

4319

1.84

93.80

3.4

3.2

90.42

60.13

mg/l

0.41

1345

3340

Other and unspecified diseases of blood and blood-forming organs

177

330

6.27

93.67

5.9

3.8

60.56

65.81

mg/l

0.10

162

288

Major coronary heart disease event excluding revascularizations

1855

7267

1.72

93.66

2.9

3.7

93.04

67.66

mg/l

0.38

1557

6246

Obesity

1602

8735

1.76

93.41

2.3

3.6

53.54

58.64

mg/l

0.28

1314

7461

Pain in joint

1464

4953

1.85

93.19

3.1

3.3

46.17

62.42

mg/l

0.92

1283

4155

Obesity and other hyperalimentation

1609

8786

1.75

92.83

2.3

3.6

54.14

58.56

mg/l

0.23

1320

7506

Renal tubulo-interstitial disorders in diseases classified elsewhere

14.72

92.81

9.9

4.4

457.88

38.84

mg/l

0.67

Type 1 diabetes, wide definition

563

2231

2.60

92.67

2.1

3.6

67.02

50.93

mg/l

2.59

467

1896

Bacterial pneumonia (organism specified)

1425

7250

1.83

92.56

5.1

3.1

89.15

64.02

mg/l

0.41

1263

6079

Atherosclerosis, excluding cerebral and coronary sclerosis

1500

6712

1.81

91.56

2.2

3.5

68.80

70.58

mg/l

0.06

1261

5711

Gastrointestinal diseases

1129

2821

2.03

90.87

3.7

3.0

52.19

41.64

mg/l

1.11

967

2358

Pleural effusion

648

2794

2.45

90.73

2.9

3.2

66.90

80.39

mg/l

0.30

520

2394

Injuries to the hip and thigh

1572

8193

1.76

90.59

2.8

3.3

69.37

64.69

mg/l

0.09

1338

6913

Use of hypnotics and sedatives

2745

10236

1.55

90.58

4.0

3.2

68.53

60.59

mg/l

0.19

2334

8686

Other disorders of white blood cells

266

702

4.17

90.45

2.6

3.7

46.38

56.74

mg/l

0.52

213

602

Other/unspecified dorsalgia

1025

5179

2.00

90.10

4.2

3.1

50.39

54.90

mg/l

0.30

860

4366

Idiopathic gout

436

1565

3.00

89.86

2.4

3.4

60.48

89.67

mg/l

0.40

365

1331

Chronic periodontitis, including avohilmo

2650

11040

1.55

89.26

3.6

3.4

47.70

69.41

mg/l

2.05

2289

9351

DVT of lower extremities and pulmonary embolism

1386

7819

1.82

89.26

4.6

3.2

59.45

65.08

mg/l

0.26

1144

6622

Intracranial trauma

1306

4788

1.87

88.69

3.4

3.6

49.37

73.41

mg/l

0.93

1070

4091

Osteomyelitis

295

845

3.79

88.65

2.9

3.5

65.24

58.53

mg/l

0.37

244

717

Periodontitis

2648

11036

1.55

88.56

3.7

3.3

47.72

69.41

mg/l

2.05

2288

9347

Arthropathies

1937

5851

1.69

88.47

3.0

3.6

50.55

77.76

mg/l

1.20

1642

5006

Vocal cord dysfunction

296

720

3.72

88.35

3.5

4.7

47.40

105.31

mg/l

0.45

246

649

Gonarthrosis [arthrosis of knee](FG)

1863

6413

1.70

87.95

3.2

3.8

52.09

77.27

mg/l

1.20

1568

5502

Nerve, nerve root and plexus disorders

2791

11075

1.53

87.85

3.2

3.4

52.45

68.40

mg/l

1.15

2384

9378

Chronic lower respiratory diseases

2961

10367

1.52

87.84

2.8

3.6

83.87

57.77

mg/l

0.55

2471

8849

Marginal zone B-cell lymphoma, including Hilmo

127

183

8.51

87.31

2.2

1.4

52.11

44.12

mg/l

0.42

111

154

Sulfasalazine

751

3476

2.22

86.92

2.1

3.7

50.27

51.18

mg/l

0.05

621

2997

Fungal Sepsis

223

533

4.64

86.89

4.7

3.3

70.74

54.87

mg/l

0.58

188

465

Chronic apical periodontitis

2816

10464

1.53

86.12

3.7

3.2

50.26

70.02

mg/l

1.63

2345

8923

Cytomegalovirus infection, IBD co-morbidity

144

238

7.03

86.10

7.7

3.7

72.50

72.03

mg/l

0.01

120

207

ILD, hospital admission 2, with pulmonary infections

415

1480

2.99

85.98

3.0

2.4

76.87

94.06

mg/l

0.17

315

1276

Calcific aortic valvular stenosis, including rheumatic fever

1152

6025

1.91

85.24

2.9

3.2

69.01

74.09

mg/l

0.18

963

5076

Calcific aortic valvular stenosis

1149

6012

1.91

85.23

2.9

3.2

69.04

74.21

mg/l

0.18

961

5062

Calcific aortic valvular stenosis, operated

1149

6012

1.91

85.23

2.9

3.2

69.04

74.21

mg/l

0.18

961

5062

Calcific aortic valvular stenosis, diagnosis (helper)

1148

6008

1.91

85.09

2.9

3.2

69.08

74.23

mg/l

0.18

960

5059

Operations 2 for CAVS

1148

6008

1.91

85.09

2.9

3.2

69.08

74.23

mg/l

0.18

960

5059

Dorsopathies

2387

7700

1.59

84.93

3.4

3.1

72.09

56.09

mg/l

0.32

2045

6515

Osteopathy in diseases classified elsewhere

14.53

84.62

21.1

5.1

63.34

108.75

mg/l

0.28

Gastro-oesophageal reflux disease

1836

9522

1.65

84.11

3.0

3.6

51.22

59.12

mg/l

0.53

1588

8038

Spondylopathies in diseases classified elsewhere

113

150

9.54

83.91

23.9

2.7

70.34

99.81

mg/l

0.29

104

126

Fracture of femur

1015

4779

1.98

83.73

2.8

3.1

82.63

71.65

mg/l

0.14

858

4025

Cytomegaloviral disease

144

245

6.78

83.51

7.7

3.5

72.50

72.57

mg/l

0.00

120

213

Myocardial infarction

1517

6170

1.76

83.49

2.8

3.7

104.89

62.57

mg/l

0.58

1256

5315

Cytomegaloviral disease, including avohilmo

144

246

6.73

83.12

7.7

3.5

72.50

72.28

mg/l

0.00

120

214

General examination and investigation of persons without complaint and reported diagnosis

1472

4314

1.80

83.01

3.4

3.2

50.76

60.11

mg/l

0.57

1346

3337

Injuries to the head

2793

11075

1.51

82.90

3.2

3.4

52.51

67.75

mg/l

1.16

2336

9455

Implicit fungal Sepsis

207

485

4.74

82.82

5.0

3.3

69.69

56.55

mg/l

0.41

174

427

Soft tissue disorders

2384

7839

1.58

82.27

3.0

3.5

75.24

62.07

mg/l

0.24

2055

6572

Persons encountering health services in other circumstances

1075

5699

1.91

82.21

3.5

3.4

99.21

60.90

mg/l

0.38

768

4826

Coxarthrosis

1412

5187

1.79

82.03

2.9

3.8

47.10

83.48

mg/l

1.62

1201

4453

Diabetic maculopathy, excluding more controls

372

1277

3.07

82.02

1.9

3.9

70.10

57.47

mg/l

0.98

300

1095

Agranulocytosis

413

1505

2.91

81.96

5.7

3.7

63.98

89.26

mg/l

0.28

325

1288

Seronegative rheumatoid arthritis

392

1387

2.97

81.78

2.6

4.0

43.86

90.87

mg/l

0.64

314

1176

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2566

10880

1.53

81.48

3.9

3.1

51.96

67.91

mg/l

1.22

2169

9229

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1661

10100

1.67

81.26

3.0

3.4

86.88

61.06

mg/l

0.42

1421

8580

Other/unspecified cytomegaloviral diseases

129

203

7.47

81.09

8.4

4.0

75.50

78.14

mg/l

0.03

108

176

Sleep apnoea

2498

10370

1.54

80.82

2.9

3.6

50.40

66.59

mg/l

1.22

1999

8950

Dizziness and giddiness

2039

10080

1.60

80.31

3.0

3.6

74.52

61.88

mg/l

0.26

1787

8489

Pacemaker

1322

7079

1.79

80.02

2.8

3.3

67.07

70.44

mg/l

0.11

1063

6027

Benign neoplasm: Colon

1752

10192

1.65

79.87

3.1

3.5

64.90

70.64

mg/l

0.22

1573

8588

Any death

1956

8632

1.62

78.94

4.3

3.4

132.47

50.24

mg/l

1.44

1582

7469

Other antidepressants

2615

8841

1.53

78.67

3.0

3.6

70.26

62.42

mg/l

0.18

2192

7552

Cough

1072

5415

1.89

78.64

3.4

58.10

53.95

mg/l

0.17

926

4629

Amputation

450

1758

2.73

78.32

2.5

3.4

81.68

89.01

mg/l

0.08

377

1501

Diseases of the respiratory system

1467

4217

1.77

77.72

3.9

2.7

92.44

55.30

mg/l

0.47

1234

3640

Other respiratory diseases principally affecting the interstitium

702

3332

2.21

77.70

3.0

3.2

72.54

75.48

mg/l

0.05

546

2853

Fibrosis and cirrhosis of liver

341

1158

3.17

77.67

1.7

3.8

67.01

102.82

mg/l

0.35

289

989

Symptoms and signs involving the skin and subcutaneous tissue

1910

11465

1.60

77.53

3.7

3.3

79.51

62.98

mg/l

0.25

1686

9677

Pain (limb, back, neck, head abdominally)

1717

5164

1.69

77.39

3.5

3.2

86.36

63.79

mg/l

0.31

1479

4329

Disorders of continuity of bone

314

1012

3.25

77.11

4.3

3.3

53.25

103.29

mg/l

0.45

268

877

Drug-induced osteoporosis with pathological fracture

133

230

7.10

77.09

2.0

4.3

65.74

71.75

mg/l

0.05

103

199

Dermatitis and eczema

2813

11323

1.49

76.84

3.0

3.4

56.68

66.97

mg/l

0.61

2359

9649

1126

6202

1.84

76.81

3.6

3.4

68.04

50.74

mg/l

0.92

938

5250

Other abnormalities of plasma proteins

121

190

7.70

76.72

5.4

4.6

47.70

52.50

mg/l

0.23

162

Malignant neoplasm of bone and articular cartilage, including Hilmo

116

173

7.77

76.42

10.4

1.3

40.22

45.71

mg/l

0.39

101

148

Hernia

2377

10461

1.53

75.55

3.4

3.3

52.12

67.89

mg/l

1.10

2063

8820

Hydronephrosis

366

1302

2.94

75.50

2.3

3.4

58.32

40.33

mg/l

4.37

289

1129

Chronic tubulo-interstitial nephritis

166

349

5.20

75.39

2.5

3.5

107.12

35.44

mg/l

2.48

140

305

Acute bronchitis

1181

6597

1.79

74.10

5.0

3.1

102.20

62.30

mg/l

0.53

967

5567

Arthrosis

1689

5630

1.67

74.05

2.9

3.7

49.82

79.76

mg/l

1.30

1414

4819

Benign neoplasms

2274

8081

1.55

73.89

3.3

3.2

60.19

65.19

mg/l

0.20

1946

6766

Osteonecrosis

269

817

3.56

73.84

11.4

3.4

66.03

121.28

mg/l

0.40

240

709

Malignant neoplasm of bone and articular cartilage

11.76

73.61

11.9

1.2

38.79

42.96

mg/l

0.23

Missing teeth due to accident, extraction or parodontitis

1844

10510

1.60

73.59

3.4

3.5

70.01

66.74

mg/l

0.05

1569

8956

Other CVD

782

3943

2.07

73.32

3.4

3.1

51.98

73.37

mg/l

0.88

656

3337

Urinary track infection

1154

3135

1.87

73.26

3.0

3.3

89.37

67.22

mg/l

0.18

983

2677

Retention of urine

1153

5256

1.82

73.14

2.8

3.5

69.43

68.31

mg/l

0.03

954

4472

Other arthrosis

1360

5319

1.74

72.89

2.8

3.8

43.17

80.78

mg/l

1.78

1177

4562

Fracture of rib(s), sternum and thoracic spine

1020

5613

1.87

72.76

3.6

3.3

53.24

66.46

mg/l

0.66

863

4744

Peripheral artery operations in Hilmo

512

2194

2.45

72.58

2.5

3.3

78.04

84.25

mg/l

0.09

426

1877

Injuries to the thorax

1388

8322

1.70

72.48

3.4

3.3

74.25

67.48

mg/l

0.11

1172

7034

Statin medication

1341

4343

1.76

72.26

2.8

4.3

49.16

77.99

mg/l

1.08

1150

3637

Amputation of toe

337

1189

3.07

71.97

2.4

3.6

85.49

55.92

mg/l

1.24

283

1003

Falls/tendency to fall

2408

7990

1.53

71.92

3.0

3.6

72.61

57.21

mg/l

0.29

2027

6824

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

542

2391

2.38

71.90

1.6

3.6

72.75

77.49

mg/l

0.07

448

2032

Pulmonary heart disease, diseases of pulmonary circulation

1065

5966

1.84

71.64

3.9

3.2

61.19

65.42

mg/l

0.15

861

5044

Other (seronegative) rheumatoid arthritis, wide

630

2958

2.22

71.33

2.3

3.4

44.75

70.58

mg/l

0.78

520

2501

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2255

11724

1.52

70.76

4.3

3.2

50.42

67.10

mg/l

1.33

1914

9957

Hypotension

704

3468

2.12

70.61

3.4

3.1

52.12

74.78

mg/l

0.80

591

2933

Other joint disorders

1799

5849

1.62

70.46

2.8

3.6

45.11

77.78

mg/l

1.65

1497

5004

Obesity related asthma

966

5277

1.88

70.14

2.3

3.6

53.10

51.00

mg/l

0.11

782

4508

Disorders of eyelid, lacrimal system and orbit

2287

11233

1.51

69.98

3.4

55.04

68.01

mg/l

0.84

1937

9536

Cardiomyopathies, Primary/intrinsic

402

1564

2.69

69.85

2.7

3.4

55.52

80.69

mg/l

0.34

342

1351

Factors influencing health status and contact with health services

655

1470

2.27

69.49

3.7

2.6

60.28

67.67

mg/l

0.13

559

1187

Other intervertebral disc disorders

1970

7586

1.57

68.75

3.2

3.1

64.84

56.40

mg/l

0.17

1732

6423

Myalgia

618

2910

2.18

68.59

3.1

3.5

113.72

48.39

mg/l

0.50

545

2420

Endocarditis

167

385

4.75

67.95

2.7

3.3

71.04

183.16

mg/l

0.38

136

332

Hypoparathyroidism

190

486

4.36

67.94

2.7

3.7

36.21

64.21

mg/l

1.23

141

428

Other and unspecified disorders of white blood cells

194

503

4.25

67.81

2.6

4.0

45.78

60.22

mg/l

0.55

165

433

Arthropathies in other diseases classified elsewhere

167

386

4.75

67.77

2.4

4.3

107.74

56.65

mg/l

0.73

139

338

ILD, hospital admissions 3, with pneumonia sepsis

358

1344

2.84

67.51

3.0

2.7

57.26

95.13

mg/l

0.46

270

1155

Cutaneous abscess, furuncle and carbuncle

698

3464

2.07

67.45

2.9

3.3

62.29

67.86

mg/l

0.12

610

2935

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

15.92

66.50

13.4

1.3

35.06

43.02

mg/l

0.51

ILD, hospital admissions

588

2776

2.22

66.24

2.8

3.4

71.35

79.70

mg/l

0.13

451

2389

Abnormalities of heart beat

926

4913

1.87

66.20

3.0

3.3

49.03

56.28

mg/l

0.50

782

4179

Other interstitial pulmonary diseases

595

2823

2.21

66.15

2.8

3.3

71.10

79.22

mg/l

0.13

455

2428

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

120

9.06

66.01

11.0

1.2

39.21

45.82

mg/l

0.44

104

Sleep apnoea, including avohilmo

2508

10404

1.48

65.96

2.9

3.6

49.83

66.61

mg/l

1.30

2006

8989

Cerebrovascular diseases

2143

9954

1.52

65.71

3.0

3.6

76.05

67.22

mg/l

0.17

1849

8442

Cardiomyopathy (excluding other)

409

1653

2.59

65.66

2.6

3.3

55.69

81.47

mg/l

0.37

348

1433

Interstitial lung disease

595

2834

2.20

65.50

2.8

3.3

71.10

79.29

mg/l

0.13

455

2434

Interstitial lung disease endpoints

595

2834

2.20

65.50

2.8

3.3

71.10

79.29

mg/l

0.13

455

2434

Undetermined asthma, excluding more controls

343

1266

2.80

65.45

2.9

2.5

56.33

43.21

mg/l

0.54

276

1093

Concussion

1083

4771

1.78

65.24

3.0

3.6

47.79

73.47

mg/l

1.01

863

4076

Viral infections characterized by skin and mucous membrane lesions

1109

6446

1.75

64.82

5.3

3.2

60.88

59.49

mg/l

0.05

927

5466

Seropositive rheumatoid arthritis, wide

811

4312

1.94

64.61

2.1

3.5

49.08

63.81

mg/l

0.59

704

3663

Organ-limited amyloidosis

18.11

64.46

5.9

2.4

35.92

181.57

mg/l

0.54

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

791

4177

1.95

64.37

2.1

3.5

49.58

64.33

mg/l

0.57

687

3544

Charcot foot

110

186

6.83

64.29

2.2

4.7

85.72

39.78

mg/l

5.47

159

Secondary and unspecified malignant neoplasm of lymph nodes

312

1116

2.96

64.28

2.0

1.5

51.08

47.71

mg/l

0.32

255

945

Sub-endpoint used in defining T1D endpoints

752

3853

1.97

62.98

2.0

3.2

69.88

67.91

mg/l

0.05

626

3252

Pulmonary embolism

957

5398

1.83

62.98

4.1

3.2

59.63

65.03

mg/l

0.18

776

4573

Symptoms and signs involving the digestive system and abdomen

2391

8155

1.49

62.86

3.2

3.4

76.00

61.65

mg/l

0.26

2025

6922

Later onset COPD, excluding more controls

714

2754

2.05

62.82

2.1

2.7

63.56

50.59

mg/l

1.15

587

2383

Other/unspecified seropositive rheumatoid arthritis

799

4269

1.93

62.72

2.1

3.5

49.38

64.07

mg/l

0.58

694

3624

Pulmonary heart disease

957

5412

1.82

62.43

4.1

3.2

59.63

65.22

mg/l

0.19

776

4579

Giant cell arteritis

223

675

3.67

62.42

1.9

3.7

37.86

63.41

mg/l

1.67

188

583

Gonarthrosis

1559

5498

1.63

62.39

3.0

3.8

52.12

80.77

mg/l

1.17

1307

4708

Diaphragmatic hernia

1116

6589

1.74

62.39

3.2

3.3

58.79

61.73

mg/l

0.10

1000

5511

Cirrhosis of liver, NAS

254

829

3.33

62.38

1.7

4.0

74.62

56.84

mg/l

1.35

213

715

Benzodiazepine use

2483

11646

1.46

62.21

3.3

3.4

58.69

66.17

mg/l

0.38

2048

9945

Sicca syndrome [Sjögren]

298

1060

2.98

62.03

2.3

3.7

49.71

105.83

mg/l

0.57

249

912

Chronic lymphocytic leukaemia, helper endpoint

162

397

4.57

61.49

2.5

1.5

58.22

44.24

mg/l

1.16

150

340

Chronic lymphocytic leukaemia

162

397

4.57

61.49

2.5

1.5

58.22

44.24

mg/l

1.16

150

340

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

162

397

4.57

61.49

2.5

1.5

58.22

44.24

mg/l

1.16

150

340

Noninfective enteritis and colitis

1158

6907

1.71

61.30

3.2

95.05

51.42

mg/l

0.45

965

5859

Failure and rejection of transplanted organs and tissues

118

8.52

61.17

8.7

3.9

59.56

92.43

mg/l

0.28

Persons encountering health services for examination and investigation

1417

4319

1.67

61.05

3.4

3.2

88.77

60.13

mg/l

0.35

1245

3340

Cardiomyopathy, other and unspecified

269

912

3.12

60.97

3.1

3.4

50.73

100.48

mg/l

0.41

237

797

Other diseases of intestine

511

2351

2.26

60.88

2.8

3.4

148.44

55.34

mg/l

0.50

435

1988

Myocardial infarction, strict

1354

5897

1.66

60.78

2.6

3.7

105.05

63.82

mg/l

0.50

1137

5070

Other noninfective gastroenteritis and colitis

687

3520

2.00

60.67

3.6

3.3

127.39

52.31

mg/l

0.47

580

2992

Other gastritis (incl. Duodenitis)

705

3655

1.99

60.64

3.0

3.3

57.30

54.25

mg/l

0.29

608

3063

Angina pectoris

1586

6708

1.60

60.58

3.1

3.8

92.93

67.54

mg/l

0.32

1341

5784

ILD, hospital admissions 1, main diag only

529

2490

2.23

60.20

2.9

3.4

56.76

82.08

mg/l

0.60

409

2148

Viral hepatitis, IBD co-morbidity

104

174

6.17

59.68

2.4

4.2

53.19

46.09

mg/l

0.36

146

Myocardial infarction, without ST-elevation

1353

7650

1.64

59.12

2.7

3.3

104.63

63.03

mg/l

0.50

1110

6489

Diffuse large B-cell lymphoma, helper endpoint

214

650

3.57

59.00

2.0

1.5

51.69

46.96

mg/l

0.28

176

544

Diffuse large B-cell lymphoma

214

650

3.57

59.00

2.0

1.5

51.69

46.96

mg/l

0.28

176

544

Diffuse large B-cell lymphoma, including Hilmo

214

650

3.57

59.00

2.0

1.5

51.69

46.96

mg/l

0.28

176

544

Symptoms and signs involving the nervous and musculoskeletal systems

1554

10070

1.57

58.80

3.3

3.4

69.24

64.55

mg/l

0.09

1308

8568

Solid cancers, including Hilmo

1830

7008

1.54

58.79

3.3

1.5

82.55

43.77

mg/l

0.71

1545

5898

Lymphoid leukaemia

252

850

3.21

58.45

3.8

3.6

61.56

56.63

mg/l

0.20

226

721

Other external causes of accidental injury

1778

5789

1.56

58.12

3.2

3.4

81.47

59.98

mg/l

0.30

1506

4962

SLE (Finngen)

140

317

4.78

58.11

1.9

3.9

48.31

74.05

mg/l

0.60

117

280

Secondary uncertain malignant neoplasm

441

1950

2.36

57.97

2.0

1.5

53.31

47.12

mg/l

0.80

357

1632

Abnormal findings on diagnostic imaging of other body structures

471

2142

2.29

57.88

3.7

3.6

46.18

79.06

mg/l

0.71

411

1836

Chronic ulcer of skin, not elsewhere classified

285

1031

2.95

57.83

2.3

3.4

71.06

110.95

mg/l

0.34

247

877

Methotrexate

391

1647

2.46

57.15

2.4

3.8

59.57

52.59

mg/l

0.22

326

1426

Pneumonia due to other infectious organisms, not elsewhere classified

149

360

4.52

57.13

7.6

2.9

62.36

44.01

mg/l

1.33

119

308

Glucagon-like peptide-1 (GLP-1) analogues

798

4389

1.86

56.79

2.1

4.0

54.33

45.37

mg/l

2.52

661

3747

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

798

4389

1.86

56.79

2.1

4.0

54.33

45.37

mg/l

2.52

661

3747

Other disorders of skin and subcutaneous tissue, not elsewhere classified

466

2128

2.28

56.67

2.6

3.4

63.57

79.33

mg/l

0.25

409

1817

Diseases of the eye and adnexa

1478

4633

1.61

56.65

3.6

3.2

48.51

57.93

mg/l

0.43

1241

3955

Abdominal and pelvic pain

2345

8155

1.46

56.48

3.5

3.4

75.78

61.65

mg/l

0.25

1978

6922

Sciatica+with lumbago

1243

6814

1.64

55.99

3.2

75.43

54.62

mg/l

0.28

1097

5766

Cellulitis

629

3222

2.01

55.87

3.4

3.3

60.33

69.75

mg/l

0.23

533

2725

Follow-up examination after treatment for conditions other than malignant neoplasms

976

3721

1.77

55.86

3.2

83.38

60.67

mg/l

0.24

909

2866

Zoster [herpes zoster], including avohilmo

1476

9233

1.57

55.75

4.5

3.2

55.04

68.46

mg/l

0.75

1265

7840

Deforming dorsopathies

699

3704

1.93

55.73

3.6

3.3

44.57

53.86

mg/l

1.47

585

3116

Cystitis

2020

8167

1.49

55.56

3.0

3.4

54.38

70.42

mg/l

0.87

1706

6937

Viral pneumonia (known virus, not influenza)

147

362

4.51

55.35

10.1

3.8

82.24

65.18

mg/l

0.25

128

313

Immunodeficiency with predominantly antibody defects

119

247

5.32

55.18

6.7

3.7

36.33

66.73

mg/l

0.66

212

Hypocalcemia

132

302

4.95

54.92

5.8

3.9

63.72

71.68

mg/l

0.15

115

263

339

1360

2.57

54.83

3.1

3.6

50.21

87.20

mg/l

0.45

284

1162

Injuries to the shoulder and upper arm

2173

11708

1.45

54.42

3.7

3.3

93.13

60.16

mg/l

0.52

1841

9947

Vascular disorders of the intestines

287

1077

2.83

54.23

2.2

3.2

65.18

60.28

mg/l

0.21

232

913

Sleep disorders (combined)

2648

9888

1.41

54.08

2.8

3.5

51.24

70.89

mg/l

1.36

2162

8506

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1300

5490

1.63

53.84

3.7

1.5

129.53

45.52

mg/l

0.99

1124

4636

Asthma, hospital admissions , main diagnosis only

1938

11583

1.47

53.78

2.8

3.5

89.46

60.89

mg/l

0.48

1632

9828

Rare circulating lymphoid malignancy, including Hilmo

130

297

4.80

53.60

7.3

1.4

439.79

44.81

mg/l

0.55

111

249

Other and unspecified aplastic anaemias

103

8.58

53.42

2.5

5.0

46.14

118.49

mg/l

0.63

Haemorrhage, not elsewhere classified

172

483

3.85

53.40

2.6

3.3

85.43

70.90

mg/l

0.15

142

420

Nonischemic cardiomyopathy

348

1444

2.53

53.02

3.3

3.4

60.17

53.54

mg/l

0.31

290

1244

Other disorders of veins

1092

6580

1.67

52.66

2.8

3.4

46.83

70.31

mg/l

1.27

927

5610

Meniscus derangement

1295

5392

1.62

52.58

3.4

3.8

54.97

80.40

mg/l

0.86

1044

4622

Peripheral arterial reconstruction

633

3337

1.98

52.44

2.3

3.3

68.97

73.90

mg/l

0.10

524

2833

Gout due to impairment of renal function

159

7.08

52.41

2.6

4.6

77.23

98.44

mg/l

0.24

137

Other pleural conditions

399

1775

2.37

52.23

3.5

3.4

139.05

85.48

mg/l

0.29

332

1540

Sequelae of external causes of morbidity and mortality

765

4274

1.84

52.05

3.2

3.4

56.22

67.36

mg/l

0.39

633

3613

Accidents

1742

5789

1.52

51.94

3.2

3.4

80.80

59.98

mg/l

0.29

1476

4962

Malignant neoplasm of skin, including Hilmo

1359

5803

1.59

51.90

3.8

1.5

128.21

45.21

mg/l

1.02

1164

4903

Chronic gastritis

840

4836

1.79

51.61

2.7

3.4

49.16

62.78

mg/l

1.25

747

4048

Asthma/COPD (KELA code 203)

2204

10365

1.44

51.52

2.7

3.6

85.96

57.77

mg/l

0.55

1849

8847

Marginal zone B-cell lymphoma

8.92

51.49

1.8

1.4

48.59

45.05

mg/l

0.17

Pneumocystosis

116

255

5.25

51.03

9.6

3.9

64.92

73.98

mg/l

0.14

217

Pneumocystosis, including avohilmo

116

255

5.25

51.03

9.6

3.9

64.92

73.98

mg/l

0.14

217

Hypothyroidism, strict autoimmune

1600

6950

1.53

51.02

3.2

3.7

90.89

69.31

mg/l

0.26

1338

5927

Other disorders of lacrimal gland

981

5903

1.70

50.89

3.9

3.4

44.68

59.25

mg/l

0.88

839

5031

Zoster [herpes zoster]

608

3191

1.97

50.70

5.9

3.2

71.20

71.89

mg/l

0.01

518

2726

Other and unspecified types of non-Hodgkin lymphoma, hilmo

195

617

3.45

50.64

3.7

3.9

73.87

59.65

mg/l

0.54

169

525

Undetermined asthma

343

1436

2.46

50.60

2.9

2.4

56.33

47.22

mg/l

0.33

276

1240

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1251

5348

1.62

50.59

3.7

1.5

132.08

45.55

mg/l

0.96

1073

4515

Diseases of spleen

106

217

5.58

50.50

2.2

3.7

55.87

76.69

mg/l

0.32

185

Congenital malformations of the urinary system

189

582

3.44

50.47

1.9

3.8

75.83

57.32

mg/l

0.86

149

496

Paralytic ileus and intestinal obstruction

762

4287

1.82

50.37

3.5

3.4

74.29

54.13

mg/l

1.20

639

3596

Pericarditis

143

368

4.19

50.20

2.6

3.1

54.42

42.22

mg/l

1.68

121

315

Biological medication for rheuma

393

1754

2.30

50.01

2.0

3.6

45.67

48.72

mg/l

0.22

320

1483

Polycystic kidney disease

122

281

4.80

49.99

1.9

3.9

81.39

69.58

mg/l

0.21

240

Cystic kidney disease

139

353

4.30

49.96

1.9

3.9

77.23

66.47

mg/l

0.25

108

306

Congenital malformations of the urinary system, including avohilmo

198

632

3.31

49.83

1.9

3.9

75.54

55.74

mg/l

1.05

156

541

Solid cancers

1757

6958

1.50

49.71

3.2

1.5

83.68

43.76

mg/l

0.70

1481

5853

Other diseases of liver

514

2560

2.07

49.64

2.9

3.5

51.02

70.42

mg/l

0.44

414

2173

Immunodeficiencies

171

501

3.65

49.61

6.5

3.8

54.44

58.19

mg/l

0.08

138

433

Dental operations

1606

5464

1.53

49.17

3.5

2.9

53.33

75.20

mg/l

1.17

1353

4656

Cystic kidney disease, including avohilmo

142

371

4.15

48.98

1.9

3.8

77.22

64.68

mg/l

0.32

110

322

Neurological diseases

1737

5858

1.50

48.81

3.1

3.6

44.54

70.98

mg/l

1.47

1464

5004

Hepatomegaly and splenomegaly, not elsewhere classified

8.45

48.76

3.0

4.6

49.48

103.74

mg/l

0.43

Systemic lupus erythematosus

140

363

4.16

48.71

1.9

4.2

48.31

63.49

mg/l

0.43

117

317

Malignant neoplasm of skin

1303

5660

1.58

48.53

3.7

1.5

129.49

45.33

mg/l

0.98

1115

4781

Valvular operations

416

1931

2.23

48.47

2.2

3.3

55.11

75.85

mg/l

0.34

351

1666

Episodal and paroxysmal disorders

2437

8870

1.41

48.39

2.8

3.6

49.04

64.65

mg/l

1.15

2038

7604

Fracture of shoulder and upper arm

985

6003

1.67

48.35

3.9

3.2

52.43

58.33

mg/l

0.46

823

5061

Other and unspecified acquired haemolytic anaemias

120

7.76

48.19

3.2

2.8

63.28

110.76

mg/l

0.40

103

Other diseases of anus and rectum

841

4910

1.74

48.16

3.3

3.4

176.42

58.95

mg/l

0.82

710

4132

Gastroduodenal ulcer

813

4720

1.76

47.93

2.7

3.3

143.85

59.10

mg/l

0.68

683

3956

Cholelithiasis, broad definition with cholecystitis

2168

10268

1.42

47.84

3.5

3.4

64.55

59.80

mg/l

0.22

1847

8730

Discitis, unspecified

101

208

5.54

47.80

3.4

3.2

56.00

90.83

mg/l

0.61

176

Basal cell carcinoma, including Hilmo

1245

5376

1.60

47.78

3.7

1.5

134.31

45.55

mg/l

0.99

1067

4541

Asthma, including avohilmo

2754

11175

1.37

47.32

2.8

3.5

76.17

62.25

mg/l

0.29

2332

9497

Chronic periodontitis, complicated

1521

10017

1.50

47.29

3.5

50.18

65.16

mg/l

1.11

1300

8555

Disorders of lacrimal system

1157

7253

1.60

47.29

3.7

3.4

43.74

68.78

mg/l

1.62

985

6170

Crystal arthropathies, rheuma endpoint

111

250

5.02

47.14

2.7

4.5

45.34

50.80

mg/l

0.33

221

Diseases of the myoneural junction and muscle

403

1877

2.24

46.89

2.6

3.4

49.73

85.75

mg/l

0.66

336

1598

Temporal arteritis

182

581

3.45

46.80

1.9

3.8

38.82

59.04

mg/l

1.20

149

505

Diseases of oral cavity, salivary glands and jaws

1474

4991

1.54

46.53

3.6

2.8

57.50

84.70

mg/l

0.98

1254

4186

Spondyloarthritis

461

2257

2.10

46.48

2.6

3.4

64.23

79.38

mg/l

0.23

381

1923

Decubitus ulcer and pressure area

258

994

2.76

46.45

2.0

3.4

55.91

113.07

mg/l

0.53

217

842

Myeloproliferative diseases

308

1290

2.52

46.43

3.2

3.5

48.62

99.04

mg/l

0.61

276

1094

Early onset COPD, excluding more controls

498

2511

2.03

46.10

2.1

2.7

136.16

49.05

mg/l

0.51

412

2154

Small fibre neuropathy

148

418

3.91

46.07

4.0

3.8

224.51

67.99

mg/l

0.40

135

361

Elevated blood glucose level

260

1005

2.71

46.00

3.0

3.5

56.84

105.99

mg/l

0.44

209

856

Obesity, other/unspecified

714

4043

1.80

45.92

2.0

3.5

53.16

60.97

mg/l

0.25

614

3458

Convulsions, not elsewhere classified

490

2425

2.03

45.89

2.3

3.1

56.81

56.31

mg/l

0.03

410

2055

Unspecified fall

1342

8729

1.53

45.82

3.2

3.3

50.56

64.64

mg/l

1.18

1096

7422

Myocarditis

117

276

4.42

45.54

4.1

3.2

50.26

37.92

mg/l

0.88

248

Other viral diseases

581

3084

1.91

45.52

5.5

3.2

56.46

67.51

mg/l

0.27

491

2624

Supplementary factors related to causes of morbidity and mortality classified elsewhere

792

4641

1.74

45.38

2.9

3.2

51.45

64.52

mg/l

0.51

671

3935

Other disorders of bone

436

2110

2.12

45.26

6.9

3.0

60.33

72.35

mg/l

0.17

376

1809

Type of accident

747

4313

1.77

45.18

2.8

3.2

51.00

65.82

mg/l

0.55

631

3663

L01XX Other antineoplastic agents

248

956

2.79

44.90

6.5

3.6

42.00

53.27

mg/l

0.92

229

828

Diabetic retinopathy

1162

4599

1.61

44.75

2.3

2.7

72.19

70.25

mg/l

0.05

951

3877

Other crystal arthropathies

111

261

4.80

44.69

2.7

3.7

45.34

261.10

mg/l

0.56

231

Other disorders of adrenal gland

159

479

3.53

44.16

3.4

3.9

39.61

66.08

mg/l

0.96

109

418

Malignant neoplasm of urinary organs, including Hilmo

372

1720

2.25

44.11

2.5

1.5

57.34

49.35

mg/l

0.92

316

1437

Viral pneumonia (unknown virus, not influenza)

221

805

2.88

44.02

6.3

3.7

53.88

60.74

mg/l

0.31

171

686

Shoulder lesions

1802

7521

1.45

43.98

3.1

3.6

44.88

62.43

mg/l

1.93

1585

6312

Basal cell carcinoma

1197

5262

1.58

43.93

3.7

1.5

139.16

45.57

mg/l

1.01

1025

4442

Eosinophilic disease (BM)

126

6.64

43.84

2.5

2.3

49.18

34.97

mg/l

1.37

112

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

329

1452

2.37

43.73

2.2

1.5

54.33

49.13

mg/l

0.67

281

1216

COPD

1347

7302

1.53

43.64

2.1

3.6

90.88

53.94

mg/l

0.60

1102

6219

Complications of internal orthopaedic prosthetic devices, implants and grafts

712

4116

1.78

43.37

2.5

3.3

50.01

67.34

mg/l

0.68

593

3477

Open wound of head

1431

9116

1.50

43.33

3.0

3.4

57.46

69.08

mg/l

0.67

1182

7783

Adrenocortical insufficiency

141

399

3.80

43.30

3.5

4.2

40.39

59.96

mg/l

0.60

348

External causes of morbidity and mortality

1340

4380

1.55

43.29

3.5

3.4

88.70

50.01

mg/l

0.47

1137

3759

Myeloproliferative diseases (CML excluded)

282

1173

2.54

43.25

3.3

3.6

49.20

103.29

mg/l

0.59

254

1000

Osteonecrosis due to drugs

212

5.34

43.19

21.3

4.2

82.47

74.27

mg/l

0.09

180

Giant cell arteritis with polymyalgia rheumatica

182

610

3.28

43.16

1.9

3.6

38.82

58.30

mg/l

1.23

149

535

Polyuria

682

3900

1.80

43.08

2.6

3.6

47.48

69.25

mg/l

0.90

596

3327

Disturbances of skin sensation

613

3388

1.84

42.92

3.1

3.4

44.26

50.37

mg/l

0.71

542

2853

Persons with potential health hazards related to communicable diseases

626

3443

1.83

42.82

3.6

3.1

51.56

62.86

mg/l

0.32

504

2920

Other specified/unspecified systemic involvement of connective tissue

186

628

3.13

42.66

2.1

4.2

46.00

61.43

mg/l

0.68

159

543

Sequelae with surgical and medical care as external cause

609

3380

1.86

42.61

3.0

3.4

57.62

69.68

mg/l

0.33

496

2891

Dysphagia

740

4339

1.75

42.59

3.2

3.4

55.47

54.90

mg/l

0.03

630

3663

Depression or dysthymia

1599

5962

1.48

42.55

3.1

3.7

51.31

67.13

mg/l

0.93

1326

5135

Idiopathic thrombocytopenic purpura

129

349

4.02

42.49

4.0

3.5

45.87

67.12

mg/l

0.63

111

302

Sarcoidosis

379

1794

2.19

42.22

2.6

3.5

61.99

81.59

mg/l

0.24

305

1536

Unspecified acute lower respiratory infection

409

1989

2.12

42.17

4.4

3.1

51.16

79.50

mg/l

0.52

350

1691

Other viral diseases, including avohilmo

707

4052

1.75

41.94

5.0

3.1

52.89

61.94

mg/l

0.29

601

3432

Candidiasis, including avohilmo

728

4262

1.74

41.87

3.6

3.3

63.93

61.64

mg/l

0.05

615

3629

SLE, ICD10

129

352

3.95

41.82

2.0

3.8

47.87

59.50

mg/l

0.30

108

307

SLE, strict definition

129

352

3.95

41.82

2.0

3.8

47.87

59.50

mg/l

0.30

108

307

Mycoses

733

4307

1.74

41.76

4.0

3.4

65.64

66.96

mg/l

0.03

622

3651

Other and unspecified immunodeficiencies with predominantly antibody defects

103

7.30

41.65

7.2

4.0

33.99

105.89

mg/l

0.66

Other/unspecified rheumatoid arthritis

399

1940

2.14

41.62

2.0

3.3

45.45

81.09

mg/l

0.68

340

1642

Any mental disorder

2532

9387

1.36

41.62

3.0

3.6

48.37

68.11

mg/l

1.67

2116

8033

Cholelithiasis

2053

10137

1.40

41.40

3.5

3.4

66.70

60.00

mg/l

0.31

1741

8614

Other diseases of arteries and capillaries

298

1291

2.41

41.39

3.0

3.6

86.18

101.60

mg/l

0.14

251

1101

Gingivitis and periodontal diseases

2354

8919

1.38

41.28

3.3

3.1

48.34

75.77

mg/l

2.09

1988

7541

Exclusions for E4_PCOS_BROAD

413

2030

2.09

41.18

3.7

3.5

50.72

77.85

mg/l

0.46

324

1717

Diseases of pulp and periapical tissues and dental caries

1663

5902

1.46

40.82

3.2

3.1

52.68

78.64

mg/l

1.25

1383

5049

Insulin, fast-acting (human)

312

1379

2.32

40.78

2.0

3.3

59.19

52.76

mg/l

0.42

262

1160

Noninfectious colitis NAS

368

1749

2.17

40.40

3.9

3.3

47.31

55.35

mg/l

0.73

317

1487

Other or unspecified ileus, impaction or obstruction

547

2986

1.88

40.24

3.7

3.3

85.05

55.99

mg/l

1.29

457

2504

Protozoal diseases

135

393

3.76

40.09

9.1

3.9

60.74

64.05

mg/l

0.07

111

341

Other coagulation defects

222

851

2.72

39.99

3.5

46.91

58.93

mg/l

0.67

192

741

Disorder of lipoprotein metabolism, unspecified

401

1982

2.10

39.88

2.4

3.2

60.48

54.64

mg/l

0.49

349

1672

Other diseases of hard tissues of teeth

1414

4937

1.50

39.78

3.2

2.8

53.03

84.79

mg/l

1.22

1217

4147

Fentanyl

316

1423

2.29

39.62

8.7

2.5

75.30

61.06

mg/l

0.48

275

1204

Other reaction to severe stress, and adjustment disorders

652

3751

1.76

39.48

4.2

3.3

43.53

61.62

mg/l

0.66

552

3185

Stroke, including SAH

1776

9104

1.42

39.33

3.0

3.6

83.84

69.66

mg/l

0.24

1516

7696

Pyogenic arthritis

207

775

2.79

39.10

3.4

4.1

71.94

130.47

mg/l

0.39

176

663

Microscopic polyangiitis

9.12

38.86

1.3

4.5

78.41

129.96

mg/l

0.29

Tubulo-interstitial nephritis, not specified as acute or chronic

191

687

2.90

38.83

3.7

3.2

81.83

36.20

mg/l

3.33

157

596

All influenza (not pneumonia)

350

1655

2.17

38.77

6.8

2.7

67.67

80.02

mg/l

0.14

294

1405

Diagnoses used for exclusion with ILD

728

4362

1.71

38.76

2.7

3.2

65.00

69.27

mg/l

0.10

572

3683

Diseases of pulp and periapical tissues, including avohilmo

2382

9160

1.36

38.33

3.4

3.2

48.65

73.71

mg/l

1.96

1952

7838

Other metabolic disorders

299

1334

2.30

38.29

5.1

3.2

49.86

48.71

mg/l

0.06

251

1132

DVT of lower extremities

549

3054

1.85

38.14

5.5

3.3

59.15

71.39

mg/l

0.30

460

2620

Other disorders of ear

2211

10585

1.36

38.08

3.5

3.4

53.27

69.07

mg/l

1.08

1841

9024

Unspecified nephritic syndrome

102

253

4.44

38.08

3.0

4.3

87.63

68.98

mg/l

0.27

217

Lumbar disc prolapse

1417

7237

1.47

37.93

3.2

43.42

55.40

mg/l

4.51

1247

6134

Fibromyalgia

214

825

2.67

37.83

3.1

3.3

30.18

47.81

mg/l

2.64

177

690

Mood disorders, excluding more controls

2123

9173

1.37

37.68

3.0

3.6

66.56

68.28

mg/l

0.03

1785

7848

Hypertrophic cardiomyopathy

175

618

3.05

37.56

4.5

3.8

47.05

61.04

mg/l

0.65

157

523

Protozoal diseases, including avohilmo

135

410

3.58

37.51

9.1

3.9

60.74

62.40

mg/l

0.04

111

357

Other chronic obstructive pulmonary disease

1274

7102

1.50

37.49

2.1

3.6

91.86

53.99

mg/l

0.57

1040

6052

Other diseases of pancreas

290

1301

2.34

37.32

2.8

3.6

83.97

92.94

mg/l

0.07

235

1110

Persons encountering health services for specific procedures, not carried out

216

848

2.63

36.88

2.6

3.3

47.35

49.33

mg/l

0.12

189

724

Visual disturbances and blindness

1316

9079

1.47

36.82

3.5

3.3

76.93

62.51

mg/l

0.19

1142

7698

Acute sinusitis

1066

6387

1.53

36.82

5.3

2.9

59.90

55.88

mg/l

0.14

911

5445

Stroke, excluding SAH

1708

8855

1.41

36.73

2.9

3.5

85.12

70.77

mg/l

0.23

1457

7495

Dental caries, including avohilmo

1814

6659

1.41

36.66

3.2

54.49

75.53

mg/l

1.03

1514

5679

Allergic asthma (mode), excluding more controls

356

1682

2.09

36.51

2.4

2.6

67.85

40.75

mg/l

0.72

319

1433

Caries of dentine, including avohilmo

1913

7083

1.39

36.38

3.2

3.3

52.74

74.36

mg/l

1.22

1596

6050

Amputation of foot

131

400

3.61

36.34

2.9

3.9

80.72

66.76

mg/l

0.40

110

347

Abnormal results of function studies

253

1079

2.43

36.32

3.8

3.9

44.33

56.72

mg/l

1.01

198

933

Systemic lupus erythematosus, unspecified

110

297

3.99

36.26

1.8

3.6

47.17

61.25

mg/l

0.30

255

Substance abuse, excluding more controls

1270

7258

1.48

36.24

2.1

3.6

87.40

63.64

mg/l

0.31

1050

6200

Vitreous haemorrhage

316

1487

2.21

35.97

2.8

3.6

100.22

94.68

mg/l

0.05

265

1264

Pruritus

318

1497

2.19

35.90

2.6

3.4

76.47

89.70

mg/l

0.12

270

1290

Infection of intervertebral disc (pyogenic)

173

5.27

35.87

1.8

3.2

53.76

94.18

mg/l

0.61

150

Folate deficiency anaemia

140

5.94

35.63

2.6

4.1

69.86

95.31

mg/l

0.24

121

Malignant neoplasm of urinary organs

305

1421

2.23

35.60

2.4

1.5

55.85

49.57

mg/l

0.80

259

1186

Other and unspecified coagulation defects

153

513

3.13

35.53

3.3

3.9

45.95

67.20

mg/l

0.80

135

450

Acute upper respiratory infections of multiple and unspecified sites

1694

8898

1.40

35.49

5.9

2.9

84.03

55.57

mg/l

0.54

1393

7572

Chronic pancreatitis

372

1869

2.06

35.46

2.6

3.5

85.65

80.21

mg/l

0.06

309

1589

Spondylopathies (FG)

277

1238

2.29

35.29

2.4

3.9

48.53

88.82

mg/l

0.45

227

1049

Soft tissue disorders related to use, overuse and pressure

703

4273

1.68

35.28

2.8

3.6

42.34

50.63

mg/l

2.82

615

3572

Other infectious diseases, including avohilmo

283

1286

2.29

35.15

3.9

3.4

59.78

98.93

mg/l

0.45

229

1092

Other neurological diseases

1883

10751

1.37

35.01

3.2

3.5

76.74

66.70

mg/l

0.18

1615

9130

Pain in thoracic spine

354

1748

2.07

34.99

4.3

3.1

38.79

51.39

mg/l

1.77

303

1454

Abnormalities of gait and mobility

399

2070

2.00

34.84

2.5

3.4

62.49

84.45

mg/l

0.35

350

1782

Intracranial injury

1409

9253

1.44

34.82

3.2

3.3

54.24

68.15

mg/l

0.91

1140

7898

Tumor necrosis factor alpha inhibitors

318

1516

2.14

34.47

2.0

3.6

45.71

50.05

mg/l

0.30

262

1279

Leisure time condition

469

2570

1.87

34.16

2.6

3.3

43.79

75.17

mg/l

0.85

391

2195

Intestinal malabsorption

157

548

3.03

34.09

2.0

4.0

53.12

57.05

mg/l

0.13

132

472

Essential (haemorrhagic) thrombocythaemia

137

445

3.29

33.89

2.9

1.5

59.88

41.00

mg/l

0.37

127

377

Vitamin deficiency

159

561

2.98

33.80

3.2

3.9

71.99

66.05

mg/l

0.08

123

483

Vitamin deficiency, wide

159

561

2.98

33.80

3.2

3.9

71.99

66.05

mg/l

0.08

123

483

Misadventures to patients during surgical and medical care

397

2072

1.97

33.77

3.0

3.4

51.83

77.92

mg/l

0.50

346

1774

Acute upper respiratory infections

2434

11142

1.32

33.56

5.1

2.9

76.89

63.51

mg/l

0.31

2033

9508

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

297

1404

2.20

33.43

4.0

3.6

56.96

55.53

mg/l

0.07

258

1205

Acute posthaemorrhagic anaemia

127

397

3.40

33.40

3.3

3.9

75.92

65.70

mg/l

0.21

344

Malignant neoplasm of kidney, except renal pelvis

278

1282

2.26

33.35

2.3

1.5

56.49

50.06

mg/l

0.74

238

1079

Benign neoplasm: Colon, unspecified

765

4836

1.62

33.13

3.0

3.4

70.67

67.56

mg/l

0.07

691

4089

Myeloid leukaemia

118

357

3.60

33.05

3.1

4.0

41.50

67.64

mg/l

0.81

101

308

Gastric ulcer

533

3071

1.78

32.95

2.8

3.3

169.51

59.31

mg/l

0.58

465

2575

Rheumatism, unspecified

346

1736

2.05

32.94

2.4

3.8

195.79

46.79

mg/l

0.47

293

1445

Iridocyclitis

557

3247

1.75

32.82

3.3

3.2

48.49

69.63

mg/l

0.67

446

2760

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

420

2258

1.91

32.66

2.4

1.6

53.83

46.95

mg/l

0.69

344

1902

Ischaemic Stroke, excluding all haemorrhages

1606

8584

1.40

32.57

2.9

3.5

87.55

66.15

mg/l

0.37

1367

7262

Abnormality of white blood cells, not elsewhere classified

7.03

32.52

2.7

4.1

36.55

38.81

mg/l

0.11

Ascites

253

1137

2.33

32.44

1.6

3.5

67.84

52.48

mg/l

1.71

207

962

Other disorders of glucose regulation and pancreatic internal secretion

233

1008

2.40

32.43

2.1

3.5

68.37

59.62

mg/l

0.37

200

860

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

122

6.10

32.35

5.1

4.0

65.61

100.47

mg/l

0.31

104

Problems related to lifestyle

228

977

2.39

32.17

2.4

3.8

44.89

53.69

mg/l

0.65

177

835

Postprocedural endocrine and metabolic disorders, not elsewhere classified

269

1236

2.23

32.16

5.4

3.2

45.75

48.90

mg/l

0.16

223

1047

Psoriatic and enteropathic arthropathies

260

1179

2.26

32.14

2.2

3.9

64.28

92.97

mg/l

0.25

208

999

Acute peritonitis

213

893

2.50

32.11

2.6

3.7

77.43

56.14

mg/l

1.77

176

755

Budesonide

308

1496

2.11

31.88

3.0

3.8

43.40

53.23

mg/l

0.89

261

1290

Open wound of lower leg

403

2154

1.92

31.83

3.0

3.4

70.13

78.02

mg/l

0.10

336

1815

Other and unspecified myopathies

287

1369

2.18

31.69

2.8

3.4

52.56

97.79

mg/l

0.59

230

1160

Phlebitis and thrombophlebitis (not including DVT)

577

3431

1.72

31.67

4.6

3.3

54.98

67.22

mg/l

0.34

484

2927

Degeneration of macula and posterior pole

1444

8008

1.41

31.54

3.0

3.4

61.11

73.54

mg/l

0.57

1191

6827

Seropositive rheumatoid arthritis, strict definition

409

2207

1.91

31.51

2.0

3.4

46.83

77.11

mg/l

0.64

361

1868

Other symptoms and signs involving cognitive functions and awareness

1291

8093

1.43

31.40

2.8

3.5

48.06

67.67

mg/l

1.79

1113

6811

Cardiodefibrillation

1067

7303

1.49

31.38

3.1

3.4

63.10

64.24

mg/l

0.04

858

6249

Oesophageal varices

155

565

2.92

31.31

1.6

3.7

64.95

62.25

mg/l

0.09

131

482

Candidiasis

360

1865

1.98

31.26

4.4

3.3

78.77

80.98

mg/l

0.02

305

1594

Other chronic obstructive pulmonary disease, including avohilmo

1520

9078

1.40

31.09

2.1

3.6

87.95

61.50

mg/l

0.43

1234

7745

1347

8577

1.42

31.07

2.1

3.5

95.67

60.56

mg/l

0.53

1083

7322

Psychiatric diseases

2202

8362

1.33

31.03

3.0

3.7

48.58

69.57

mg/l

1.57

1828

7186

Eosinophilia

173

4.80

30.86

2.5

4.3

49.18

84.37

mg/l

0.50

150

L04AC Interleukin inhibitors

160

595

2.79

30.60

2.1

3.8

44.97

61.90

mg/l

0.68

127

504

Other skin changes

567

3393

1.71

30.55

4.6

3.4

136.59

56.76

mg/l

0.43

509

2857

Acidosis

258

3.98

30.52

1.9

3.7

58.70

68.92

mg/l

0.18

221

Disorders of the thyroid gland

2129

10515

1.32

30.51

3.2

3.5

79.51

59.49

mg/l

0.35

1803

8932

Nonalcoholic fatty liver disease

258

1195

2.23

30.46

2.6

3.9

44.91

55.00

mg/l

0.81

218

1019

1396

8736

1.41

30.43

2.1

3.6

93.55

60.41

mg/l

0.51

1127

7451

Disorders of sclera, cornea, iris and ciliary body

1263

8973

1.42

30.31

3.2

3.4

50.51

57.23

mg/l

0.48

1052

7628

Cardiac arrest

158

489

2.83

30.14

2.7

3.2

61.56

42.89

mg/l

1.83

132

437

Diabetic retinopathy, strict definition

540

2842

1.74

29.95

2.0

2.8

81.35

76.79

mg/l

0.08

436

2383

Collagenous colitis

266

1259

2.19

29.87

3.6

3.5

264.90

52.88

mg/l

0.51

219

1088

Vasculitis limited to skin, not elsewhere classified

109

335

3.52

29.75

3.1

4.1

54.50

68.37

mg/l

0.34

292

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

255

3.81

29.71

1.8

3.3

52.16

48.61

mg/l

0.08

222

Mycoses, including avohilmo

2050

11908

1.32

29.68

3.3

3.4

53.56

66.40

mg/l

0.85

1754

10106

Non-allergic asthma (mode), excluding more controls

364

1904

1.93

29.55

2.9

2.5

52.80

44.99

mg/l

0.29

304

1630

Acute nephritic syndrome

223

4.14

29.37

3.0

4.2

69.52

73.83

mg/l

0.06

187

Alcohol use disorder, Swedish definition

1279

8304

1.42

29.33

2.0

3.5

62.49

66.17

mg/l

0.14

1047

7068

Injury, poisoning and certain other consequences of external causes

1047

3537

1.50

29.28

3.4

3.5

51.42

52.16

mg/l

0.05

898

3013

Heart failure and hypertrophic cardiomyopathy

273

3.88

29.13

4.4

4.1

55.90

79.57

mg/l

0.49

233

Other and unspecified vasculitis limited to skin

291

3.69

28.99

3.4

3.9

57.06

70.56

mg/l

0.27

252

Acute and subacute iridocyclitis

460

2635

1.79

28.95

3.5

3.3

48.76

74.07

mg/l

0.64

366

2234

Irritable bowel syndrome

559

3373

1.68

28.82

3.2

3.4

42.07

47.92

mg/l

0.89

481

2860

Visual disturbances

1174

8315

1.43

28.79

3.6

3.3

80.03

58.64

mg/l

0.26

1012

7064

Suppurative and necrotic conditions of lower respiratory tract

193

815

2.49

28.76

3.7

3.8

294.88

57.44

mg/l

0.56

164

688

Cyst of kidney

244

1138

2.25

28.74

3.8

3.7

100.21

57.77

mg/l

0.72

207

974

Conductive and sensorineural hearing loss

1982

10019

1.33

28.74

3.5

3.4

53.05

71.11

mg/l

1.21

1650

8553

Intestinal stricture

858

5738

1.52

28.68

3.4

3.3

70.95

64.46

mg/l

0.20

729

4813

Other respiratory disorders and diseases

605

3746

1.65

28.60

2.6

3.2

107.47

73.86

mg/l

0.28

486

3180

Other diseases of the respiratory system

605

3746

1.65

28.60

2.6

3.2

107.47

73.86

mg/l

0.28

486

3180

Other infectious diseases

237

1095

2.25

28.42

3.9

3.5

57.90

54.54

mg/l

0.20

186

933

Other renal tubulo-interstitial diseases

174

4.45

28.41

2.0

3.4

82.53

32.44

mg/l

1.75

152

Rotator cuff syndrome

1456

7311

1.39

28.30

3.2

3.7

44.79

63.00

mg/l

1.95

1291

6140

Open wound of ankle and foot

262

1258

2.14

28.20

3.0

3.5

67.88

56.09

mg/l

0.69

232

1070

Allergic asthma (mode)

356

1849

1.90

28.00

2.4

2.5

67.85

43.83

mg/l

0.61

319

1575

Mixed hyperlipidaemia

134

479

2.95

27.97

2.2

3.7

65.15

57.77

mg/l

0.15

118

408

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

236

1093

2.23

27.94

5.4

3.4

55.54

56.42

mg/l

0.03

205

934

Urticaria and erythema

726

4706

1.56

27.74

3.9

3.3

49.05

60.19

mg/l

0.44

620

3996

Need for other prophylactic measures

174

711

2.56

27.74

3.1

3.6

51.75

62.99

mg/l

0.46

166

602

Other embolism and thrombosis

346

1847

1.93

27.62

4.3

3.4

60.66

83.41

mg/l

0.35

287

1582

Spondylolisthesis/Spondylolysis

435

2489

1.79

27.49

3.9

3.2

46.63

53.03

mg/l

0.58

371

2091

Alcoholic liver disease

291

1470

2.05

27.48

1.4

3.7

78.99

57.21

mg/l

0.80

231

1252

Sulfonylureas

1004

5516

1.47

27.47

2.1

3.6

85.96

61.48

mg/l

1.82

852

4666

Other specified/unspecified necrotizing vasculopathies

147

4.91

27.47

2.5

4.6

42.78

86.02

mg/l

0.54

127

Etanercept

156

611

2.64

26.97

2.1

3.8

47.37

57.37

mg/l

0.35

127

522

Other symptoms and signs involving the nervous and musculoskeletal systems

947

6526

1.47

26.97

3.4

78.14

59.75

mg/l

0.24

778

5547

COPD related to multimorbidity

1177

7121

1.42

26.84

2.1

3.4

99.07

65.93

mg/l

0.42

960

6057

Pneumonia derived septicemia

121

419

3.06

26.84

8.0

3.6

71.70

63.51

mg/l

0.20

100

359

Artificial joint operation, meniscal resection

2229

11124

1.29

26.73

3.2

3.5

52.65

68.35

mg/l

1.03

1839

9506

Abnormal serum enzyme levels

822

5335

1.52

26.64

3.0

3.5

103.40

60.38

mg/l

0.44

750

4504

Unstable angina pectoris

1007

5505

1.46

26.54

3.0

3.6

74.25

60.54

mg/l

0.60

860

4700

Other and unspecified local infections of skin and subcutaneous tissue

258

1263

2.11

26.47

4.4

3.7

69.17

97.29

mg/l

0.28

226

1081

Delirium, not induced by alcohol and other psychoactive substances

419

2402

1.80

26.47

2.4

3.2

62.36

81.12

mg/l

0.36

330

2042

Dermatitis due to substances taken internally

152

596

2.66

26.34

5.2

4.0

74.17

61.88

mg/l

0.18

124

524

Mental and behavioural disorders due to psychoactive substance use

1322

8856

1.38

26.33

2.1

3.5

87.01

60.70

mg/l

0.37

1080

7536

Benign neoplasm of other and ill-defined parts of digestive system

498

3000

1.70

26.33

3.1

3.4

58.28

70.05

mg/l

0.25

444

2548

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

356

1884

1.87

26.28

2.2

3.6

67.62

79.17

mg/l

0.16

291

1609

Membranous nephropathy

9.33

26.26

2.2

3.2

58.32

31.17

mg/l

2.63

Non-selective monoamine reuptake inhibitors

891

5852

1.48

26.20

2.9

3.6

104.29

66.88

mg/l

0.26

752

5012

Extreme obesity with alveolar hypoventilation

136

508

2.83

26.19

2.3

4.1

65.12

58.86

mg/l

0.18

436

Acute myeloid leukaemia

133

4.98

25.95

1.3

1.2

30.38

48.96

mg/l

3.53

115

Acute myeloid leukaemia, including Hilmo

133

4.98

25.95

1.3

1.2

30.38

48.96

mg/l

3.53

115

Acute myeloid leukaemia, helper endpoint

133

4.98

25.95

1.3

1.2

30.38

48.96

mg/l

3.53

115

Primary biliary cholangitis, wide definition

238

3.78

25.92

1.4

4.1

48.57

88.49

mg/l

0.73

208

Other disorders of bladder

351

1925

1.88

25.87

2.7

3.5

78.90

89.48

mg/l

0.11

263

1650

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

332

1725

1.90

25.84

2.3

3.6

69.64

81.83

mg/l

0.15

270

1480

Injuries to the elbow and forearm

1553

9990

1.34

25.83

2.9

3.5

78.95

63.95

mg/l

0.22

1313

8485

Fluid overload

11.23

25.73

3.0

3.7

65.68

33.87

mg/l

1.28

Bipolar affective disorders

320

1698

1.91

25.69

2.3

3.6

165.86

48.82

mg/l

0.45

280

1451

Sensorineural hearing loss

1906

9782

1.31

25.61

3.4

51.38

71.91

mg/l

1.47

1583

8347

Unspecified privation

274

1389

2.03

25.53

3.0

3.5

57.64

94.37

mg/l

0.46

246

1191

Anterior Iridocyclitis

475

2845

1.70

25.48

3.5

3.3

48.53

71.47

mg/l

0.63

378

2418

Coxarthrosis, primary

1638

10318

1.33

25.48

3.0

3.5

47.90

73.50

mg/l

2.37

1409

8753

Acute pancreatitis

504

3068

1.68

25.45

3.0

3.2

70.93

70.97

mg/l

0.00

413

2602

Other local infections of skin and subcutaneous tissue

268

1350

2.04

25.42

4.4

3.6

68.21

94.49

mg/l

0.27

235

1152

Diabetic neuropathy

408

2351

1.80

25.41

2.5

2.6

71.48

82.59

mg/l

0.19

345

1963

Drug-induced adrenocortical insufficiency

210

3.99

25.27

5.2

3.7

31.90

74.40

mg/l

0.83

179

Injuries to the knee and lower leg

2611

11257

1.26

25.25

2.9

3.5

64.76

65.06

mg/l

0.01

2216

9565

Disorders of synovium and tendon

1119

6788

1.41

25.24

2.6

3.7

95.22

59.57

mg/l

0.34

962

5694

Pneumococcal septicemia

115

401

3.04

25.22

8.0

3.5

70.92

65.05

mg/l

0.13

344

Selective serotonin reuptake inhibitors

2181

8844

1.29

25.19

3.0

3.6

72.07

62.42

mg/l

0.19

1824

7554

Gonarthrosis,primary

2234

10615

1.28

24.62

3.2

3.5

50.16

68.13

mg/l

1.45

1884

9013

Invasive ventilation

216

1023

2.19

24.40

3.0

3.7

92.67

60.82

mg/l

0.41

141

866

COPD, early/later onset

1288

7980

1.37

24.30

2.1

3.5

94.35

63.54

mg/l

0.43

1049

6788

Haemorrhoids and perianal venous thrombosis

818

5556

1.48

24.29

3.2

3.4

107.03

57.39

mg/l

0.39

682

4675

Reactive arthropathies

195

885

2.26

24.25

2.9

4.0

49.89

112.88

mg/l

0.51

164

750

Personality disorders, excluding more controls

389

2224

1.77

24.21

2.5

3.5

41.11

47.99

mg/l

1.02

328

1920

Vitamin B12 deficiency anaemia

299

1592

1.94

24.20

3.0

3.4

55.91

62.38

mg/l

0.45

261

1365

Superficial injury of hip and thigh

408

2382

1.75

24.13

2.5

3.2

55.38

80.36

mg/l

0.53

342

2014

Anxiety disorders, excluding more controls

1692

8246

1.32

24.01

3.4

3.6

45.92

66.21

mg/l

1.40

1449

7064

Other complications of surgical and medical care, not elsewhere classified

242

1200

2.07

23.99

3.2

3.5

57.39

98.32

mg/l

0.43

201

1028

Artrosis, including avohilmo

1769

7408

1.32

23.98

2.9

3.7

49.69

73.99

mg/l

1.36

1490

6261

Polycythaemia vera

114

407

2.97

23.98

2.5

1.5

69.46

43.15

mg/l

0.42

100

342

Inflammatory bowel disease

639

4173

1.55

23.77

2.6

3.4

45.24

64.54

mg/l

0.84

528

3547

5-aminosalicylic acid

375

2141

1.78

23.76

2.6

3.6

41.83

52.36

mg/l

1.80

319

1837

Other diseases of stomach and duodenum

201

937

2.23

23.68

3.1

3.8

51.06

54.15

mg/l

0.21

176

795

Injuries to unspecified part of trunk, limb or body region

267

1378

1.99

23.67

2.7

3.5

76.25

95.83

mg/l

0.16

235

1172

Late syphilis

166

4.34

23.55

2.3

3.9

84.51

82.80

mg/l

0.02

138

Exposure to other specified factors

1696

11210

1.31

23.52

3.0

3.5

53.66

64.63

mg/l

0.67

1483

9492

Substance abuse

1270

8740

1.36

23.44

2.1

3.5

87.40

60.74

mg/l

0.36

1050

7427

Mood [affective] disorders

2181

11047

1.27

23.41

2.9

3.5

65.71

62.76

mg/l

0.05

1835

9409

Diseases of peritoneum

277

1455

1.96

23.39

2.4

3.6

68.82

92.42

mg/l

0.28

229

1236

COPD, hospital admissions

1270

7931

1.37

23.35

2.1

3.5

94.35

63.66

mg/l

0.42

1032

6747

Mood disorders

2185

11066

1.27

23.14

2.9

3.5

65.66

62.75

mg/l

0.05

1839

9424

Other or ill-defined heart diseases

132

514

2.65

23.14

2.7

3.1

85.07

146.46

mg/l

0.24

105

439

1219

8115

1.37

22.94

3.8

3.2

109.60

61.17

mg/l

0.54

1030

6890

Familial hypercholesterolemia

404

2390

1.73

22.91

3.5

3.2

55.64

54.57

mg/l

0.08

368

2018

Bronchiectasis

252

1296

2.02

22.85

2.9

3.6

63.57

57.08

mg/l

0.14

205

1119

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

736

4996

1.49

22.82

3.2

3.4

47.84

59.94

mg/l

0.50

643

4236

Other hammer toe(s) (acquired)

414

2234

1.72

22.75

2.8

3.9

38.66

98.35

mg/l

1.18

356

1908

Carpal tunnel syndrome

1387

9052

1.34

22.73

3.3

3.5

54.32

70.28

mg/l

0.74

1210

7693

Superficial injury of head

580

3747

1.57

22.67

2.5

3.2

53.68

69.85

mg/l

0.54

484

3198

In situ neoplasms

1017

7339

1.41

22.62

3.7

3.3

73.31

65.19

mg/l

0.25

853

6227

Polyarthritis, unspecified

107

380

2.95

22.61

2.9

4.0

56.31

184.57

mg/l

0.45

331

Aortic aneurysm

662

4334

1.53

22.45

3.2

3.4

61.68

73.82

mg/l

0.43

524

3703

Juvenile arthritis (FINNGEN)

210

3.62

22.40

2.6

4.2

42.97

41.70

mg/l

0.08

185

Polyarteritis nodosa and related conditions

132

4.62

22.39

2.7

4.1

57.44

93.42

mg/l

0.35

110

Hypoglycaemia, other or unspecified

176

795

2.29

22.30

1.8

3.4

60.89

55.83

mg/l

0.24

150

673

Reactive arthropathies, FINNGEN

153

650

2.42

22.26

3.3

4.2

53.71

49.82

mg/l

0.16

131

559

Pneumonia due to Streptococcus pneumoniae

115

428

2.80

22.20

7.4

2.5

50.55

44.05

mg/l

0.67

366

Psoriatic arthropathies

218

1072

2.08

22.08

2.3

4.1

69.79

100.84

mg/l

0.24

173

915

Dilated cardiomyopathy

342

1957

1.80

22.04

2.4

3.5

52.32

55.36

mg/l

0.29

287

1666

Late syphilis, including avohilmo

202

3.83

21.99

2.2

3.8

82.26

73.86

mg/l

0.10

171

Pyothorax

148

628

2.48

21.98

4.0

3.8

347.07

59.84

mg/l

0.51

126

526

Congenital malformations, deformations and chromosomal abnormalities

1041

7163

1.39

21.83

2.8

3.4

91.69

55.45

mg/l

0.42

864

6091

Acute pancreatitis (for exclusion)

504

3191

1.61

21.78

3.0

3.3

70.93

70.47

mg/l

0.01

413

2721

Substance use, excluding alcohol

372

2175

1.74

21.77

2.1

3.6

153.11

50.85

mg/l

0.45

321

1855

Scoliosis

180

827

2.23

21.74

3.1

42.69

56.11

mg/l

0.75

152

705

Diseases of external ear

840

5904

1.44

21.73

3.4

3.3

45.71

63.13

mg/l

1.15

740

4983

Hypothyroidism, other/unspecified

1902

9825

1.28

21.71

3.3

3.4

82.78

59.83

mg/l

0.36

1601

8332

Adalimumab

188

879

2.19

21.69

1.7

3.9

44.52

53.69

mg/l

0.45

157

746

Drug-induced osteoporosis

168

4.15

21.54

1.5

4.1

28.75

84.88

mg/l

0.94

146

Other symptoms and signs involving the circulatory and respiratory systems

164

730

2.31

21.48

3.1

3.6

48.20

53.33

mg/l

0.20

140

629

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1178

7960

1.36

21.44

2.8

3.4

84.60

55.47

mg/l

0.37

985

6781

Nonhereditary hypogammaglobulinemia

108

5.01

21.40

4.6

3.8

32.22

97.29

mg/l

0.65

Hypothyroidism, strict autoimmune, 3 medication purchases required

1803

9480

1.29

21.38

3.2

3.4

84.71

60.34

mg/l

0.36

1506

8056

Stomatitis and related lesions

435

2669

1.66

21.30

3.5

3.3

57.65

70.98

mg/l

0.27

381

2268

Diseases of salivary glands

711

4863

1.48

21.26

3.2

3.3

57.49

61.08

mg/l

0.10

611

4134

Acute generalized exanthematous pustulosis

130

527

2.58

21.20

5.6

4.1

52.05

60.27

mg/l

0.24

108

455

Collapsed vertebra, not elsewhere classified

5.44

21.10

14.9

3.6

68.25

72.91

mg/l

0.05

Traumatic subdural haemorrhage

399

2245

1.70

21.07

3.1

3.5

62.04

88.29

mg/l

0.52

329

1888

Other diseases of lip and oral mucosa

937

6748

1.41

21.05

4.1

3.4

43.89

58.20

mg/l

1.04

796

5732

Disease of hard tissues of teeth, NOS

1230

4765

1.36

20.92

3.2

2.8

42.94

85.11

mg/l

1.93

1051

4011

Benign neoplasm: Transverse colon

326

1870

1.80

20.90

3.7

3.6

52.04

83.56

mg/l

0.55

294

1599

Other and unspecified drugs and medicaments

220

1112

2.04

20.83

5.5

3.5

54.69

55.34

mg/l

0.02

191

955

Hypothyreosis and Thyroxine purchase for inclusion criteria

1981

10301

1.27

20.77

3.2

3.4

81.13

63.89

mg/l

0.26

1665

8756

Somatoform disorder

333

1919

1.77

20.63

3.3

3.4

55.91

81.21

mg/l

0.38

283

1629

Skin changes due to chronic exposure to nonionizing radiation

1159

7845

1.36

20.50

3.8

3.2

112.93

61.55

mg/l

0.55

984

6668

Thiazolidinediones

317

1814

1.80

20.44

2.1

3.8

64.45

54.67

mg/l

0.77

275

1554

Viral and other specified intestinal infections, including avohilmo

425

2510

1.65

20.44

3.7

3.0

54.70

72.40

mg/l

0.36

359

2122

Benign neoplasm of other and unspecified endocrine glands

335

1945

1.77

20.41

3.1

3.5

48.28

79.38

mg/l

0.56

280

1655

Other nutritional anaemias

121

4.68

20.36

2.0

3.5

48.06

108.52

mg/l

0.62

101

Amiodarone users

306

1740

1.82

20.28

2.6

3.6

78.32

85.87

mg/l

0.07

275

1481

Ulcerative colitis

488

3115

1.59

20.23

2.8

3.3

45.42

51.45

mg/l

0.97

410

2640

Wegener granulomatosis

157

4.07

20.10

2.0

5.0

63.01

88.51

mg/l

0.27

128

Functional dyspepsia

576

3821

1.53

20.07

3.6

3.4

63.08

49.88

mg/l

0.44

493

3235

Actinic keratosis

1135

7723

1.36

20.06

3.8

3.2

114.75

61.90

mg/l

0.56

962

6562

Psoriasis

630

4263

1.50

19.97

2.5

3.4

59.97

65.36

mg/l

0.14

519

3613

Asthma and allergy, excluding more controls

157

694

2.26

19.96

3.1

2.1

38.62

36.94

mg/l

0.09

137

595

Chronic myeloproliferative disease

188

3.82

19.82

4.2

84.77

85.24

mg/l

0.00

165

Dermatopolymyositis (FG)

136

4.30

19.81

5.3

45.34

49.28

mg/l

0.14

121

Trochanteric bursitis

349

2068

1.72

19.67

2.8

3.6

36.17

48.64

mg/l

3.78

303

1713

Depression

1958

10449

1.26

19.66

3.0

3.5

68.12

63.00

mg/l

0.08

1643

8890

Squamous cell neoplasms and carcinomas of the skin

298

1695

1.81

19.57

3.0

1.5

53.62

48.76

mg/l

0.46

251

1423

Non-allergic asthma (mode)

364

2159

1.69

19.53

2.9

2.6

52.80

47.79

mg/l

0.17

304

1854

Hyperplasia of prostate

920

3714

1.41

19.53

3.5

3.7

60.48

58.95

mg/l

0.08

790

3124

Carcinoma in situ of skin of other and unspecified parts of face

300

1718

1.81

19.52

2.9

3.1

71.52

87.56

mg/l

0.19

242

1476

Conjunctivitis (acute, non atopic)

547

3595

1.53

19.45

4.6

3.2

48.15

66.44

mg/l

0.57

473

3046

Other obstructive and reflux uropathy

337

2.88

19.43

1.6

3.4

72.20

34.55

mg/l

5.43

293

Malnutrition

249

3.30

19.40

2.3

3.6

48.82

70.99

mg/l

0.42

214

Amputation of ankle bones

303

3.08

19.36

2.5

3.9

78.87

74.75

mg/l

0.07

264

Other symptoms and signs involving the digestive system and abdomen

385

2349

1.67

19.35

3.5

3.4

56.17

47.90

mg/l

0.29

319

1991

Respiratory insufficiency

212

1083

2.01

19.29

2.5

2.4

50.19

53.91

mg/l

0.27

160

933

Other diseases of upper respiratory tract

2449

10423

1.23

19.10

3.2

3.4

50.67

70.45

mg/l

1.54

2108

8819

917

5741

1.40

19.09

2.9

3.3

58.49

75.34

mg/l

0.75

758

4887

Secondary right heart disease

145

650

2.35

19.08

2.4

3.4

72.99

60.53

mg/l

0.35

116

573

Thyroiditis, ILD-related definition

229

1207

1.94

19.05

2.9

3.5

49.88

94.15

mg/l

0.49

189

1041

Use of pramipexole

563

3767

1.52

19.05

2.5

3.4

107.33

68.15

mg/l

0.32

466

3199

Other headache syndromes

807

5741

1.41

19.03

3.1

3.7

44.69

67.13

mg/l

1.01

686

4927

Neuromuscular dysfunction of bladder

236

1261

1.93

19.01

2.5

3.7

85.92

98.52

mg/l

0.09

200

1075

Other viral diseases, not elsewhere classified

338

1994

1.72

18.98

5.6

3.2

53.02

77.43

mg/l

0.43

290

1697

Crohn disease

251

1364

1.88

18.98

1.8

3.6

48.54

53.86

mg/l

0.39

200

1172

Special screening examination for other diseases and disorders

253

1378

1.87

18.92

3.1

3.2

61.90

53.53

mg/l

0.47

225

1055

Pyoderma gangrenosum

5.64

18.90

2.4

5.2

62.12

50.88

mg/l

0.22

Generalized skin eruption due to drugs and medicaments

114

460

2.59

18.85

6.0

4.0

53.19

60.93

mg/l

0.19

397

Other juvenile arthritis

186

3.53

18.76

2.8

3.8

44.46

61.62

mg/l

0.37

166

Other disorders of the musculoskeletal system and connective tissue

376

2304

1.67

18.75

3.2

3.4

300.23

54.34

mg/l

0.75

317

1969

Primary biliary cholangitis (PBC)

224

3.36

18.60

1.9

3.6

45.36

86.90

mg/l

0.73

199

Superficial injury of lower leg

532

3528

1.53

18.58

2.7

3.3

62.67

65.76

mg/l

0.06

455

2978

Ankylosing spondylitis

181

888

2.09

18.54

2.1

3.4

48.06

56.04

mg/l

0.47

148

728

Pain associated with micturition

287

1639

1.79

18.53

3.4

3.5

48.03

85.39

mg/l

0.59

248

1409

Clear cell adenocarcinoma of kidney

138

612

2.35

18.53

2.0

1.6

49.12

46.02

mg/l

0.24

111

520

Psoriasis vulgaris

416

2617

1.62

18.52

2.3

3.5

55.05

72.27

mg/l

0.38

339

2236

Diabetic maculopathy

369

2134

1.68

18.49

1.9

2.7

70.14

82.65

mg/l

0.20

298

1794

Explicit fungal Sepsis, including avohilmo

5.58

18.44

1.5

3.1

81.28

119.75

mg/l

0.21

Other chondrocalcinosis

203

3.61

18.40

3.4

4.3

41.05

84.21

mg/l

0.82

173

Duodenal ulcer

307

1795

1.76

18.34

2.1

3.4

79.21

58.05

mg/l

0.50

243

1527

Diseases of the ear and mastoid process

2324

9495

1.23

18.34

3.5

3.3

52.37

71.14

mg/l

1.22

1966

8048

COPD, hospital admissions 3, with asthma pneumonia sepsis

792

4861

1.42

18.30

2.2

3.4

122.15

72.39

mg/l

0.41

634

4129

Gonarthrosis, primary, with knee surgery

1524

9316

1.29

18.28

2.9

3.5

50.67

71.11

mg/l

1.37

1284

7904

Viral and other specified intestinal infections

302

1705

1.75

18.26

4.0

2.9

60.32

86.25

mg/l

0.36

250

1441

Other pulmonary heart/vessel disease

154

720

2.24

18.26

2.3

3.4

72.77

58.55

mg/l

0.44

120

632

Dermatopolymyositis

145

4.01

18.15

5.3

4.8

45.34

96.10

mg/l

0.63

124

Sequelae of cerebrovascular disease

1020

6503

1.36

18.14

2.4

3.4

66.06

71.75

mg/l

0.20

883

5489

Fitting and adjustment of other devices

922

5966

1.38

18.13

3.5

3.0

58.22

55.72

mg/l

0.13

882

5069

Hallux valgus (acquired)

648

3180

1.47

18.12

3.3

3.9

39.25

83.24

mg/l

1.28

570

2724

Exclusions for E4_PCOS_CONSORTIUM

1259

5988

1.32

18.10

3.4

3.3

47.89

67.91

mg/l

0.84

1076

5066

Syphilis

286

3.03

18.09

2.1

3.9

75.36

68.91

mg/l

0.10

239

Syphilis, including avohilmo

286

3.03

18.09

2.1

3.9

75.36

68.91

mg/l

0.10

239

COPD, hospital admission 2, with asthma infections

901

5685

1.38

18.07

2.2

3.4

113.35

69.41

mg/l

0.42

723

4827

Fracture of forearm

1178

8060

1.32

18.04

2.9

3.5

48.06

67.46

mg/l

1.08

1004

6851

Other viral diseases, not elsewhere classified, including avohilmo

439

2789

1.58

18.02

5.0

3.2

49.55

69.47

mg/l

0.50

377

2363

Abnormal findings in nipple discharge synovial fluid wound secretions

146

3.98

17.97

4.0

3.7

68.83

90.62

mg/l

0.19

127

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

409

2540

1.61

17.95

2.9

3.4

39.56

69.03

mg/l

0.78

337

2182

Poisoning by drugs, medicaments and biological substances

385

2394

1.63

17.83

3.1

3.3

45.73

70.54

mg/l

0.55

317

2031

Chronic rhinitis, nasopharyngitis and pharyngitis

651

4530

1.45

17.80

2.9

3.4

46.68

61.36

mg/l

0.61

566

3835

Papulosquamous disorders

883

6480

1.38

17.80

2.8

3.5

58.78

58.76

mg/l

0.00

733

5519

Vitamin D deficiency

175

3.63

17.76

1.9

3.5

35.88

80.50

mg/l

0.70

148

Explicit fungal Sepsis

5.49

17.68

1.5

3.1

83.15

121.32

mg/l

0.21

Barrett oesophagus

158

757

2.18

17.58

2.9

4.1

51.67

53.70

mg/l

0.12

142

653

Alcohol-induced chronic pancreatitis

167

815

2.12

17.57

2.1

4.0

105.08

49.75

mg/l

0.82

133

680

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

581

3855

1.48

17.45

4.0

1.6

41.98

47.01

mg/l

0.99

485

3244

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

356

2169

1.66

17.45

3.0

1.5

54.34

49.65

mg/l

0.51

295

1814

COPD-related respiratory insufficiency

355

2190

1.67

17.42

2.1

3.5

177.90

83.17

mg/l

0.35

289

1872

Mental and behavioural disorders due to alcohol

1098

7939

1.33

17.41

2.1

3.5

96.23

61.69

mg/l

0.40

881

6758

Disorders of oesophagus in diseases classified elsewhere

305

2.95

17.38

4.4

4.0

153.64

52.87

mg/l

0.51

258

Secondary thrombocytopenia

141

4.02

17.34

6.2

3.9

57.17

92.07

mg/l

0.36

119

Other blood glucose lowering drugs, excl. Insulins

416

2664

1.60

17.33

2.4

3.6

61.37

52.53

mg/l

0.89

354

2261

Left ventricular outflow tract obstruction (LVOTO), broad definition

209

1107

1.93

17.25

2.7

3.8

68.29

54.28

mg/l

0.59

178

938

Drug-induced cataract

262

3.08

17.17

4.6

4.0

54.43

71.71

mg/l

0.32

224

Cervicalgia

433

2799

1.57

17.11

3.0

3.2

46.13

54.05

mg/l

0.87

379

2357

Thoracic aortic aneurysm

398

2534

1.61

17.08

3.6

3.7

56.48

78.30

mg/l

0.48

321

2171

Hepatic failure, not elsewhere classified

118

508

2.44

17.05

2.2

3.8

73.60

61.05

mg/l

0.37

437

Combinations of oral blood glucose lowering drugs

689

4898

1.43

16.96

2.3

3.9

65.63

50.60

mg/l

1.46

588

4166

Internal derangement of knee

691

4853

1.42

16.94

3.3

3.9

41.50

82.04

mg/l

1.71

548

4171

Other anxiety disorders

717

4336

1.42

16.93

2.5

3.4

50.53

60.42

mg/l

0.32

635

3668

Cervical disc disorders

770

5574

1.40

16.90

3.3

163.56

55.02

mg/l

0.68

670

4702

Subjective visual disturbances

562

3849

1.48

16.87

3.8

3.4

116.37

66.25

mg/l

0.30

486

3266

Other hearing loss

788

5554

1.39

16.82

3.3

3.2

61.66

73.96

mg/l

0.46

635

4711

Benign neoplasm: Ascending colon

398

2545

1.60

16.80

3.1

3.5

72.58

73.43

mg/l

0.01

363

2170

Coronary artery bypass grafting

690

3619

1.44

16.77

2.1

3.6

66.09

58.40

mg/l

0.62

602

3106

Sequelae of other external causes

149

709

2.17

16.75

3.3

3.9

54.70

58.43

mg/l

0.12

132

607

Other condition

303

1807

1.71

16.72

3.2

3.4

61.46

81.89

mg/l

0.28

262

1535

Systemic sclerosis (FG)

228

3.19

16.72

2.4

4.6

59.33

47.20

mg/l

0.42

208

Abnormal involuntary movements

313

1885

1.70

16.71

3.5

43.13

85.08

mg/l

0.83

271

1617

Vascular diseases of the intestine

132

602

2.30

16.67

2.4

3.3

65.51

60.05

mg/l

0.12

110

518

Intestinal adhesions without obstruction

221

1208

1.88

16.64

4.0

3.4

62.96

55.88

mg/l

0.28

188

1028

Rash and other nonspecific skin eruption

229

1265

1.86

16.63

2.6

3.5

51.19

55.11

mg/l

0.19

194

1075

Fracture of lower leg, including ankle

1188

9014

1.30

16.58

2.7

3.5

72.57

67.37

mg/l

0.07

1007

7664

Covid-19 suspected case

359

2237

1.62

16.55

3.3

3.2

50.11

72.89

mg/l

0.45

336

1894

Anxiety (asthma-related co-morbidities)

999

5698

1.34

16.54

2.7

3.6

47.56

56.21

mg/l

0.39

872

4863

Recurrent and persistent haematuria

5.07

16.54

2.4

4.0

46.13

117.27

mg/l

0.48

Adverse effects, not elsewhere classified

359

2239

1.63

16.53

3.1

3.4

48.93

72.26

mg/l

0.47

302

1908

Diseases of male genital organs

1071

4052

1.34

16.51

3.1

3.5

58.44

57.26

mg/l

0.07

913

3402

Fissure and fistula of anal and rectal regions

488

3262

1.52

16.50

3.2

3.4

42.62

53.13

mg/l

2.31

406

2760

Benign neoplasm: Adrenal gland

216

1178

1.89

16.50

3.0

3.9

49.50

55.82

mg/l

0.27

176

1016

Carrier of infectious disease

235

3.13

16.49

1.6

3.8

51.83

75.67

mg/l

0.43

200

Iron deficiency

163

3.54

16.44

1.8

4.0

38.86

77.72

mg/l

0.54

142

Drug-induced neutropenia

190

995

1.97

16.43

4.3

3.9

50.76

56.59

mg/l

0.27

137

859

Infarction of spleen

4.99

16.39

1.2

3.9

49.66

124.04

mg/l

0.56

Recurrent aphthous stomatitis , including avohilmo

318

1933

1.68

16.35

3.4

58.58

80.12

mg/l

0.34

278

1649

Other and unspecified effects of external causes

476

3169

1.52

16.34

3.2

48.07

66.97

mg/l

0.55

391

2688

Respiratory disorders in diseases classified elsewhere

172

3.60

16.24

3.4

3.9

47.95

80.59

mg/l

0.44

146

Malignant neoplasm, without specification of site, including Hilmo

132

606

2.25

16.24

2.8

1.5

53.43

44.84

mg/l

0.49

109

508

Complications of cardiac and vascular prosthetic devices, implants and grafts

294

2.91

16.20

2.2

4.1

100.93

67.93

mg/l

0.57

249

Visual impairment including blindness (binocular or monocular)

194

1029

1.94

16.12

2.3

3.1

49.66

111.45

mg/l

0.62

179

879

Injury of unspecified body region

194

1029

1.94

16.07

2.2

3.5

44.73

54.25

mg/l

0.77

168

876

Disorders of muscles

220

1212

1.85

16.06

2.4

3.5

49.17

49.74

mg/l

0.03

182

1001

Chronic sinusitis

865

6419

1.36

16.06

3.5

47.52

59.27

mg/l

0.61

719

5426

Asthma and allergy

157

758

2.07

16.04

3.1

2.3

38.62

43.23

mg/l

0.21

137

645

Carcinoma in situ of skin of scalp and neck

116

513

2.42

16.04

3.4

3.6

74.32

65.52

mg/l

0.18

439

Paracetamol or NSAID medication

266

749

1.81

15.98

4.0

2.7

76.35

62.46

mg/l

0.25

227

640

Impacted cerumen

314

1919

1.68

15.98

2.9

3.5

42.57

84.53

mg/l

0.86

274

1632

Symptoms and signs involving speech and voice

771

5643

1.38

15.92

3.3

48.94

63.07

mg/l

0.68

658

4759

Herpesviral [herpes simplex] infections

248

1420

1.78

15.91

4.8

3.4

55.04

91.75

mg/l

0.43

199

1216

Lichen simplex chronicus and prurigo

165

833

2.04

15.84

2.8

4.0

53.80

59.43

mg/l

0.22

134

721

Aortic valve malfunction, age under 60 years

197

1054

1.91

15.83

2.8

3.8

70.02

54.79

mg/l

0.62

168

895

Viral warts

196

1048

1.91

15.73

2.6

3.6

60.74

56.25

mg/l

0.16

164

903

Gingival hyperplasia

100

414

2.52

15.72

4.1

62.44

60.82

mg/l

0.04

356

Other abnormal uterine and vaginal bleeding

459

2178

1.53

15.65

3.1

3.4

43.21

59.17

mg/l

0.59

383

1850

Artificial joint re-operation

211

1167

1.87

15.52

2.1

3.4

52.64

105.86

mg/l

0.59

181

998

Primary gonarthrosis, bilateral

1326

8764

1.28

15.51

2.8

3.5

51.88

71.64

mg/l

1.16

1117

7432

Mucosal proctocolitis

231

1305

1.80

15.47

2.8

3.7

47.87

54.90

mg/l

0.46

195

1117

Diplopia

317

1958

1.65

15.40

3.2

3.4

48.52

83.62

mg/l

0.67

276

1660

Poisoning by medicine

340

2129

1.62

15.39

2.9

3.3

46.66

72.61

mg/l

0.50

279

1806

Mantle cell lymphoma, including Hilmo

158

3.61

15.35

2.1

1.3

56.72

50.46

mg/l

0.26

135

Anxiety disorders

1736

9660

1.24

15.28

3.4

3.5

45.82

63.88

mg/l

1.32

1485

8210

Corns and callosities

172

893

1.99

15.26

3.7

50.91

118.36

mg/l

0.58

159

770

Crohn's disease NAS

133

628

2.17

15.20

2.0

3.6

50.17

56.86

mg/l

0.27

106

537

Acute gastritis

192

1035

1.91

15.18

3.0

3.7

49.46

53.71

mg/l

0.31

164

885

Neurotic, stress-related and somatoform disorders

1709

9545

1.24

15.12

3.4

3.5

45.82

64.08

mg/l

1.32

1469

8105

Migraine without aura

250

1451

1.74

15.09

3.7

3.4

39.90

47.55

mg/l

0.38

208

1247

Malignant neoplasm of other connective and soft tissue

287

2.82

15.08

7.5

1.5

42.86

44.15

mg/l

0.04

242

Unspecified contracted kidney

5.74

15.06

2.3

3.9

77.95

66.08

mg/l

0.15

Enthesopathies of lower limb, excluding foot

427

2832

1.53

15.02

3.1

3.2

40.80

52.13

mg/l

2.08

369

2390

malignant neoplasm of male genital organs, including Hilmo

675

2896

1.42

14.94

3.1

1.6

56.73

52.80

mg/l

0.21

553

2442

Urticaria

515

3550

1.47

14.89

4.3

3.2

46.92

63.74

mg/l

0.54

442

3013

Other extrapyramidal and movement disorders in other diseases

592

4198

1.43

14.86

2.7

3.3

48.55

65.03

mg/l

0.57

513

3560

Ulcerative colitis, NAS

263

1560

1.71

14.85

2.4

3.6

43.78

52.73

mg/l

0.91

220

1335

Cachexia

6.15

14.71

3.7

3.3

54.17

174.24

mg/l

0.49

Polycystic ovarian syndrome, consortium definition

1205

5381

1.29

14.68

3.1

3.4

46.45

60.02

mg/l

0.58

1014

4587

Fracture of skull and facial bones

443

2978

1.51

14.66

3.6

3.3

43.26

72.06

mg/l

0.93

387

2553

Coxibs

606

2222

1.45

14.64

2.8

3.2

135.44

62.67

mg/l

0.38

515

1857

Type 1 diabetes, definitions combined

114

512

2.25

14.50

2.5

3.6

56.73

57.68

mg/l

0.02

431

Localized swelling, mass and lump of skin and subcutaneous tissue

691

5046

1.39

14.49

3.6

3.3

60.54

53.36

mg/l

0.27

617

4229

Disorders of adult personality and behaviour

404

2668

1.53

14.45

2.5

3.4

37.96

48.15

mg/l

2.39

340

2262

Personality disorders

389

2550

1.54

14.41

2.5

3.3

41.11

48.02

mg/l

1.14

328

2162

Other general symptoms and signs

388

2.45

14.38

1.6

3.5

48.25

71.77

mg/l

0.58

338

Superficial injury of abdomen, lower back and pelvis

309

1926

1.63

14.38

2.8

3.4

45.87

81.66

mg/l

0.68

259

1639

Other inflammation of eyelid, including avohilmo

790

5889

1.35

14.38

3.9

3.4

57.35

57.98

mg/l

0.02

686

5011

Benign neoplasm: Sigmoid colon

496

3432

1.47

14.36

3.5

3.4

56.87

72.69

mg/l

0.47

451

2918

Infective dermatitis

260

1555

1.71

14.35

2.1

3.7

65.47

89.75

mg/l

0.31

195

1335

Herpesviral [herpes simplex] infections, including avohilmo

443

2989

1.50

14.34

4.2

3.1

45.46

66.17

mg/l

0.52

372

2534

Faecal incontinence

241

1415

1.75

14.31

2.4

3.3

44.26

48.49

mg/l

0.29

202

1196

Disorders of magnesium metabolism

4.44

14.29

1.3

4.2

52.78

99.78

mg/l

0.34

Type 1 diabetes, strict (exclude DM2)

113

509

2.24

14.28

2.5

3.6

56.28

57.44

mg/l

0.03

428

Disorders of conjunctiva

1653

10434

1.23

14.26

3.6

3.3

46.32

63.37

mg/l

1.45

1411

8864

Unspecified urinary incontinence

224

1290

1.78

14.26

1.9

3.4

56.45

92.83

mg/l

0.38

210

1114

Mental and behavioural disorders due to alcohol, excluding acute intoxication

949

7214

1.32

14.21

2.0

3.5

56.07

67.30

mg/l

0.54

772

6130

Radiculopathy

366

2383

1.56

14.18

3.4

3.1

53.41

58.11

mg/l

0.25

293

2000

Bacterial, viral and other infectious agents, including avohilmo

171

906

1.93

14.17

3.9

3.6

51.01

59.34

mg/l

0.34

143

767

Excessive earwax

1498

10988

1.24

14.16

3.6

3.4

44.59

70.93

mg/l

2.82

1257

9366

Status post-ami

674

3716

1.40

14.12

2.2

3.5

145.28

57.97

mg/l

0.60

605

3189

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

193

1068

1.86

14.08

3.0

3.5

48.53

106.68

mg/l

0.61

168

918

Hernia of abdominal wall

1051

8192

1.30

14.01

3.2

3.4

54.92

64.02

mg/l

0.50

902

6938

Transient ischemic attack

1344

8567

1.26

13.96

2.9

3.5

54.77

65.85

mg/l

0.76

1158

7254

Moderate visual impairment, binocular

432

2.40

13.96

1.6

3.0

47.06

66.47

mg/l

0.72

367

Total colectomy

103

456

2.34

13.94

3.8

4.1

74.26

61.39

mg/l

0.27

388

Total colectomy operation

103

456

2.34

13.94

3.8

4.1

74.26

61.39

mg/l

0.27

388

Disorders of vitreous body and globe

1257

9465

1.27

13.93

3.7

3.5

57.72

66.74

mg/l

0.42

1065

8096

Autoimmune hepatitis, wide definition

104

464

2.31

13.77

2.0

3.8

51.81

64.22

mg/l

0.33

402

Tobacco use

125

602

2.14

13.68

2.1

3.8

53.29

66.61

mg/l

0.49

103

509

Olecranon bursitis

158

828

1.96

13.68

2.9

3.6

47.22

49.26

mg/l

0.20

139

684

Polyarteritis nodosa

5.31

13.68

2.4

4.7

54.55

167.54

mg/l

0.58

Other bursopathies

300

1884

1.62

13.65

3.7

3.5

53.09

51.53

mg/l

0.10

254

1568

Kela reimbursement Agammaglobulinemia (D80-84)

4.93

13.60

9.1

4.4

23.02

125.05

mg/l

0.66

Varicose veins

1407

8562

1.25

13.58

3.2

3.4

50.88

69.77

mg/l

1.25

1160

7295

Phobic anxiety disorders

161

844

1.92

13.54

3.0

3.4

40.35

54.73

mg/l

0.87

136

717

Lesion of ulnar nerve

299

1880

1.62

13.52

2.9

3.4

50.58

81.56

mg/l

0.54

255

1591

Fall on and from stairs and steps

571

4092

1.41

13.49

3.1

3.4

100.19

66.50

mg/l

0.28

486

3472

Neuralgia and neuritis, unspecified

121

579

2.15

13.47

4.3

3.7

41.04

55.23

mg/l

0.68

103

486

Thyrotoxicosis, other and/or unspecified

399

2679

1.51

13.35

2.8

3.3

42.33

51.44

mg/l

1.26

346

2247

Hyperhidrosis

224

2.89

13.34

2.0

3.8

51.93

70.80

mg/l

0.22

194

Artificial opening status

148

767

1.99

13.31

3.7

3.3

59.33

120.81

mg/l

0.43

116

667

All anxiety disorders

1003

6034

1.30

13.29

2.7

3.4

47.43

56.00

mg/l

0.40

876

5108

Other inflammation of eyelid

327

2110

1.58

13.26

4.5

3.3

47.34

80.70

mg/l

0.69

284

1792

Coeliac disease

239

1429

1.70

13.20

3.7

3.6

293.12

52.07

mg/l

0.50

191

1229

Monoarthritis, not elsewhere classified

423

2.34

13.11

2.0

4.6

62.93

178.37

mg/l

0.45

370

Oter anti-inflammatory and antirheumatic agents, non-steroids

548

2117

1.44

13.10

3.2

3.3

60.53

63.47

mg/l

0.12

466

1765

Other enthesopathies

566

4066

1.41

13.09

2.9

3.7

45.56

49.19

mg/l

0.38

472

3398

Injuries to the ankle and foot

1321

9072

1.25

13.09

2.9

3.4

47.71

53.88

mg/l

0.46

1146

7678

Malignant neoplasm of prostate, including Hilmo

663

2852

1.39

13.07

3.1

1.6

57.14

52.95

mg/l

0.23

545

2407

Acute bronchiolitis

211

2.82

13.06

9.8

2.3

73.55

76.64

mg/l

0.03

180

Thyrotoxicosis

515

3650

1.43

12.98

2.7

3.4

42.91

64.96

mg/l

0.83

444

3086

Other symptoms and signs involving the urinary system

251

1530

1.68

12.96

3.5

3.7

54.18

88.32

mg/l

0.48

218

1318

Spontaneous rupture of synovium and tendon

196

1117

1.80

12.95

2.5

3.6

47.24

50.76

mg/l

0.18

163

924

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

373

2487

1.52

12.95

4.2

3.4

46.51

73.75

mg/l

0.67

333

2123

Disorders of skin appendages

889

6807

1.31

12.94

3.2

3.4

97.72

56.91

mg/l

0.42

769

5782

Deficiency of other B group vitamins

258

2.78

12.94

4.3

3.8

53.22

72.09

mg/l

0.37

221

Prurigo nodularis

311

2.60

12.92

2.2

4.5

56.18

69.35

mg/l

0.25

274

Cardiomyopathy, Hypertrophic obstructive

197

3.05

12.90

3.0

3.8

55.30

40.86

mg/l

0.47

171

Disorders of vitreous body

1216

9269

1.26

12.82

3.7

3.5

57.95

66.80

mg/l

0.39

1028

7927

IBD patients in KELA-register

388

2611

1.50

12.81

2.9

3.4

43.87

50.21

mg/l

0.91

324

2209

Malignant neoplasm of bladder, including Hilmo

294

1844

1.61

12.77

3.0

1.6

72.35

51.81

mg/l

1.95

248

1555

Other nonthrombocytopenic purpura

103

4.00

12.74

2.2

3.7

108.04

109.18

mg/l

0.01

Primary Sclerosing Cholangitis, IBD and UDCA required

182

3.09

12.69

2.4

3.5

44.13

44.62

mg/l

0.03

157

Arterial embolism and thrombosis

163

887

1.89

12.63

2.2

3.4

60.32

59.18

mg/l

0.04

131

749

Cardiac murmurs and other cardiac sounds

160

851

1.89

12.61

4.1

3.3

48.79

50.59

mg/l

0.07

134

737

Other Crohn's disease

124

613

2.07

12.60

1.7

3.5

50.45

60.34

mg/l

0.36

102

519

Acetic acid derivatives and related substances

597

2212

1.41

12.58

3.0

3.2

49.80

62.75

mg/l

2.38

507

1847

Viral warts, including avohilmo

375

2516

1.51

12.57

2.9

3.2

47.85

70.67

mg/l

0.52

316

2140

Other abnormal immunological findings in serum

162

3.22

12.56

3.8

4.0

44.87

41.98

mg/l

0.11

136

Chronic hepatitis, not elsewhere classified

389

2.38

12.48

1.7

4.1

43.12

56.51

mg/l

0.41

343

Disorders of phosphorus metabolism and phosphatases

6.09

12.45

3.3

3.4

56.54

178.80

mg/l

0.41

Other and unspecified nerve root and plexus disorders, also in other diseases

417

2866

1.47

12.45

3.1

3.4

38.83

71.48

mg/l

1.05

354

2425

Asthma and opportunity respiratory infection

141

738

1.99

12.44

2.6

3.9

79.99

62.82

mg/l

0.22

115

640

Hodgkin lymphoma, hilmo

298

2.59

12.43

2.0

4.0

63.45

69.66

mg/l

0.09

260

Bacterial, viral and other infectious agents

157

846

1.89

12.42

3.9

3.6

52.99

60.29

mg/l

0.26

131

715

Other specified disorders of kidney and ureter

384

2.39

12.42

2.8

4.2

80.23

63.93

mg/l

0.30

327

Protein-energy malnutrition of moderate and mild degree

105

3.93

12.41

2.6

3.5

49.27

114.50

mg/l

0.57

Other specified/unspecified inflammatory spondylopathies

351

2.42

12.40

2.7

3.5

50.13

64.96

mg/l

0.29

293

Glaucoma

1427

9906

1.23

12.35

3.2

3.4

53.35

69.55

mg/l

1.27

1154

8474

Other shoulder lesions

185

1050

1.79

12.34

1.9

3.5

39.51

49.24

mg/l

1.21

156

859

Arthropathic psoriasis

236

1435

1.68

12.29

2.2

3.8

65.80

53.60

mg/l

0.23

187

1229

Drug-induced hypoglycaemia without coma

181

3.10

12.29

2.4

3.9

103.22

87.45

mg/l

0.13

156

Conjunctivitis

1408

9240

1.23

12.23

3.7

3.3

47.34

64.18

mg/l

1.18

1198

7852

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

328

2156

1.55

12.22

4.2

3.4

45.81

77.28

mg/l

0.67

295

1840

Psoriasis (vulgaris), strict definition

355

2.42

12.21

1.6

4.1

54.20

61.42

mg/l

0.15

295

Ankylosing spondylitis, ICD10

173

967

1.83

12.20

2.2

3.8

48.31

57.55

mg/l

0.53

140

827

Overexertion and strenuous or repetitive movements

200

1166

1.75

12.19

4.7

3.6

46.38

56.12

mg/l

0.60

182

1002

Emphysema

206

1216

1.74

12.13

2.8

3.9

82.85

63.73

mg/l

0.37

161

1044

Post-traumatic stress disorder

397

2.29

12.11

1.9

3.3

43.31

60.19

mg/l

0.39

336

Postzoster neuralgia

205

2.96

12.09

4.7

3.5

118.49

84.63

mg/l

0.21

173

Systemic sclerosis

273

2.65

12.08

2.4

3.8

59.33

66.25

mg/l

0.10

232

Ventral hernia

555

4040

1.39

12.04

3.3

3.4

52.53

68.65

mg/l

0.58

466

3376

Voice disturbances

578

4234

1.38

12.04

3.7

3.4

49.09

64.86

mg/l

0.55

506

3597

Use of anticholinesterases

638

6566

0.74

12.02

2.3

3.2

49.51

75.78

mg/l

1.85

516

5556

N06DA Anticholinesterases

638

6566

0.74

12.02

2.3

3.2

49.51

75.78

mg/l

1.85

516

5556

Idiopathic pulmonary fibrosis

225

1366

1.70

11.98

2.5

3.4

67.81

57.84

mg/l

0.52

181

1176

Nonorganic sleeping disorders, excluding more controls

321

2106

1.54

11.97

2.5

3.4

42.49

77.08

mg/l

0.75

278

1822

Wet age-related macular degeneration

517

3595

1.41

11.93

2.7

3.1

61.77

81.87

mg/l

0.51

433

3036

Other disorders of eyelid

1105

8336

1.26

11.92

2.9

3.4

61.24

70.78

mg/l

0.38

931

7082

Fall involving bed

110

536

2.14

11.91

3.1

3.5

77.01

61.04

mg/l

0.42

461

Oxicams

535

2167

1.42

11.91

3.2

54.51

63.05

mg/l

0.77

465

1808

Infections with a predominantly sexual mode of transmission

397

2718

1.47

11.83

2.7

3.2

46.43

65.29

mg/l

0.45

334

2301

Alcohol use disorder, ICD-based

864

6718

1.30

11.81

2.0

3.5

56.60

68.83

mg/l

0.54

705

5697

Superficial injury of thorax

323

2135

1.54

11.76

2.5

3.3

59.60

80.68

mg/l

0.35

269

1820

Cholecystitis

350

2356

1.51

11.74

3.2

95.37

77.94

mg/l

0.20

302

1991

Orchitis and epididymitis

220

1332

1.69

11.71

3.4

3.5

44.24

60.16

mg/l

3.91

178

1109

Other disorders of nervous system

170

961

1.82

11.67

3.5

3.9

42.28

58.39

mg/l

1.12

136

819

Presbycusis

426

2947

1.45

11.67

3.1

2.9

53.08

87.10

mg/l

0.94

312

2493

malignant neoplasm of male genital organs

644

2869

1.37

11.66

3.1

1.6

57.37

52.91

mg/l

0.24

528

2418

Carcinoma in situ of skin

245

1531

1.64

11.64

3.7

3.4

75.33

91.19

mg/l

0.16

202

1320

Benign neoplasm: Stomach

247

1546

1.64

11.60

3.2

3.5

57.75

91.46

mg/l

0.46

224

1318

Paralytic ileus

105

507

2.15

11.57

4.3

3.4

65.96

50.49

mg/l

0.52

428

Mixed and other personality disorders

120

606

2.01

11.50

3.2

3.5

39.76

60.89

mg/l

1.00

101

513

Myositis

304

2.51

11.48

2.3

3.7

52.82

63.26

mg/l

0.25

255

Inguinal hernia

1289

6954

1.24

11.47

3.8

3.3

52.69

68.90

mg/l

0.92

1109

5831

Chronic laryngitis and laryngotracheitis

315

2084

1.54

11.47

2.4

3.2

40.85

78.05

mg/l

0.81

270

1769

Other peripheral vascular diseases

180

1038

1.77

11.47

2.3

3.5

36.44

55.16

mg/l

1.72

153

896

Specific personality disorders

324

2150

1.52

11.47

2.2

3.5

36.90

48.40

mg/l

2.22

271

1820

Psoriatic arthropathies, ICD10

214

1294

1.69

11.44

2.3

3.9

70.32

55.43

mg/l

0.26

170

1113

Mixed connective tissue disease

183

2.99

11.43

1.9

4.4

45.70

74.55

mg/l

0.42

158

Other localized connective tissue disorders

211

2.84

11.41

3.9

68.55

70.62

mg/l

0.02

183

Benign neoplasm: Caecum

292

1909

1.57

11.38

4.0

3.6

97.66

79.88

mg/l

0.18

260

1628

Retinal vascular occlusion

328

2197

1.53

11.38

3.3

3.4

54.10

83.75

mg/l

0.63

274

1868

Other psoriatic arthropathies

209

1258

1.69

11.37

2.3

3.9

70.69

55.64

mg/l

0.26

165

1081

Benign neoplasm: Rectum

458

3268

1.43

11.33

3.2

3.4

152.25

72.91

mg/l

0.37

411

2780

Inflammatory diseases of the central nervous system

173

990

1.78

11.32

3.5

3.6

44.25

56.96

mg/l

0.84

147

844

Inflammatory bowel disease, strict (require KELA)

388

2682

1.46

11.25

2.9

3.4

43.87

70.21

mg/l

0.70

324

2272

Other congenital malformations

129

673

1.95

11.24

2.7

3.6

40.68

59.96

mg/l

1.03

109

574

Benign thyroid growths and nodules

710

5028

1.33

11.23

3.2

3.5

61.12

56.18

mg/l

0.17

619

4283

Right bundle-branch block

433

2.22

11.22

3.1

3.5

64.00

166.52

mg/l

0.39

373

Allergic purpura

277

2.54

11.15

1.9

4.0

42.37

69.54

mg/l

0.63

234

Malignant neoplasm of other connective and soft tissue, including Hilmo

103

501

2.12

11.12

7.6

1.5

39.66

44.50

mg/l

0.23

418

Coxarthrosis, primary, with hip surgery

1210

9137

1.24

11.11

3.0

3.5

49.46

71.49

mg/l

1.83

1035

7751

Hypopituitarism

130

684

1.94

11.11

3.6

3.7

38.44

56.44

mg/l

1.19

105

579

Retinal detachments and breaks

861

6754

1.29

11.09

3.7

3.5

52.36

63.54

mg/l

0.70

727

5737

Dermatophytosis

313

2086

1.53

11.05

3.4

3.5

52.43

80.49

mg/l

0.52

266

1775

Umbilical hernia

579

4302

1.36

11.04

3.1

3.5

55.69

76.27

mg/l

0.67

504

3630

Malignant neoplasm of digestive organs, including Hilmo

918

5307

1.28

11.03

2.7

1.5

61.25

45.95

mg/l

1.54

784

4474

Background retinopathy and retinal vascular changes

274

2.57

11.02

2.3

3.9

52.24

74.57

mg/l

0.48

233

Benign neoplasm: Rectum, anus and anal canal

506

3688

1.39

11.02

3.3

3.4

144.79

71.23

mg/l

0.37

447

3130

ILD-related respiratory insufficiency

110

553

2.08

11.01

2.9

3.9

65.42

61.84

mg/l

0.10

482

Oesophagitis

140

760

1.90

11.01

2.5

3.8

54.02

51.09

mg/l

0.13

112

647

Unspecified misadventure during surgical and medical care

147

811

1.87

10.99

3.1

3.7

58.22

55.21

mg/l

0.12

130

700

Adhesive capsulitis of shoulder

345

2347

1.49

10.96

2.5

3.7

47.33

50.39

mg/l

0.32

292

1967

Bullous disorders

156

878

1.83

10.94

3.4

3.6

66.89

55.50

mg/l

0.41

131

757

Infection due to other mycobacteria, including avohilmo

199

2.86

10.94

1.8

3.6

135.66

72.66

mg/l

0.34

172

Mental and behavioural disorders due to tobacco

183

1075

1.74

10.93

2.4

3.9

262.63

57.74

mg/l

0.46

162

914

Infection due to other mycobacteria

188

2.93

10.93

1.8

3.5

140.57

75.02

mg/l

0.34

163

Other inflammatory liver diseases

150

833

1.85

10.92

2.2

3.9

49.31

58.72

mg/l

0.43

129

712

Smoking dependency

183

1076

1.74

10.90

2.4

3.9

262.63

57.31

mg/l

0.46

162

914

Mantle cell lymphoma

105

3.71

10.89

1.3

1.2

66.49

52.30

mg/l

0.47

Leukaemia of unspecified cell type

115

3.58

10.88

4.5

4.0

54.11

110.61

mg/l

0.52

100

Erosion of teeth , including avohilmo

425

3005

1.43

10.88

3.1

3.3

42.32

66.38

mg/l

0.73

362

2561

630

4438

1.34

10.83

2.9

3.1

52.79

78.81

mg/l

1.11

512

3780

Recurrent or chronic depression

646

3362

1.34

10.83

3.2

3.8

40.99

49.00

mg/l

1.46

550

2927

Other noninfective disorders of lymphatic vessels and lymph nodes

420

2.21

10.82

1.5

3.6

44.60

59.84

mg/l

0.51

365

Other/unspecified reactive arthropathies

138

749

1.89

10.80

3.3

3.7

52.36

58.59

mg/l

0.19

120

640

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

4.15

10.79

7.6

1.3

41.58

43.67

mg/l

0.05

Migraine

753

4503

1.31

10.79

3.2

3.7

40.68

58.30

mg/l

0.80

642

3870

Generalized anxiety disorder

199

1194

1.68

10.75

2.5

3.6

39.54

50.73

mg/l

0.91

176

1023

Suicide or other Intentional self-harm

383

2665

1.45

10.73

3.0

3.3

39.88

68.39

mg/l

0.78

318

2259

Epilepsy

617

4630

1.34

10.73

2.7

3.5

100.63

67.87

mg/l

0.30

534

3938

Other degenerative diseases of the nervous system

634

3475

1.34

10.68

3.1

3.6

45.61

86.70

mg/l

1.29

531

2966

Transport accidents

798

5163

1.29

10.61

2.6

3.4

55.03

50.55

mg/l

0.18

695

4415

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

409

2885

1.43

10.60

2.9

3.2

39.56

65.85

mg/l

0.78

337

2441

Systemic sclerosis, icd10

285

2.50

10.60

2.5

3.6

60.02

63.35

mg/l

0.05

245

!Aliquae complicationes praecoces traumatis

104

517

2.07

10.59

2.9

3.6

87.27

62.34

mg/l

0.31

434

Early complications of trauma

104

517

2.07

10.59

2.9

3.6

87.27

62.34

mg/l

0.31

434

Colectomy operation

411

2914

1.43

10.57

2.9

3.4

91.60

72.42

mg/l

0.31

366

2480

Other specified/unspecified spondylopathies

310

2.42

10.56

3.7

3.1

48.99

75.07

mg/l

0.71

274

Retinal vascular disorders

329

2240

1.50

10.56

3.2

3.4

53.99

83.01

mg/l

0.62

275

1904

Fracture of neck

166

962

1.78

10.55

4.7

3.4

58.08

57.11

mg/l

0.03

137

809

Pulmonary oedema

256

2.60

10.54

4.5

3.9

89.45

79.72

mg/l

0.16

222

Keratitis

702

5396

1.31

10.53

3.1

3.3

52.57

62.51

mg/l

0.41

592

4585

Other/unspecified synovitis and tenosynovitis

223

1391

1.63

10.53

2.1

3.6

316.05

50.29

mg/l

0.54

184

1151

Malignant neoplasm, without specification of site

412

2.21

10.52

2.6

1.5

64.95

45.85

mg/l

0.84

342

Other secondary gonarthrosis

134

729

1.89

10.50

2.4

4.1

52.56

54.71

mg/l

0.07

105

622

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

138

3.23

10.47

2.5

4.0

48.78

92.54

mg/l

0.48

116

Early onset COPD

498

3650

1.38

10.46

2.1

3.5

136.16

69.17

mg/l

0.36

412

3102

Fibroblastic disorders

522

3854

1.37

10.42

2.9

3.5

102.52

56.78

mg/l

0.38

445

3205

Post-traumatic wound infection, not elsewhere classified

299

2.43

10.41

2.4

3.7

93.98

67.16

mg/l

0.21

254

Extrapyramidal and movement disorders

926

7386

1.27

10.40

2.5

3.4

48.75

62.77

mg/l

0.90

789

6231

Fall on same level involving ice and snow

1219

10000

1.23

10.38

2.9

3.5

97.86

59.09

mg/l

0.41

1042

8488

Flat foot [pes planus] (acquired)

183

1091

1.71

10.34

2.5

4.2

37.03

101.46

mg/l

0.72

155

932

Drug-induced systemic lupus erythematosus

4.69

10.32

1.4

3.0

41.74

130.78

mg/l

0.44

Fracture of foot, except ankle

428

3062

1.41

10.30

3.2

3.3

45.20

67.66

mg/l

0.66

359

2590

Renal agenesis and other reduction defects of kidney, including avohilmo

5.46

10.29

1.5

4.0

93.77

197.19

mg/l

0.33

Other specified/unspecified disorders of bone/cartilage

276

2.48

10.29

3.2

3.6

39.33

62.88

mg/l

0.54

234

Restless leg syndrome

311

2105

1.50

10.21

2.1

3.4

38.18

79.35

mg/l

0.95

274

1790

Postprocedural musculoskeletal disorders, not elsewhere classified

187

1130

1.70

10.20

3.6

271.51

57.34

mg/l

0.47

157

971

Persistent mood disorders

353

2448

1.46

10.15

2.5

3.3

171.27

73.56

mg/l

0.40

314

2080

Acquired absence of limb

115

3.45

10.14

2.6

3.9

97.82

64.69

mg/l

0.72

Pure hyperglyceridaemia

248

2.56

10.13

2.5

3.3

97.80

66.48

mg/l

0.34

208

Urolithiasis

747

5828

1.30

10.10

2.8

3.4

60.73

66.81

mg/l

0.19

617

4934

Other congenital malformations, including avohilmo

194

1180

1.66

10.08

2.5

3.7

37.75

53.36

mg/l

1.64

170

1022

Other specified/unspecified bacterial intestinal infections

156

899

1.78

10.08

5.1

3.4

56.72

57.70

mg/l

0.03

135

767

Ovarian cyst

548

2310

1.37

10.05

3.1

3.3

41.40

57.43

mg/l

0.64

466

1959

Other disorders of eye and adnexa

268

1763

1.54

10.05

2.8

3.5

39.30

81.64

mg/l

0.77

239

1501

Synovial cyst of popliteal space [Baker]

167

981

1.74

10.05

3.4

3.5

46.77

50.29

mg/l

0.17

144

814

Hyperaldosteronism

362

2.27

10.05

3.2

4.1

46.75

62.16

mg/l

0.42

311

Carcinoma in situ of skin of upper limb, including shoulder

471

2.13

10.00

3.1

3.8

66.80

64.40

mg/l

0.04

410

Benign neoplasm of urinary organs

127

691

1.90

9.99

2.3

3.8

85.47

57.84

mg/l

0.32

104

601

Other encephalitis

286

2.43

9.99

3.0

4.0

39.24

69.43

mg/l

0.76

243

Injuries to the neck

403

2870

1.42

9.99

4.3

3.3

46.04

69.52

mg/l

0.64

342

2450

Malignant neoplasm of prostate

632

2828

1.34

9.98

3.1

1.6

57.71

53.13

mg/l

0.24

520

2387

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

459

2.08

9.94

1.9

3.2

38.39

59.62

mg/l

0.86

379

Benign neoplasm: Duodenum

391

2.23

9.93

3.2

4.0

99.59

65.18

mg/l

0.31

335

Organic, including symptomatic, mental disorders

1389

8133

1.21

9.90

2.8

3.4

53.08

68.17

mg/l

1.17

1137

6965

Abnormal findings on diagnostic imaging of central nervous system

105

537

2.00

9.87

3.0

4.1

38.63

61.31

mg/l

1.18

465

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

546

4031

1.35

9.87

2.9

3.4

45.14

60.58

mg/l

0.56

487

3406

Other and unspecified injuries of lower leg

138

770

1.82

9.86

2.7

3.8

68.10

60.22

mg/l

0.11

111

651

Seborrhoeic dermatitis

219

1387

1.61

9.80

3.2

3.7

49.79

57.20

mg/l

0.56

189

1192

Alcohol abuse, main dg, excluding more controls

260

1709

1.54

9.77

1.9

3.8

216.59

54.21

mg/l

0.48

212

1484

Secondary polycythaemia

271

2.46

9.76

2.7

4.1

48.23

74.60

mg/l

0.59

233

Abnormal blood-pressure reading, without diagnosis

478

2.06

9.72

3.4

60.24

54.96

mg/l

0.09

421

Use of donepezil

333

4519

0.69

9.72

2.3

3.0

52.99

80.38

mg/l

1.08

272

3811

4.44

9.71

1.2

4.4

48.41

45.22

mg/l

0.12

KRA_PSY_EATING, excluding more controls

260

2.42

9.69

3.2

42.40

37.50

mg/l

0.25

233

Erythema nodosum

309

2.35

9.68

3.1

4.1

42.26

62.64

mg/l

0.51

263

Left bundle-branch block

162

954

1.73

9.66

2.6

3.4

43.96

99.09

mg/l

0.50

136

828

Encephalitis

303

2.36

9.65

3.0

4.0

39.99

67.71

mg/l

0.72

256

Nummular dermatitis

193

1191

1.65

9.65

3.0

3.8

54.38

57.85

mg/l

0.17

155

1025

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

228

1460

1.58

9.61

3.5

41.74

50.45

mg/l

0.80

189

1236

Other and unspecified haemorrhagic conditions

167

2.89

9.61

4.5

3.5

44.04

89.61

mg/l

0.70

147

ILD and respiratory illness in diseases classified elsewhere

4.25

9.60

1.2

4.2

46.80

44.26

mg/l

0.10

Crohn's disease of large intestine

481

2.04

9.55

1.7

3.8

49.93

66.24

mg/l

0.52

412

Exposure to other and unspecified inanimate mechanical forces

142

808

1.79

9.53

2.9

3.8

42.51

54.30

mg/l

0.81

126

690

Other/unspecified enthesopathies of lower limb, excluding foot

128

706

1.84

9.51

3.2

33.34

55.44

mg/l

1.72

107

592

Ulcer of oesophagus

176

1068

1.69

9.47

3.3

3.7

319.64

53.73

mg/l

0.49

150

905

Assault

178

1078

1.67

9.44

2.6

3.4

44.99

54.78

mg/l

0.63

148

907

Viral hepatitis, including avohilmo

122

665

1.87

9.42

2.5

3.4

50.21

62.14

mg/l

0.48

106

557

Other and unspecified urticaria

327

2271

1.46

9.36

3.8

3.2

48.04

73.31

mg/l

0.52

282

1920

Viral hepatitis

118

638

1.88

9.35

2.4

3.5

51.22

61.42

mg/l

0.38

103

536

Other specified/unspecified soft tissue disorders

111

590

1.93

9.35

3.0

3.6

50.09

55.08

mg/l

0.22

502

Panic disorder

182

1111

1.65

9.34

2.5

3.6

41.87

51.05

mg/l

0.64

154

949

Benign neoplasm: Small intestine

116

629

1.91

9.33

3.1

3.8

83.46

59.13

mg/l

0.32

107

547

Other bacterial agents as the cause of diseases classified to other chapters

116

3.31

9.32

2.7

4.2

50.10

50.97

mg/l

0.02

Speech therapy

567

4314

1.33

9.31

2.9

3.4

57.94

66.36

mg/l

0.26

547

3646

Calculus of kidney and ureter

680

5301

1.30

9.31

2.9

3.4

62.29

66.71

mg/l

0.12

560

4493

Sequelae of injuries, of poisoning and of other consequences of external causes

441

3230

1.38

9.30

3.5

3.4

45.48

68.18

mg/l

0.71

388

2742

Intracranial and intraspinal abscess and granuloma

143

3.06

9.29

3.7

4.9

55.14

92.19

mg/l

0.41

125

Rare circulating lymphoid malignancy

4.45

9.25

6.0

1.4

2320.94

51.25

mg/l

0.52

Type 1 diabetes, strict definition, subgroup 1

244

2.44

9.22

1.7

2.7

48.05

29.14

mg/l

2.38

207

Disorders of vestibular function (Vertigo)

1068

8536

1.23

9.20

3.2

3.4

44.44

68.73

mg/l

1.94

933

7227

Alcohol-induced acute pancreatitis

435

2.09

9.20

3.0

3.9

54.91

68.78

mg/l

0.40

359

Carcinoma in situ of skin of trunk

108

576

1.96

9.19

4.5

3.6

49.31

63.05

mg/l

0.60

492

Migraine without aura and triptan purchases

185

1139

1.64

9.18

2.6

3.3

30.79

47.56

mg/l

1.72

153

969

Unknown and unspecified causes of morbidity

122

672

1.85

9.12

3.1

3.2

42.91

65.55

mg/l

1.23

104

577

Malignant neoplasm of endocrine gland, including Hilmo

151

886

1.73

9.12

4.0

1.5

42.60

41.64

mg/l

0.09

126

746

Lung cancer and mesothelioma

419

2583

1.39

9.11

2.5

2.7

48.82

50.54

mg/l

0.19

331

2234

Familial hypercholesterolemia, with ischemic heart disease

246

1631

1.54

9.10

2.1

3.6

54.75

57.06

mg/l

0.12

217

1401

Other symptoms and signs involving general sensations and perceptions

102

533

1.97

9.09

1.9

3.7

36.93

164.95

mg/l

0.69

460

Carcinoma in situ of skin of lower limb, including hip

366

2.22

9.08

4.1

3.8

68.27

66.27

mg/l

0.03

316

Complications of other internal prosthetic devices, implants and grafts

109

583

1.93

9.08

3.4

3.3

49.06

148.26

mg/l

0.55

500

Primary coxarthrosis, bilateral

735

5814

1.28

9.01

2.5

3.5

47.12

70.58

mg/l

1.45

624

4915

Cholecystectomy

1534

11050

1.19

9.00

3.3

3.4

66.94

63.37

mg/l

0.13

1305

9393

Cholangitis (primary sclerosing, PSC), with reimbursement 202

167

2.80

8.99

2.7

4.1

45.13

76.65

mg/l

0.42

143

Atopic dermatitis, strict definition with reimbursement

366

2504

1.41

8.99

2.8

3.3

43.90

67.02

mg/l

0.53

298

2123

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

259

1733

1.51

8.98

3.3

3.5

43.44

51.91

mg/l

0.84

218

1472

Other diseases of oesophagus

224

1457

1.57

8.98

3.1

3.6

50.85

56.43

mg/l

0.40

181

1244

Type 1 diabetes, strict definition

278

2.32

8.97

1.7

2.8

49.05

45.33

mg/l

0.09

235

Other abnormal findings in urine

197

2.67

8.97

4.4

3.8

54.50

89.86

mg/l

0.57

169

Hepatocellular carcinoma, including Hilmo

366

2.18

8.95

2.4

1.4

55.10

45.21

mg/l

1.03

310

Heartburn

225

1464

1.56

8.95

3.1

3.3

42.85

50.62

mg/l

0.61

210

1234

therapeutic use

441

2.07

8.93

2.5

4.0

56.75

61.95

mg/l

0.13

381

Schizophrenia or delusion, excluding more controls

480

3537

1.35

8.90

2.7

3.5

49.01

66.68

mg/l

0.58

401

3046

Otitis externa

434

3195

1.37

8.89

3.6

3.2

44.76

68.19

mg/l

0.75

391

2703

Cerebral palsy and other paralytic syndromes

219

1419

1.57

8.89

3.2

3.4

174.50

92.97

mg/l

0.26

192

1206

Benign paroxysmal vertigo

665

5204

1.29

8.86

3.2

3.4

50.09

68.85

mg/l

0.86

567

4399

Other viral hepatitis

487

1.98

8.85

2.6

3.4

52.46

60.28

mg/l

0.24

407

Arterial embolism and thrombosis of lower extremity artery

101

533

1.96

8.80

2.5

3.9

52.37

60.66

mg/l

0.25

462

Ulcerative colitis (strict definition, require KELA)

268

1814

1.49

8.80

3.3

3.6

43.33

51.50

mg/l

0.84

224

1541

Acute suppurative otitis media

293

1874

1.47

8.78

4.8

3.2

51.61

76.78

mg/l

0.40

245

1597

Personal history of other diseases and conditions

132

748

1.77

8.78

6.1

3.3

36.76

45.48

mg/l

0.74

119

656

Migraine with aura

327

2296

1.43

8.76

3.1

3.7

36.59

70.58

mg/l

0.82

284

1964

Open wound of forearm

189

1188

1.62

8.75

2.6

3.5

298.54

99.86

mg/l

0.41

156

1012

Other sleep disorders

219

1424

1.56

8.75

2.4

3.9

47.14

93.13

mg/l

0.65

176

1225

Scabies, including avohilmo

200

1272

1.59

8.72

2.7

3.5

52.95

52.80

mg/l

0.01

160

1090

Redundant prepuce, phimosis and paraphimosis

383

2727

1.40

8.71

2.8

3.6

68.57

55.72

mg/l

1.00

331

2286

Raynaud syndrome

164

997

1.67

8.70

2.0

3.6

33.23

55.16

mg/l

2.27

141

865

Trigger finger

273

1863

1.48

8.64

2.4

3.6

44.31

47.80

mg/l

0.35

237

1559

Alzheimer’s disease, strict definition

456

4896

0.74

8.62

2.7

3.0

57.68

80.71

mg/l

0.93

396

4127

Conjunctivitis (acute, non atopic), including avohilmo

2063

10805

1.16

8.62

3.5

3.4

88.75

60.86

mg/l

0.43

1766

9160

Enteropathic arthropathies

188

2.64

8.61

1.5

4.2

36.44

41.00

mg/l

0.40

169

Metatarsalgia

178

1108

1.63

8.58

2.7

3.5

46.39

48.96

mg/l

0.12

152

916

Other and unspecified mononeuropathies, also in other diseases

366

2.15

8.56

2.5

3.9

65.48

64.21

mg/l

0.01

313

Emotionally unstable personality disorder

135

780

1.75

8.55

2.3

3.4

30.69

53.80

mg/l

1.70

110

665

Disorders of parathyroid gland, other and/or unspecified

3.50

8.53

1.9

4.0

38.71

112.70

mg/l

0.64

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

290

2006

1.46

8.53

3.2

3.5

43.68

50.64

mg/l

0.75

242

1698

Lung diseases due to external agents

340

2427

1.42

8.51

2.9

3.3

69.27

83.83

mg/l

0.26

259

2056

Golimumab

281

2.30

8.49

2.4

3.5

43.56

59.63

mg/l

0.33

239

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.52

8.46

1.7

4.3

45.33

122.17

mg/l

0.64

Otitis externa, unspecified

202

1300

1.58

8.45

4.0

3.6

41.24

97.17

mg/l

0.74

178

1107

Other enthesopathy of foot (+metatarsalgia)

188

1190

1.60

8.45

2.6

3.5

45.82

49.22

mg/l

0.17

161

987

Other salmonella infections

401

2.08

8.43

3.4

3.5

39.35

60.39

mg/l

0.73

339

Hyperosmolality and hypernatraemia

168

2.76

8.41

2.6

3.1

56.31

79.09

mg/l

0.27

140

Other and unspecified glaucoma

188

1197

1.61

8.39

2.1

3.2

45.42

105.48

mg/l

0.74

153

1028

Other viral hepatitis, including avohilmo

520

1.92

8.28

2.7

3.5

51.56

58.94

mg/l

0.24

435

Menorrhagia

544

2304

1.33

8.24

3.2

3.3

49.02

57.60

mg/l

0.24

473

1956

Cervicobrachial syndrome

374

2722

1.39

8.24

3.4

3.3

45.01

51.61

mg/l

0.63

329

2287

Other and unspecified nonorganic psychotic disorders

262

1789

1.48

8.23

2.4

3.6

38.76

79.35

mg/l

0.74

217

1522

Neovascular glaucoma

104

568

1.88

8.16

2.9

3.5

87.85

58.55

mg/l

0.70

489

Temporomandibular joint disorders, including avohilmo

655

4997

1.28

8.14

3.5

3.4

34.03

55.55

mg/l

1.29

560

4250

Other diseases of biliary tract

209

1372

1.55

8.11

2.8

3.4

196.88

93.59

mg/l

0.29

162

1156

Excessive, frequent and irregular menstruation

572

2339

1.31

8.08

3.1

3.3

44.71

57.06

mg/l

0.45

495

1985

severe traumatic brain injury, does not include concussion

540

4168

1.31

8.08

3.3

3.1

59.06

74.62

mg/l

0.56

450

3512

Sacroiliitis, not elsewhere classified

287

2.23

8.04

2.4

3.2

36.08

64.48

mg/l

0.73

243

Implicit parasitic Sepsis

4.42

8.04

2.4

4.4

51.40

152.34

mg/l

0.44

Malignant neoplasm of endocrine gland

130

760

1.74

8.02

3.8

1.5

43.42

40.61

mg/l

0.27

108

641

COPD, hospital admissions 1, only main diagnosis

877

6151

1.24

8.00

2.1

3.4

65.57

68.12

mg/l

0.08

716

5211

Glaucoma secondary to other eye disorders

104

572

1.87

7.99

2.9

3.7

87.85

61.72

mg/l

0.59

490

Macular pucker

415

3097

1.36

7.98

3.1

3.6

63.35

74.49

mg/l

0.22

340

2643

378

2.10

7.96

2.1

3.8

121.19

68.42

mg/l

0.36

327

Abscess of anal and rectal regions

143

859

1.69

7.96

2.3

3.8

50.70

52.49

mg/l

0.10

115

730

Disorders of optic nerve and visual pathways

169

1060

1.62

7.95

3.7

3.5

65.19

55.90

mg/l

0.15

142

913

Lesion of lateral popliteal nerve

110

616

1.83

7.94

4.3

3.6

44.77

62.73

mg/l

0.77

519

Other disorders of iris and ciliary body

357

2.12

7.93

2.3

4.0

57.07

66.90

mg/l

0.23

307

Endometriosis

521

2304

1.32

7.89

2.7

3.3

56.28

57.53

mg/l

0.03

445

1954

Acquired absence of organs, not elsewhere classified

145

2.84

7.88

4.0

4.6

113.13

55.91

mg/l

0.57

122

Necrosis of pulp, including avohilmo

1023

8392

1.21

7.84

3.9

3.4

44.87

59.91

mg/l

1.10

847

7143

Other salmonella infections, including avohilmo

454

1.96

7.81

3.2

3.7

39.72

59.53

mg/l

0.77

381

Hyperfunction of pituitary gland

378

2.05

7.78

3.7

31.72

58.31

mg/l

1.00

327

Cholangitis (primary sclerosing, PSC)

143

867

1.69

7.78

1.9

3.2

48.96

47.13

mg/l

0.19

116

724

Agoraphobia

150

2.71

7.78

2.2

3.1

27.16

36.64

mg/l

1.49

127

Diseases of inner ear

1212

9788

1.19

7.76

3.3

3.4

44.25

67.84

mg/l

2.28

1062

8302

Mental and behavioural disorders due to opioids

216

2.40

7.73

2.3

3.2

37.89

78.17

mg/l

0.78

181

Mental and behavioural disorders due to sedatives or hypnotics

111

627

1.80

7.72

1.6

3.3

39.47

61.91

mg/l

0.98

528

Contact with and exposure to communicable diseases

325

2326

1.40

7.67

4.3

3.2

43.32

46.10

mg/l

0.21

228

1977

Kyphosis

147

2.79

7.66

4.1

3.0

52.91

94.41

mg/l

0.48

122

Benign neoplasm: Kidney

487

1.93

7.66

2.3

4.0

102.03

61.70

mg/l

0.33

424

Dermatophytosis, including avohilmo

1293

10766

1.18

7.62

3.2

3.4

46.89

59.54

mg/l

1.17

1114

9136

Unspecified/other endometriosis

106

579

1.81

7.61

2.9

3.2

70.83

46.11

mg/l

0.29

498

Other benign neoplasms of skin

814

6639

1.24

7.61

4.3

3.3

56.77

61.42

mg/l

0.19

709

5602

Benign neoplasm of mouth and pharynx

232

1578

1.49

7.60

4.3

3.6

43.46

88.24

mg/l

0.70

197

1340

Other ulcerative colitis

102

565

1.84

7.60

1.9

3.8

57.77

59.72

mg/l

0.06

476

Striking against or struck by other objects

560

4366

1.29

7.58

2.8

3.4

45.57

63.50

mg/l

0.80

482

3697

Thyrotoxicosis with toxic multinodular goitre

146

898

1.67

7.56

1.9

3.4

49.94

120.49

mg/l

0.63

129

780

Biomechanical lesions, not elsewhere classified

117

678

1.77

7.55

3.0

3.8

503.44

63.56

mg/l

0.47

589

Visual field defects

192

1258

1.56

7.55

2.8

3.4

41.01

99.31

mg/l

0.75

165

1065

Central retinal artery occlusion

345

2.12

7.53

4.7

3.4

56.48

71.08

mg/l

0.35

293

Syndrome of inappropriate secretion of antidiuretic hormone

3.81

7.53

2.1

5.9

29.15

60.25

mg/l

1.07

Chronic viral hepatitis

369

2.04

7.52

2.1

3.3

55.96

62.32

mg/l

0.14

309

Benign neoplasm: Descending colon

178

1151

1.58

7.48

2.6

3.7

56.57

58.29

mg/l

0.07

162

989

Acute lymphadenitis

517

1.87

7.48

2.9

3.8

44.33

56.79

mg/l

0.47

443

Abscess of lung

191

2.52

7.45

2.7

4.5

124.92

85.29

mg/l

0.19

164

Cluster headache, wide

318

2.12

7.39

1.6

4.7

39.81

79.68

mg/l

1.05

274

Paraplegia, diplegia of upper limbs

235

2.34

7.37

2.6

3.9

585.20

77.16

mg/l

0.45

206

Xerosis cutis

230

2.37

7.33

2.5

4.1

81.25

79.30

mg/l

0.02

200

Other and unspecified tonsillitis

391

2417

1.35

7.31

3.0

2.9

52.54

48.62

mg/l

0.25

314

2056

6-mercaptopurine

197

2.43

7.30

1.7

4.2

33.36

43.07

mg/l

1.06

174

Paralytic strabismus

161

1023

1.61

7.28

2.8

3.6

59.45

59.60

mg/l

0.01

137

874

Primary adrenocortical insufficiency

112

3.01

7.23

1.3

4.4

27.27

52.63

mg/l

1.39

Speech and linguistic disorders, excluding more controls

441

1.89

7.21

2.6

3.6

36.73

176.86

mg/l

0.63

391

Colonic or urogenital fistula

525

4100

1.29

7.19

3.4

3.3

44.05

66.00

mg/l

0.97

438

3473

Postprocedural disorders of digestive system, not elsewhere classified

419

1.97

7.19

1.8

4.0

54.80

64.12

mg/l

0.26

366

Pre-eclampsia or eclampsia

282

2007

1.42

7.16

3.4

3.3

35.76

67.48

mg/l

0.62

240

1713

Renal agenesis and other reduction defects of kidney

5.94

7.15

1.5

4.5

96.23

228.99

mg/l

0.34

Superficial injury of shoulder and upper arm

227

1555

1.48

7.15

3.4

45.59

54.05

mg/l

0.56

197

1304

Ulcerative colitis (strict definition, all Crohn cases excluded)

223

1522

1.48

7.13

3.6

42.57

53.66

mg/l

1.05

189

1299

Entropion and trichiasis of eyelid

230

1587

1.48

7.09

3.2

3.4

71.19

96.59

mg/l

0.28

199

1357

Restrictive cardiomyopathy

4.61

7.09

7.6

4.0

89.29

81.25

mg/l

0.06

Infections with a predominantly sexual mode of transmission, including avohilmo

464

3257

1.31

7.08

2.7

3.1

44.20

60.68

mg/l

0.47

393

2744

Aspergillosis

114

3.00

7.07

1.9

4.2

53.56

57.05

mg/l

0.09

100

Viral infections of the central nervous system

128

773

1.68

7.06

3.0

3.5

50.60

59.91

mg/l

0.35

103

668

Pre-eclampsia or poor fetal growth

336

2455

1.37

7.05

3.2

34.84

61.62

mg/l

0.65

284

2085

Congenital malformations of gallbladder, bile ducts and liver

103

3.08

7.03

2.1

4.0

1529.05

99.49

mg/l

0.47

Malignant neoplasm of thyroid gland, including Hilmo

129

782

1.68

7.02

4.1

1.5

44.77

39.30

mg/l

0.66

107

655

Other erythematous conditions

437

1.93

7.00

3.0

3.9

72.57

61.92

mg/l

0.15

377

Disorders of orbit

494

1.86

6.98

4.8

3.7

46.73

66.97

mg/l

0.53

430

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

183

2.44

6.97

5.1

3.6

50.29

75.18

mg/l

0.33

155

Viral agents as the cause of diseases classified to other chapters, including avohilmo

247

2.25

6.97

4.9

4.0

61.62

69.70

mg/l

0.09

215

Juvenile rheumatoid arthirtis

119

2.84

6.96

1.4

4.1

39.18

66.20

mg/l

0.38

106

Malignant melanoma, including Hilmo

356

2650

1.36

6.95

4.5

1.6

55.09

46.80

mg/l

0.73

296

2222

Necrotizing fasciitis

3.79

6.93

1.9

2.9

61.03

63.51

mg/l

0.03

Implicit parasitic Sepsis, including avohilmo

3.88

6.92

2.4

4.2

51.40

140.24

mg/l

0.43

Corneal ulcer

324

2377

1.38

6.91

2.9

3.3

57.34

76.06

mg/l

0.34

276

2027

Other and unspecified erythematous conditions

390

1.98

6.90

3.1

4.0

73.17

63.45

mg/l

0.12

335

Malignant neoplasm of thyroid gland

118

703

1.71

6.87

3.9

1.4

45.10

39.24

mg/l

0.66

594

Other and unspecified vascular occlusions

237

1655

1.46

6.86

3.2

3.4

52.48

93.44

mg/l

0.66

202

1398

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

886

7042

1.21

6.85

3.1

3.3

46.45

61.11

mg/l

0.75

751

5992

Disorders of ocular muscles, binocular movement, accommodation and refraction

805

6566

1.22

6.85

3.2

3.4

47.72

57.69

mg/l

0.59

648

5593

Other and unspecified disorders of skin and subcutaneous tissue

135

835

1.65

6.84

2.4

3.8

62.80

121.39

mg/l

0.44

123

728

Pemphigoid

435

1.93

6.84

2.4

3.3

53.20

65.49

mg/l

0.34

369

Other and unspecified psoriasis

143

897

1.63

6.84

2.2

4.0

53.43

60.83

mg/l

0.35

110

767

Other noninflammatory disorders of uterus, except cervix

427

2164

1.33

6.84

3.2

3.4

173.68

59.49

mg/l

0.43

362

1841

Type1 diabetes, definitions combined, early onset

227

2.26

6.83

1.7

2.1

45.73

34.22

mg/l

0.96

189

Hyperkinetic disorders, excluding more controls

348

1.97

6.80

1.4

3.2

33.29

32.72

mg/l

0.04

304

Pediculosis, acariasis and other infestations, including avohilmo

242

1693

1.44

6.79

2.6

3.4

52.81

82.10

mg/l

0.44

196

1446

Later onset COPD

795

5253

1.23

6.77

2.1

3.4

67.34

71.86

mg/l

0.14

641

4475

Other/unspecified enthesopathies, not elsewhere classified

165

1072

1.56

6.76

2.4

3.6

45.42

50.31

mg/l

0.26

140

884

Seronegative juvenile rheumatoid arthritis

3.28

6.75

2.2

2.8

47.99

30.44

mg/l

0.75

Iridocyclitis in diseases classified elsewhere

206

2.37

6.75

2.0

4.1

54.26

79.35

mg/l

0.38

177

Special screening examination for neoplasms

129

791

1.66

6.74

4.1

3.3

53.88

58.28

mg/l

0.15

117

608

Malignant neoplasm of mesothelium and soft tissue

501

1.84

6.71

6.8

1.5

43.18

47.32

mg/l

0.16

420

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

487

1.86

6.71

3.4

3.7

98.57

59.72

mg/l

0.44

422

Other disorders of patella

229

1590

1.45

6.70

2.7

3.9

36.49

81.27

mg/l

0.73

201

1364

Mature T/NK-cell lymphomas, hilmo

183

2.48

6.67

1.6

4.2

73.11

88.53

mg/l

0.17

153

Malignant melanoma

318

2344

1.37

6.65

4.7

1.5

54.15

47.40

mg/l

0.51

264

1971

Ulcerative colitis (strict) with PSC

3.98

6.64

3.1

4.4

39.73

43.37

mg/l

0.22

Otalgia

150

959

1.59

6.58

3.0

3.4

57.49

109.29

mg/l

0.44

130

829

Hydrocele

260

1858

1.42

6.58

2.5

3.6

90.95

61.19

mg/l

0.49

228

1548

Ulcerative ileocolitis

354

1.99

6.56

3.0

3.6

55.70

65.14

mg/l

0.19

296

Aspergillosis, including avohilmo

119

2.87

6.55

1.9

4.0

53.56

56.24

mg/l

0.07

105

Cramp and spasm

519

1.81

6.54

4.4

3.6

52.72

60.02

mg/l

0.17

443

Malignant neoplasm of breast, HER-positive

543

3194

1.27

6.53

3.1

1.5

44.13

37.30

mg/l

0.40

455

2700

Hyphaema and other vascular disorders of iris and ciliary body

268

2.17

6.53

2.6

3.9

60.49

75.25

mg/l

0.27

232

Malignant neoplasm of breast, ER-positive, including Hilmo

544

3197

1.27

6.52

3.1

1.5

44.17

37.33

mg/l

0.40

456

2702

Seborrhoeic keratosis

564

4505

1.26

6.50

3.9

3.4

49.37

64.78

mg/l

0.63

476

3810

Alzheimer’s disease (Late onset)

439

4638

0.77

6.50

2.7

3.0

57.09

81.66

mg/l

0.96

381

3915

Cystic disease of liver

3.16

6.49

2.1

4.2

1740.91

105.18

mg/l

0.47

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1001

8149

1.19

6.46

3.3

3.5

49.38

62.63

mg/l

0.75

843

6901

Cluster headache, strict

281

2.10

6.45

1.7

5.0

40.06

82.11

mg/l

0.95

243

Campylobacter enteritis

282

2.11

6.44

3.3

4.0

93.31

69.01

mg/l

0.30

246

Crohn's disease of small intestine

110

655

1.70

6.43

2.2

3.6

42.22

63.61

mg/l

1.14

560

Strabismus

442

3418

1.30

6.43

3.1

3.3

46.32

67.08

mg/l

0.69

367

2897

Respiratory conditions due to other external agents

270

2.16

6.42

4.8

3.5

80.33

74.44

mg/l

0.07

233

Other specified and unspecified personality disorders

123

754

1.65

6.41

2.5

3.7

38.41

59.70

mg/l

1.36

106

639

Other follicular disorders

119

724

1.67

6.41

2.5

3.8

48.20

60.19

mg/l

0.54

625

Diseases of tongue

125

771

1.65

6.41

4.1

2.8

52.31

117.93

mg/l

0.45

109

652

Benign neoplasm: Liver/bile ducts

256

2.17

6.40

4.6

3.9

41.78

68.46

mg/l

0.58

221

Asthma mixed form (mode), excluding more controls

420

1.88

6.39

2.1

2.3

52.59

43.73

mg/l

0.30

359

Hypotension due to drugs

206

2.34

6.36

4.2

4.0

50.22

87.30

mg/l

0.65

172

Rosacea

232

1634

1.44

6.36

2.8

3.5

38.75

82.56

mg/l

0.73

189

1398

Nonorganic sleeping disorders

321

2385

1.36

6.33

2.5

3.4

42.49

71.64

mg/l

0.68

278

2027

Other drug-induced secondary parkinsonism

133

2.71

6.32

2.1

3.6

41.67

93.48

mg/l

0.59

114

Unspecified protein-energy malnutrition

3.63

6.31

1.4

3.5

52.82

70.23

mg/l

0.28

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.06

6.30

1.4

3.6

49.44

111.16

mg/l

0.47

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

546

4359

1.26

6.28

3.7

3.2

122.08

53.19

mg/l

0.44

465

3667

Chronic conjunctivitis

312

2.04

6.28

2.6

3.9

54.67

66.98

mg/l

0.23

266

Malignant neoplasm of renal pelvis, including Hilmo

133

2.68

6.28

3.4

1.3

51.37

46.35

mg/l

0.32

111

Other disorders of penis

197

1349

1.48

6.27

2.3

3.6

93.26

58.53

mg/l

0.42

176

1128

Pre-eclampsia

251

1796

1.41

6.24

3.7

3.2

34.92

70.00

mg/l

0.61

211

1531

Speech and linguistic disorders

474

1.79

6.22

2.6

3.3

36.73

58.01

mg/l

0.95

403

Additional codes for the location of defect, injury or illness

118

724

1.66

6.21

1.8

3.7

79.31

61.49

mg/l

0.22

113

626

Corticotropin deficiency

3.04

6.21

1.4

4.6

26.86

38.44

mg/l

1.38

Brain meningioma, including Hilmo

103

610

1.72

6.21

3.7

1.4

40.09

40.22

mg/l

0.01

522

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

374

1.91

6.21

4.1

3.2

45.70

59.14

mg/l

0.36

318

D07AA Corticosteroids, weak (group I)

216

1505

1.45

6.19

2.3

3.4

61.06

88.30

mg/l

0.28

181

1281

Inflammatory diseases of female pelvic organs

983

5672

1.19

6.17

2.8

3.5

43.64

67.89

mg/l

1.01

837

4847

Malignant neoplasm of breast, including Hilmo

658

3417

1.24

6.17

3.2

1.6

44.97

36.94

mg/l

0.60

554

2887

Alcohol abuse, main dg

260

1879

1.40

6.15

1.9

3.6

216.59

54.42

mg/l

0.48

212

1590

Bronchitis, not specified as acute or chronic

163

1080

1.53

6.13

2.9

3.7

58.98

58.70

mg/l

0.01

139

920

Other epidermal thickening

100

590

1.73

6.13

2.6

3.9

72.07

65.67

mg/l

0.12

513

Varicella [chickenpox]

384

1.91

6.12

10.5

3.2

57.77

64.24

mg/l

0.11

319

Pleural plaque

255

1845

1.41

6.12

2.7

3.4

57.75

63.59

mg/l

0.38

201

1576

Malignant neoplasm of breast, HER2-negative, including Hilmo

657

3417

1.24

6.09

3.2

1.6

44.95

36.94

mg/l

0.60

553

2887

Urethral stricture

143

925

1.58

6.09

2.6

3.8

115.73

60.22

mg/l

0.48

121

775

Alzheimer disease

658

5735

0.81

6.07

2.8

3.2

54.32

78.57

mg/l

1.32

541

4839

Benign neoplasm: Pancreas

424

1.88

6.06

3.0

4.3

37.83

65.73

mg/l

1.22

365

Superficial injury of forearm

159

1050

1.53

6.05

2.8

3.6

46.14

55.92

mg/l

0.44

136

892

Brain meningioma

100

592

1.72

6.05

3.6

1.4

40.72

39.78

mg/l

0.09

505

Ulcerative enterocolitis

282

2.07

6.04

2.3

3.9

42.53

67.88

mg/l

0.61

242

Primary open-angle glaucoma, strict

664

5434

1.23

6.03

3.4

3.3

53.26

73.45

mg/l

1.01

533

4607

Event of undetermined intent

104

622

1.70

6.01

3.8

3.4

75.34

58.81

mg/l

0.16

529

Hidradenitis suppurativa

262

2.10

6.00

2.4

3.5

49.50

59.24

mg/l

0.16

222

Secondary parkinsonism, excluding more controls

325

2.00

5.99

2.6

4.1

40.65

235.86

mg/l

0.64

283

Ingrowing nail

548

1.75

5.99

2.4

3.6

52.15

57.90

mg/l

0.20

467

Attention to artificial openings

557

1.75

5.98

2.6

3.2

77.99

48.26

mg/l

0.97

477

Malignant neoplasm of breast

648

3395

1.24

5.98

3.2

1.6

45.17

37.02

mg/l

0.60

546

2868

Benign neoplasm: Skin of eyelid, including canthus

334

2526

1.34

5.96

4.5

3.3

53.08

74.82

mg/l

0.48

297

2147

Other disorders of optic [2nd] nerve and visual pathways

125

787

1.62

5.94

3.8

3.7

74.74

60.95

mg/l

0.17

105

676

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

102

609

1.70

5.93

2.7

3.5

46.47

64.54

mg/l

0.76

517

Malignant neoplasm of breast, HER2-negative

647

3393

1.24

5.93

3.2

1.6

45.08

37.03

mg/l

0.59

545

2866

Sudden idiopathic hearing loss

217

1534

1.44

5.91

3.1

3.5

48.20

89.29

mg/l

0.61

192

1310

Other other unspecified disorders of the circulatory system

478

1.80

5.89

3.6

3.7

48.88

60.09

mg/l

0.35

410

Allergic conjunctivitis

918

7464

1.19

5.89

3.1

3.4

46.31

60.45

mg/l

0.77

776

6349

Other injuries of lower limb, level unspecified

2.92

5.86

2.9

3.3

57.91

117.30

mg/l

0.46

Benign neoplasm: Liver

219

2.21

5.85

4.4

4.1

44.23

73.64

mg/l

0.53

188

Suggestive for eosinophilic asthma

188

1298

1.47

5.82

2.6

3.7

56.11

56.01

mg/l

0.00

147

1112

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

135

862

1.57

5.81

2.4

3.4

34.74

54.89

mg/l

1.62

121

740

Other noninflammatory disorders of vagina

133

854

1.58

5.79

2.6

3.4

39.65

48.13

mg/l

0.70

126

727

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

108

661

1.67

5.79

2.1

1.6

55.98

50.84

mg/l

0.42

559

Specific development disorders of speech and language

376

1.87

5.78

1.9

3.5

33.43

65.06

mg/l

1.26

321

Impingement syndrome of shoulder

446

3516

1.28

5.78

3.6

3.7

41.36

51.76

mg/l

2.58

418

2944

Nail disorders

151

999

1.53

5.76

2.5

3.5

55.24

55.90

mg/l

0.02

141

855

Superficial injury of wrist and hand

314

2362

1.34

5.74

2.7

3.3

46.43

71.93

mg/l

0.55

275

1998

Presence of other devices

553

4400

1.25

5.74

3.4

3.2

53.79

73.84

mg/l

0.70

536

3781

Colitis, primary sclerosing

2.85

5.71

2.5

3.7

42.80

102.06

mg/l

0.51

Palmar fascial fibromatosis [Dupuytren]

348

2665

1.32

5.70

2.9

3.4

134.03

60.24

mg/l

0.42

294

2209

Testicular dysfunction

387

1.87

5.69

3.3

3.7

51.17

67.14

mg/l

0.36

318

Delivery

502

3308

0.79

5.65

3.9

3.0

47.98

74.70

mg/l

0.72

441

2825

Demyelinating diseases of the central nervous system

115

718

1.62

5.63

3.0

3.5

35.68

57.88

mg/l

1.32

102

612

Single spontaneous delivery

501

3306

0.80

5.61

3.8

3.0

48.32

74.71

mg/l

0.71

439

2824

Other congenital malformations of skin

382

1.87

5.60

2.1

4.0

42.40

59.14

mg/l

0.51

330

Disorders of adrenal gland, other and/or unspecified

3.71

5.60

1.2

3.8

21.56

39.08

mg/l

2.19

Use of rivastigmine

259

3472

0.73

5.57

2.7

3.1

48.56

74.79

mg/l

0.93

212

2938

Eating disorders

595

1.67

5.56

3.0

3.1

43.03

57.03

mg/l

0.54

508

Manic episode

264

2.05

5.54

3.3

4.3

43.50

70.66

mg/l

0.60

224

Other and unspecified rosacea

171

1171

1.48

5.53

3.1

3.6

41.42

53.50

mg/l

1.04

137

1009

Varicella [chickenpox], including avohilmo

426

1.81

5.53

10.1

3.0

55.70

61.84

mg/l

0.12

353

Malignant neoplasm of eye and adnexa, including Hilmo

160

2.40

5.53

5.4

1.3

36.48

43.46

mg/l

0.62

136

Papilloedema, unspecified

211

2.19

5.53

1.5

3.7

129.50

75.47

mg/l

0.23

180

Other and unspecified acute skin changes due to ultraviolet radiation

328

1.95

5.53

3.0

3.7

41.16

70.32

mg/l

0.90

283

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

189

1321

1.45

5.52

3.5

3.7

44.77

54.29

mg/l

0.80

161

1135

Amputation of thigh

481

1.78

5.51

1.8

3.4

72.61

65.47

mg/l

0.20

409

Sixth [abducent] nerve palsy

466

1.79

5.51

3.8

4.0

54.09

61.90

mg/l

0.20

396

Assault by bodily force

568

1.69

5.50

3.0

3.5

40.41

54.28

mg/l

0.60

477

Sequelae of injuries of upper limb

170

1164

1.48

5.50

3.3

3.9

38.37

56.19

mg/l

1.90

144

999

Other disorders of bone density and structure

218

2.16

5.49

2.7

3.9

32.17

69.83

mg/l

0.78

189

Melanocytic naevi

527

4260

1.24

5.49

3.8

3.3

64.15

64.43

mg/l

0.01

448

3615

UC patients in KELA-register (code 208), prior to 1994

541

1.72

5.49

3.0

4.0

38.46

61.71

mg/l

1.26

457

Acute pharyngitis

176

1199

1.46

5.47

5.0

3.2

45.98

54.01

mg/l

0.44

155

1029

Other aneurysm

129

837

1.57

5.46

2.6

3.6

59.83

56.38

mg/l

0.15

107

718

Other and unspecified mood [affective] disorders

457

1.77

5.45

2.6

3.6

44.13

65.29

mg/l

0.69

391

Thyroiditis

123

788

1.58

5.45

3.0

3.7

421.63

124.05

mg/l

0.35

105

684

Alzheimer disease, including avohilmo

771

6343

0.83

5.45

2.7

3.2

57.92

75.48

mg/l

0.85

644

5359

Spontaneous abortion

428

3623

0.79

5.44

3.1

3.5

34.85

67.99

mg/l

1.03

360

3114

Exfoliative dermatitis

125

2.60

5.42

2.7

4.4

64.56

111.77

mg/l

0.43

105

Other female pelvic inflammatory diseases

262

1939

1.36

5.41

2.7

3.6

35.76

72.82

mg/l

0.74

225

1658

Chorioretinal inflammation

330

1.93

5.41

3.6

3.5

36.23

64.06

mg/l

0.87

286

Kela-code for severe mental illness

581

4753

1.23

5.40

2.4

3.3

124.40

61.92

mg/l

0.40

485

4039

Scabies

438

1.79

5.38

4.5

3.5

54.57

58.10

mg/l

0.08

362

Speech disturbances, not elsewhere classified

201

1429

1.43

5.36

2.1

3.5

47.68

98.63

mg/l

0.73

161

1219

Complications of genitourinary prosthetic devices, implants and grafts

282

2.00

5.35

3.1

3.3

55.70

62.97

mg/l

0.13

239

Atopic dermatitis, strict definition

328

2451

1.31

5.35

3.0

3.1

42.75

68.25

mg/l

0.59

273

2082

Guillain-Barre syndrome

182

2.28

5.34

4.9

4.0

43.46

87.51

mg/l

0.72

158

Algoneurodystrophy

241

2.07

5.30

1.4

3.9

37.78

59.72

mg/l

0.43

210

Disorders of optic nerve, not elsewhere classified

277

2.02

5.30

3.6

3.9

122.98

74.92

mg/l

0.28

238

Chondrocostal junction syndrome [Tietze]

419

1.80

5.29

3.3

3.7

39.64

59.58

mg/l

0.72

358

Chronic iridocyclitis

569

1.68

5.28

2.4

3.6

53.72

64.73

mg/l

0.33

493

Malignant neoplasm of bladder

150

1011

1.51

5.28

2.2

1.5

73.49

53.68

mg/l

1.14

125

846

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

131

859

1.55

5.27

6.3

1.5

39.29

46.17

mg/l

0.46

113

727

Use of antiglaucoma preparations and miotics

193

1368

1.43

5.27

2.9

3.2

50.51

97.02

mg/l

0.62

160

1174

Psychotic depression

100

615

1.65

5.25

3.3

4.0

38.06

66.63

mg/l

1.48

550

Childhood asthma (age<16), excluding more controls

288

1.85

5.24

3.6

1.8

35.29

30.52

mg/l

0.31

242

Bullous pemphigoid

335

1.92

5.24

1.4

3.8

47.69

71.69

mg/l

0.63

283

Other and specified injuries of hip and thigh

292

1.98

5.22

2.4

4.0

52.04

67.61

mg/l

0.32

254

Cutaneous lupus erythematosus

285

1.99

5.22

2.3

4.2

43.67

68.82

mg/l

0.61

249

Viral infections of the central nervous system, including avohilmo

129

844

1.55

5.22

2.9

3.5

50.47

59.67

mg/l

0.37

104

729

Residual foreign body in soft tissue

525

1.70

5.21

3.5

4.0

49.80

58.00

mg/l

0.38

435

Impetigo

355

1.86

5.18

3.7

4.0

67.79

59.89

mg/l

0.13

303

Erythema multiforme

258

2.03

5.18

3.4

3.9

38.88

70.30

mg/l

0.73

223

Unspecified mental disorder

633

5244

1.21

5.17

2.6

3.3

116.71

60.47

mg/l

0.39

533

4452

Atypical mycobacterium lung infection

166

2.34

5.17

1.9

3.8

162.44

92.13

mg/l

0.24

137

Gluteal tendinitis

474

1.74

5.16

2.3

3.6

28.10

57.97

mg/l

1.73

413

Carbimazole or st.post thyroidectomy, condition for graves disease

353

2745

1.30

5.15

3.6

3.4

42.34

69.52

mg/l

0.75

313

2325

Oligomenorrhoea

230

2.08

5.15

2.7

4.1

37.64

57.54

mg/l

0.61

211

Vascular dementia (other)

105

2.74

5.14

1.1

4.4

56.98

118.15

mg/l

0.52

Colitis, primary sclerosing, strict definition

3.00

5.11

2.8

4.3

42.39

117.68

mg/l

0.50

Nonsuppurative otitis media

280

1825

1.34

5.10

3.3

3.2

66.34

79.11

mg/l

0.15

235

1559

Melanocytic naevi of trunk

211

1525

1.40

5.09

3.6

3.8

65.17

53.00

mg/l

0.53

178

1301

Achilles tendinitis

179

1258

1.44

5.07

3.2

3.3

47.01

55.47

mg/l

0.51

161

1042

Viral agents as the cause of diseases classified to other chapters

226

2.09

5.06

4.7

3.8

68.50

72.34

mg/l

0.04

195

Other endocrine disorders

349

1.84

5.05

3.7

3.8

48.73

62.46

mg/l

0.35

306

Volvulus

338

1.88

5.05

2.5

3.5

39.53

48.10

mg/l

1.03

287

Dislocation of lens

200

2.18

5.04

3.3

3.6

46.39

83.18

mg/l

0.64

171

Other surgical follow-up care

316

1.90

5.04

2.1

3.4

42.98

43.99

mg/l

0.06

288

Myocardial infarction, with ST-elevation

411

3272

1.27

5.02

2.0

3.2

89.19

76.79

mg/l

0.18

343

2761

Crohn disease (strict definition, require KELA, min 2 HDR)

553

1.67

5.02

2.2

3.4

45.36

64.32

mg/l

0.76

469

Schizophrenia or delusion

480

3881

1.24

5.02

2.7

3.3

49.01

63.55

mg/l

0.50

401

3305

Other ill-defined and unspecified causes of mortality

224

1643

1.38

5.01

3.2

3.3

79.35

92.72

mg/l

0.12

143

1397

Chromophobe cell carcinoma of kidney

3.70

5.01

3.4

1.2

59.69

46.52

mg/l

0.23

Carcinoma in situ of skin of ear and external auricular canal

256

2.04

5.00

3.0

3.5

240.29

84.06

mg/l

0.48

220

Exophthalmic conditions

118

2.57

5.00

5.3

4.1

35.29

48.34

mg/l

0.59

100

Cervicocranial syndrome

182

1287

1.43

4.98

3.3

3.1

34.38

57.43

mg/l

3.27

159

1063

Cluster headache, wide,, including avohilmo

471

1.72

4.98

1.5

3.7

38.11

56.13

mg/l

0.70

398

Migraine with aura and triptan purchases

168

1169

1.45

4.97

2.8

3.2

31.77

48.11

mg/l

1.65

143

993

Nontoxic multinodular goitre

397

3151

1.27

4.96

3.4

3.5

73.93

51.69

mg/l

0.68

344

2657

Use of memantine

557

5425

0.82

4.93

2.5

3.1

57.14

79.70

mg/l

1.05

468

4581

Use of other anti-dementia drugs

557

5425

0.82

4.93

2.5

3.1

57.14

79.70

mg/l

1.05

468

4581

Testicular hypofunction

340

1.86

4.93

3.5

53.64

70.63

mg/l

0.33

280

Other acute skin changes due to ultraviolet radiation

429

1.77

4.93

2.9

3.6

40.43

63.09

mg/l

0.91

372

Ethmoidectomy

215

1568

1.39

4.92

3.5

3.7

54.80

52.67

mg/l

0.06

160

1345

Vasomotor and allergic rhinitis

547

4388

1.22

4.91

3.3

3.4

41.42

59.64

mg/l

0.80

474

3723

Other otitis externa (chronic)

127

841

1.53

4.91

3.2

3.7

47.11

58.99

mg/l

0.50

118

719

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

138

805

1.50

4.86

2.3

2.5

40.86

43.77

mg/l

0.12

116

677

Abdominal aortic aneurysm (AAA)

242

1790

1.36

4.85

2.2

3.4

69.03

62.48

mg/l

0.43

190

1515

Malignant neoplasm of renal pelvis

3.12

4.84

1.8

1.3

41.60

50.10

mg/l

0.53

Open wound of abdomen, lower back and pelvis

292

1.92

4.84

2.6

3.8

56.37

68.31

mg/l

0.21

244

Other/unspecified soft tissue disorders related to use, overuse and pressure

285

1.93

4.84

2.8

4.3

34.04

51.06

mg/l

1.79

241

Amenorrhoea

341

1.83

4.83

1.7

3.7

41.50

49.81

mg/l

0.27

305

Congenital malformations and deformations of the musculoskeletal system

586

1.63

4.81

2.5

3.4

36.15

51.63

mg/l

0.81

504

Chondropathies

236

1753

1.36

4.81

3.8

3.3

69.61

82.83

mg/l

0.14

205

1494

Viral encephalitis, not elsewhere classified/unspecified

224

2.07

4.80

4.9

3.9

60.79

78.09

mg/l

0.22

190

Postmenopausal bleeding

516

2192

1.24

4.79

3.2

3.4

55.72

59.27

mg/l

0.08

447

1861

Childhood asthma (age<16)

297

1.79

4.79

3.6

1.8

35.29

30.27

mg/l

0.33

248

Ocular pain

139

942

1.49

4.79

2.2

3.7

38.43

112.82

mg/l

0.72

119

809

Glucosamine medication

1122

7821

1.15

4.78

3.4

51.93

72.14

mg/l

1.15

964

6631

Paget disease

3.13

4.77

2.6

3.9

73.13

138.64

mg/l

0.31

Injury of muscle and tendon at lower leg level

275

2093

1.33

4.77

3.7

80.01

80.74

mg/l

0.01

238

1778

Other and unspecified injuries of head

147

1010

1.48

4.75

2.1

3.5

44.34

110.36

mg/l

0.67

136

869

Disorders of psychological development

101

590

1.60

4.74

2.5

3.0

37.86

53.65

mg/l

0.80

494

Alcohol dependence

514

4219

1.23

4.72

2.0

3.6

58.23

55.65

mg/l

0.12

417

3588

Mouth breathing

731

6188

1.19

4.71

3.5

47.19

67.32

mg/l

1.12

602

5279

Complications of labour and delivery

668

4422

0.84

4.71

4.1

3.4

39.74

63.39

mg/l

0.83

561

3800

Alport

11.40

4.68

1.4

7.4

57.51

42.30

mg/l

—

Unspecified human immunodeficiency virus [HIV] disease

2.78

4.67

1.3

2.4

63.93

107.17

mg/l

0.26

Renal cell carcinoma of kidney

406

1.76

4.67

2.5

1.4

59.35

46.09

mg/l

0.95

337

Other and unspecified abdominal hernia

574

1.64

4.67

1.9

3.3

45.89

57.78

mg/l

0.49

487

Lichen simplex chronicus

406

1.76

4.67

3.9

4.3

50.48

59.45

mg/l

0.24

350

Congenital iodine-deficiency syndrome/hypothyroidism

362

1.81

4.66

4.4

3.5

192.81

81.66

mg/l

0.54

307

Alcohol withdrawal state with delirium

135

917

1.50

4.65

1.6

3.8

50.97

57.70

mg/l

0.39

104

770

Malignant neoplasm of colon, including Hilmo

379

3005

1.27

4.63

2.9

1.5

72.77

47.95

mg/l

0.90

326

2506

Lesion of radial nerve

437

1.73

4.62

3.1

3.7

39.44

60.22

mg/l

0.79

369

Embolic stroke with flimmer

363

1.81

4.62

2.9

54.75

63.51

mg/l

0.30

318

Crohn disease (strict definition, require KELA)

566

1.63

4.61

2.2

3.5

45.36

64.71

mg/l

0.80

481

Acute drug-induced interstitial lung disorder

105

2.63

4.61

5.3

4.1

114.11

115.37

mg/l

0.01

Hordeolum and other deep inflammation of eyelid

103

661

1.58

4.60

3.3

3.9

89.53

63.56

mg/l

0.28

573

Colorectal cancer, including Hilmo

547

4219

1.22

4.60

3.0

1.6

69.02

47.26

mg/l

1.23

469

3555

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

305

2334

1.30

4.59

2.9

3.3

41.96

47.20

mg/l

0.64

255

1978

Pneumonitis due to solids and liquids

189

1369

1.40

4.59

2.5

3.2

73.92

101.61

mg/l

0.28

149

1143

IBD (strict) with PSC

2.96

4.56

2.9

3.8

39.15

43.25

mg/l

0.29

Other specific arthropathies, wide

201

2.09

4.55

2.5

4.5

42.80

47.34

mg/l

0.20

178

Cluster headache, strict, including avohilmo

423

1.73

4.55

1.6

3.7

38.12

56.75

mg/l

0.63

356

Schizophrenia, schizotypal and delusional disorders

479

3917

1.23

4.55

2.7

3.3

48.68

63.91

mg/l

0.54

400

3333

Allergic urticaria

119

790

1.52

4.54

4.9

3.6

41.33

57.30

mg/l

0.96

107

684

conjunctival haemorrhage

169

1204

1.43

4.54

2.6

3.4

40.65

101.80

mg/l

0.75

148

1019

Other mycoses, not elsewhere classified/unspecified, including avohilmo

195

2.11

4.53

3.5

3.9

84.92

78.66

mg/l

0.05

166

Eating disorder

355

1.78

4.52

3.2

3.0

42.40

31.28

mg/l

0.94

316

Anti-inflammatory and antirheumatic products, non-steroids

540

2227

1.23

4.51

3.7

3.2

58.05

62.56

mg/l

0.15

456

1861

Viral meningitis

271

1.91

4.49

1.5

3.6

50.03

61.99

mg/l

0.21

227

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

230

2.01

4.49

4.9

3.8

60.79

77.05

mg/l

0.21

195

Pediculosis, acariasis and other infestations

626

1.59

4.47

3.8

3.6

56.27

56.04

mg/l

0.01

524

Portal vein thrombosis

211

2.06

4.42

2.5

3.5

52.75

76.29

mg/l

0.37

180

Impotence

121

814

1.51

4.41

2.0

3.8

57.84

55.33

mg/l

0.13

106

688

Other congenital malformations of skin, including avohilmo

119

796

1.51

4.40

2.3

3.7

38.42

58.30

mg/l

1.34

104

687

Acute alcohol intoxication, ICD10

335

2645

1.28

4.40

2.1

3.6

192.78

53.29

mg/l

0.50

255

2259

Other diseases of spinal cord

354

1.79

4.39

5.3

4.2

45.12

64.17

mg/l

0.49

301

Rheumatic valve diseases

282

1.89

4.37

5.5

3.3

69.00

73.08

mg/l

0.07

238

Scleritis and episcleritis

638

1.57

4.36

3.8

3.6

44.19

60.56

mg/l

0.73

552

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

615

1.58

4.33

2.1

3.6

44.35

63.21

mg/l

0.86

519

Focal brain injury

121

816

1.50

4.32

3.4

3.8

49.42

128.71

mg/l

0.63

692

Other specified/unspecified dorsopathies

363

1.77

4.31

4.5

3.4

44.33

66.27

mg/l

0.65

311

Sequelae of injuries of neck and trunk

334

1.81

4.30

3.8

4.1

44.34

63.75

mg/l

0.49

285

Primary open-angle glaucoma

783

6477

1.17

4.30

3.4

3.3

53.35

72.27

mg/l

1.16

631

5504

FESS (DNB20)

203

1503

1.36

4.29

3.2

3.7

57.02

52.73

mg/l

0.12

148

1288

Asthma mixed form (mode)

477

1.66

4.26

2.1

2.5

52.59

52.77

mg/l

0.00

409

Haemorrhagic disorder due to circulating anticoagulants

215

2.03

4.24

2.5

3.7

62.86

83.08

mg/l

0.31

187

Nonalcoholic steatohepatitis

103

2.54

4.24

2.1

3.8

37.56

38.52

mg/l

0.05

Carcinoma in situ of other and unspecified digestive organs

105

693

1.55

4.24

3.1

3.9

113.20

65.34

mg/l

0.40

592

Contraceptive management

360

3142

0.80

4.24

3.9

3.4

37.68

43.76

mg/l

0.86

320

2639

Autoimmune hyperthyroidism

603

1.58

4.23

3.3

3.5

42.12

56.36

mg/l

0.51

523

Malignant neoplasm of digestive organs

780

5120

1.17

4.22

2.7

1.5

63.17

46.10

mg/l

1.44

667

4322

Sequelae of injuries of lower limb

152

1077

1.43

4.20

3.2

3.6

59.22

55.91

mg/l

0.09

138

923

Viral conjunctivitis, including avohilmo

336

1.78

4.19

2.3

3.7

32.42

59.82

mg/l

0.87

291

Other secondary gout

3.64

4.19

6.9

3.3

56.64

45.44

mg/l

0.40

Viral meningitis, including avohilmo

278

1.86

4.17

1.5

3.6

50.03

62.30

mg/l

0.22

233

Hypermobility syndrome

292

1.83

4.17

3.7

26.58

48.77

mg/l

0.94

256

Other specified and unspecified retinal disorders

490

1.65

4.16

3.5

3.6

39.73

61.79

mg/l

1.06

422

Endocrine disorders, other/unspecified

202

2.04

4.15

3.1

4.0

47.35

71.06

mg/l

—

179

Malignant neoplasm of head and neck, including Hilmo

184

1350

1.38

4.14

3.2

1.5

47.09

49.47

mg/l

0.15

160

1141

Leiomyoma of uterus

1032

5060

1.15

4.14

3.5

3.3

43.31

70.30

mg/l

1.07

887

4308

Postpartum haemorrhage

122

1461

0.69

4.14

3.4

31.55

37.53

mg/l

0.60

1248

Other and unspecified trigeminal disorders

155

2.19

4.13

3.8

41.59

73.74

mg/l

0.39

136

Other demyelinating diseases of the central nervous system

272

1.87

4.12

3.4

3.9

33.90

37.99

mg/l

0.30

235

Somnolence

104

2.48

4.12

1.9

3.2

45.81

109.52

mg/l

0.56

Benign neoplasm: Rectosigmoid junction

650

1.56

4.11

3.3

3.9

65.23

59.81

mg/l

0.13

556

Malignant neoplasm of oral cavity, including Hilmo

514

1.62

4.10

2.6

1.5

55.55

43.86

mg/l

0.45

435

Universal erythroderma, KELA reimbursement

163

2.16

4.07

1.8

4.3

57.17

93.34

mg/l

0.38

137

Failure of sterile precautions during surgical operation

4.15

4.06

4.7

2.9

52.59

207.97

mg/l

0.46

Other misadventures during surgical and medical care

304

1.82

4.05

2.2

4.5

53.19

68.24

mg/l

0.33

262

Disorders of speech understanding and production

311

1.79

4.04

1.9

3.5

36.71

68.82

mg/l

0.99

268

Thiamine deficiency

2.88

4.04

4.8

4.6

64.97

139.55

mg/l

0.42

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

132

920

1.46

4.04

2.6

1.5

53.63

50.10

mg/l

0.32

109

785

Chronic diseases of tonsils and adenoids

1052

7533

0.88

4.03

3.2

3.5

48.80

67.42

mg/l

0.91

933

6398

Nonspecific lymphadenitis

571

1.58

4.02

2.7

3.5

36.54

55.45

mg/l

1.00

481

Pregnancy hypertension

484

3582

1.21

4.02

3.1

3.4

40.69

54.16

mg/l

0.41

415

3049

Other keratitis

178

1306

1.38

4.01

2.7

3.4

48.96

95.89

mg/l

0.59

145

1120

Malignant neoplasm of liver and intrahepatic bile ducts

410

1.69

4.00

2.1

1.4

51.80

46.09

mg/l

0.44

349

Traumatic subarachnoid haemorrhage

495

1.63

3.99

3.6

4.3

48.77

177.35

mg/l

0.62

423

Diffuse brain injury

349

1.75

3.98

3.1

3.9

49.91

74.08

mg/l

0.57

296

Follicular lymphoma, hilmo

655

1.54

3.98

2.1

3.8

29.60

59.70

mg/l

2.65

570

Panniculitis affecting regions of neck and back

372

1.72

3.98

3.1

3.5

38.35

65.39

mg/l

0.94

317

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

2.54

3.96

1.3

2.3

63.93

102.43

mg/l

0.25

Allergic rhinitis

370

2954

1.24

3.94

3.5

3.1

37.65

64.94

mg/l

0.84

323

2500

Injury of intra-abdominal organs

241

1.91

3.93

3.8

4.0

47.49

70.33

mg/l

0.40

201

Benign neoplasm of major salivary glands

192

1433

1.36

3.92

2.7

3.8

60.98

92.98

mg/l

0.38

157

1223

All dysplastic lesions of the cervix uteri, vagina or vulva

302

2329

1.27

3.91

3.2

3.1

35.15

62.17

mg/l

0.61

262

1981

100

2.43

3.91

1.6

4.2

24.25

33.33

mg/l

0.90

Pneumonia due to Haemophilus influenzae

3.95

3.91

8.3

1.2

20.26

38.62

mg/l

—

Bicipital tendinitis

585

1.56

3.88

4.1

4.3

38.83

55.95

mg/l

1.22

490

Unspecific neurodegenerative disorder

908

7092

0.87

3.88

2.7

3.4

49.70

73.80

mg/l

1.95

741

6038

Other problems related to primary support group, including family circumstances

108

707

1.50

3.88

2.6

3.7

37.50

55.51

mg/l

1.01

604

Crohn disease (strict definition, all UC cases excluded)

467

1.63

3.86

2.1

3.7

41.25

56.81

mg/l

0.59

398

Hepatocellular carcinoma

287

1.82

3.85

2.2

1.4

51.15

45.79

mg/l

0.38

241

Social phobias

435

1.64

3.85

3.2

3.5

39.31

39.43

mg/l

0.01

372

Atopic dermatitis

842

5830

1.15

3.84

2.6

3.4

40.77

55.39

mg/l

0.90

722

4977

Superficial injury of ankle and foot

158

1145

1.39

3.84

2.0

3.6

43.81

54.39

mg/l

0.81

136

979

Bell's palsy

209

1584

1.33

3.83

3.5

41.96

87.15

mg/l

0.71

172

1333

Prolonged pregnancy

665

0.55

3.83

4.5

3.2

35.54

39.25

mg/l

0.15

570

Tonsillectomy and adenotomy

464

3885

0.83

3.82

3.0

3.2

43.24

58.62

mg/l

0.53

404

3282

Degenerative diseases of the nervous system

758

6286

0.86

3.81

2.8

3.2

53.47

76.25

mg/l

1.39

621

5316

Other predominantly sexually transmitted diseases, not elsewhere classified

176

1299

1.36

3.81

2.9

3.4

37.74

48.15

mg/l

0.96

149

1099

Other acquired deformities of musculoskeletal system and connective tissue

533

1.58

3.79

3.1

3.5

42.47

61.08

mg/l

0.80

455

Cerebral cysts

588

1.55

3.78

3.0

3.5

62.79

56.47

mg/l

0.18

499

Hypothyroidism due to medicaments and other exogenous substances

148

2.17

3.78

2.4

3.9

58.69

87.54

mg/l

0.26

125

Abnormal spermatozoa

295

2347

1.27

3.78

3.1

3.6

46.02

62.46

mg/l

3.40

175

2009

Disorders of tooth development and eruption

222

1376

1.32

3.78

3.3

2.9

231.52

90.31

mg/l

0.33

185

1162

Other disorders of conjunctiva

298

2372

1.27

3.77

2.9

3.3

40.11

78.80

mg/l

1.03

263

2018

Benign neoplasm: salivary glands, exclude unknown (D119)

173

1280

1.37

3.76

2.7

3.7

62.93

98.22

mg/l

0.37

140

1095

Ill-defined and unknown causes of mortality

231

1783

1.31

3.76

3.3

78.12

91.20

mg/l

0.13

147

1516

Dislocation, sprain and strain of joint and ligaments of hip

535

1.58

3.75

2.8

3.6

42.10

56.87

mg/l

0.65

458

Pollen allergy

176

1283

1.36

3.75

3.9

3.4

41.42

48.09

mg/l

0.36

157

1090

Atypical facial pain

582

1.55

3.74

3.8

56.16

61.00

mg/l

0.12

503

Other secondary coxarthrosis

434

1.65

3.72

1.5

3.6

41.64

60.59

mg/l

0.59

373

Inflammatory diseases of prostate (prostatitis)

260

2039

1.29

3.72

3.0

3.7

79.68

59.09

mg/l

0.29

215

1708

Benign neoplasm: Cerebral meninges

191

1438

1.34

3.71

3.5

3.4

35.73

92.66

mg/l

0.90

165

1251

Benign neoplasm of meninges

210

1603

1.33

3.70

3.3

3.4

37.36

88.63

mg/l

0.90

182

1391

malignant neoplasm of female genital organs, including Hilmo

303

2305

1.26

3.69

2.8

1.5

44.05

38.02

mg/l

0.83

257

1945

Somnolence, stupor and coma

537

1.57

3.68

2.3

3.9

51.98

61.10

mg/l

0.32

448

Suppurative and unspecified otitis media

434

3180

1.21

3.68

4.5

3.1

50.34

64.99

mg/l

0.38

358

2702

Ectropion of eyelid

104

708

1.50

3.67

2.1

3.3

75.43

68.98

mg/l

0.10

593

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

196

1479

1.33

3.67

3.0

3.4

37.01

46.84

mg/l

1.04

166

1249

Human immunodeficiency virus [HIV] disease

163

2.07

3.66

1.3

2.5

55.94

76.18

mg/l

0.21

129

Blepharochalasis

641

5507

1.17

3.65

2.8

3.5

52.32

63.05

mg/l

0.44

535

4679

Focal epilepsy

379

3104

1.23

3.65

2.8

3.3

50.28

72.96

mg/l

0.66

331

2643

Status epilepticus

428

1.64

3.65

1.5

4.3

52.66

65.14

mg/l

0.37

357

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

101

683

1.50

3.65

2.6

1.5

49.55

49.89

mg/l

0.02

576

Fenamates

271

1447

1.28

3.65

3.2

236.36

58.91

mg/l

0.44

235

1203

Schizoaffective disorder

101

682

1.50

3.64

2.0

3.7

41.57

62.22

mg/l

1.12

576

Other and unspecified paralytic syndromes

130

2.21

3.64

9.1

4.0

43.38

102.85

mg/l

0.70

113

Obsessive-compulsive disorder

335

1.71

3.63

2.4

3.4

32.13

59.44

mg/l

0.84

285

Other arterial embolism and thrombosis

391

1.67

3.63

1.8

3.8

69.85

65.22

mg/l

0.10

337

Follow-up care involving plastic surgery

367

1.69

3.62

4.0

3.2

34.73

54.49

mg/l

1.03

328

Injury of muscle and tendon at hip and thigh level

168

1244

1.36

3.62

2.8

3.7

38.73

98.69

mg/l

0.76

149

1054

Labour and delivery complicated by fetal stress [distress]

776

0.64

3.60

1.9

2.9

27.41

36.22

mg/l

0.78

663

Adenomyosis (Endometriosis of uterus)

221

1701

1.31

3.59

3.3

3.4

66.06

46.20

mg/l

0.49

195

1436

Brachial plexus disorders

117

815

1.45

3.59

4.2

3.8

44.16

53.16

mg/l

0.31

698

Papillary adenocarcinoma of thyroid gland

516

1.57

3.59

3.5

1.4

42.90

39.06

mg/l

0.34

437

Benign neoplasm: Skin of trunk

509

1.58

3.58

5.1

3.9

46.26

59.83

mg/l

0.53

444

Hyperprolactinaemia

220

1.89

3.57

4.2

3.7

31.01

66.13

mg/l

0.73

196

Delivery, wide proxy

433

2767

0.83

3.56

3.5

2.9

38.49

82.49

mg/l

1.29

380

2350

Other superficial mycoses, including avohilmo

139

1000

1.40

3.56

2.6

3.5

42.25

57.93

mg/l

0.99

123

861

Benign neoplasm of middle ear and respiratory system

154

1130

1.38

3.55

3.2

3.7

53.34

58.06

mg/l

0.20

125

964

Hallux rigidus

241

1883

1.29

3.55

3.1

3.9

42.48

81.38

mg/l

0.73

213

1611

Retinal detachment with retinal break

267

2115

1.28

3.55

4.1

3.5

62.84

82.30

mg/l

0.33

223

1807

Non-small cell lung cancer, including Hilmo

304

2294

1.25

3.49

2.2

1.6

49.38

49.37

mg/l

0.00

238

1927

Human immunodeficiency virus [HIV] disease, including avohilmo

166

2.03

3.49

1.3

2.5

55.94

75.49

mg/l

0.21

131

Localized skin eruption due to drugs and medicaments

126

2.22

3.49

3.4

3.9

178.23

95.56

mg/l

0.22

109

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

113

788

1.45

3.48

3.7

1.5

34.86

47.04

mg/l

2.53

659

Malignant neoplasm of oropharynx, including Hilmo

223

1.88

3.48

5.1

1.3

45.64

44.19

mg/l

0.07

188

Nonsuppurative otitis media, including avohilmo

401

2864

1.21

3.47

3.4

3.1

161.94

67.10

mg/l

0.44

344

2428

Ptosis of eyelid

244

1918

1.29

3.47

3.2

3.4

48.56

85.39

mg/l

0.70

218

1637

Carcinoma in situ of skin, other sites/unspecified

261

1.83

3.46

2.9

3.8

58.84

75.19

mg/l

0.30

223

Ovarian dysfunction

325

1.70

3.46

3.6

3.2

33.72

44.22

mg/l

0.36

288

Disorders of iron metabolism

160

2.05

3.45

1.6

4.0

43.29

72.27

mg/l

0.36

137

Malignant melanoma of skin, including Hilmo

268

2130

1.27

3.45

3.8

1.6

58.36

48.04

mg/l

0.71

228

1789

Other disorders of pigmentation

594

1.52

3.45

4.0

3.5

48.34

152.65

mg/l

0.62

520

Hypertension, Pulmonary Arterial

2.53

3.45

3.6

4.3

37.67

106.16

mg/l

0.48

Follow-up examination after treatment for malignant neoplasms

196

1497

1.32

3.45

2.9

3.0

77.33

57.32

mg/l

0.50

171

1148

341

1.68

3.43

1.6

2.6

22.64

33.11

mg/l

2.48

302

Ganglion

301

2425

1.25

3.41

3.0

3.6

40.73

45.86

mg/l

0.44

270

2026

Acute and transient psychotic disorders

161

1196

1.36

3.41

2.4

3.5

45.62

52.45

mg/l

0.40

131

1023

Dementia in Alzheimer disease

343

3493

0.81

3.40

2.6

3.0

52.58

87.80

mg/l

1.15

266

2969

Morphin

299

1.74

3.38

2.2

88.60

68.23

mg/l

0.26

255

Corneal scars and opacities

337

1.70

3.37

3.2

4.0

43.21

65.16

mg/l

0.62

289

Acne

472

1.57

3.37

3.0

2.7

64.05

47.53

mg/l

0.56

402

Parkinson's disease, excluding more controls

293

2169

1.25

3.37

2.1

3.8

45.30

84.98

mg/l

0.93

248

1856

Third [oculomotor] nerve palsy

248

1.83

3.36

2.0

4.4

54.35

77.18

mg/l

0.41

210

Other and unspecified injuries of shoulder and upper arm

360

1.67

3.36

3.3

3.7

50.94

60.04

mg/l

0.19

302

Need for immunization against other single infectious diseases

9.52

3.36

1.0

1.1

75.02

35.69

mg/l

—

Pleural plaque with presence of asbestos

185

1412

1.33

3.35

2.7

3.6

63.01

63.40

mg/l

0.02

145

1209

Other congenital malformations of the digestive system, including avohilmo

481

1.57

3.35

2.9

3.9

587.12

60.22

mg/l

0.47

411

Episcleritis

533

1.54

3.35

3.2

3.7

42.26

64.35

mg/l

0.89

463

Plantar fascial fibromatosis

155

1149

1.36

3.35

3.6

3.5

38.53

49.46

mg/l

0.81

140

957

Non-small cell lung cancer, adenocarcinoma

129

930

1.41

3.35

2.6

1.5

42.95

46.51

mg/l

0.37

101

786

Use of galantamine

113

1582

0.70

3.34

2.1

3.0

41.76

94.73

mg/l

0.91

1348

LSIL lesion of the cervix uteri, vagina or vulva

150

1105

1.37

3.34

3.7

3.3

36.83

40.32

mg/l

0.25

132

952

All dysplastic lesions of the cervix uteri

238

1839

1.28

3.34

3.3

3.2

37.14

37.18

mg/l

0.00

203

1562

Benign neoplasm of other and unspecified intrathoracic organs

122

2.21

3.34

3.3

4.5

135.35

97.56

mg/l

0.20

106

Dislocation, sprain and strain of joints and ligaments at neck level

198

1521

1.31

3.32

3.8

3.6

38.77

51.82

mg/l

1.24

165

1302

Special screening examination for infectious and parasitic diseases

229

1299

1.29

3.32

3.2

39.75

47.94

mg/l

0.71

215

1011

Early lumbar disc prolapse, operated

557

1.52

3.31

3.2

2.8

32.23

39.22

mg/l

0.95

462

Conductive hearing loss, unspecified

143

1050

1.38

3.30

4.2

3.4

69.81

106.61

mg/l

0.29

131

888

Periapical abscess

833

7344

1.14

3.30

3.4

3.5

43.72

64.02

mg/l

1.46

698

6269

Use of disulfiram, acamprosate or naltrexone

129

932

1.40

3.28

1.8

3.8

37.38

59.24

mg/l

1.94

105

782

Rheumatic fever incl heart disease

402

1.62

3.27

6.4

3.5

62.55

64.41

mg/l

0.04

345

Meralgia paraesthetica

394

1.63

3.27

1.5

3.9

56.92

71.17

mg/l

0.29

331

Disorders of synovium and tendon in diseases classified elsewhere

235

1.83

3.27

2.2

3.4

45.15

46.52

mg/l

0.06

195

Erythema intertrigo

310

1.71

3.26

2.5

4.5

38.55

67.43

mg/l

0.87

275

Congenital malformations of heart and great arteries

173

1270

1.33

3.24

3.2

3.6

58.12

96.43

mg/l

0.41

141

1084

Nasal polyp

367

3041

1.22

3.23

3.5

3.4

53.97

74.45

mg/l

0.54

307

2568

Irregular menses

583

3758

1.17

3.23

3.4

3.3

35.28

55.03

mg/l

0.76

506

3200

Fracture at wrist and hand level

576

4941

1.17

3.22

3.3

3.4

49.82

63.20

mg/l

0.58

495

4182

Disturbances of smell and taste

523

1.53

3.21

3.9

4.4

637.90

63.83

mg/l

0.46

458

Focal epilepsy, strict definition

352

2905

1.22

3.21

2.7

3.3

49.94

74.34

mg/l

0.67

308

2478

Unspecified chronic bronchitis

483

1.56

3.21

1.7

3.9

103.01

66.77

mg/l

0.22

416

Other diseases of gallbladder

621

1.49

3.20

3.6

3.4

34.54

132.21

mg/l

0.60

537

Congenital malformations of the circulatory system

199

1494

1.30

3.20

2.6

3.6

64.35

87.85

mg/l

0.27

167

1279

Ulcerative rectosigmoiditis

121

869

1.41

3.19

3.7

44.76

58.67

mg/l

0.83

100

743

Tularaemia

138

2.09

3.17

5.5

4.1

30.29

97.76

mg/l

0.90

118

Malignant neoplasm of corpus uteri

161

1213

1.34

3.17

2.1

1.5

35.84

38.18

mg/l

0.50

135

1018

Dronedarone medication

383

1.63

3.15

2.3

3.3

56.49

178.54

mg/l

0.42

333

Systemic sclerosis,strict definition

2.41

3.14

3.4

4.1

80.07

37.19

mg/l

0.57

Excessive attrition of teeth

1009

8930

1.12

3.14

3.5

83.98

54.86

mg/l

0.31

852

7597

Single delivery by forceps and vacuum extractor

530

0.62

3.14

2.5

2.3

24.81

32.13

mg/l

0.94

461

Other intracranial haemorrhages

519

1.53

3.14

4.3

3.6

54.85

63.68

mg/l

0.30

440

Retinal haemorrhage

376

1.63

3.13

3.6

3.8

57.52

206.43

mg/l

0.53

326

Malignant neoplasm of corpus uteri, including Hilmo

173

1320

1.33

3.12

2.1

1.5

35.33

39.01

mg/l

0.93

143

1103

Perineal laceration during delivery

702

0.62

3.12

3.4

2.9

23.70

40.40

mg/l

1.82

601

Nontoxic goitre/thyroid nodule

570

4921

1.16

3.11

3.4

63.77

60.93

mg/l

0.06

499

4168

Hyperkinetic disorders

464

1.54

3.11

1.4

2.4

33.29

32.53

mg/l

0.05

392

Convalescence

559

1.50

3.10

4.3

3.1

39.49

52.71

mg/l

0.68

494

Parkinson's disease, strict definition, excluding more controls

273

2055

1.25

3.10

2.0

3.8

41.97

87.43

mg/l

1.06

231

1758

Endometriosis of pelvic peritoneum

198

1395

1.30

3.10

2.2

3.4

41.72

42.43

mg/l

0.03

166

1190

Focal epilepsy, mode (most common among epilepsy diagnosis)

329

2708

1.22

3.10

3.0

3.4

49.29

75.52

mg/l

0.67

285

2310

Benign neoplasm: Parotid gland

153

1149

1.35

3.10

2.6

3.6

54.54

104.68

mg/l

0.53

121

979

Secondary parkinsonism

401

1.61

3.09

2.6

3.7

40.65

67.22

mg/l

1.03

341

Left ventricular outflow tract obstruction, narrow definition

487

1.54

3.09

3.4

3.7

78.38

59.70

mg/l

0.26

406

Secondary parkinsonism+Parkinsonism in other disease

409

1.60

3.08

2.7

3.8

40.85

66.24

mg/l

0.99

348

Injuries involving multiple body regions

400

1.60

3.08

4.0

3.8

63.05

63.98

mg/l

0.02

339

Single delivery by caesarean section

732

0.68

3.07

2.8

2.3

26.60

35.21

mg/l

2.54

633

Other specified/unspecified hearing loss

183

1411

1.31

3.07

3.8

3.3

95.17

94.86

mg/l

0.00

167

1203

Heterophoria

108

766

1.42

3.07

3.5

35.37

57.16

mg/l

1.36

662

Crushed, pushed or stepped on by crowd or human stampede

584

1.48

3.07

3.7

3.4

62.22

57.58

mg/l

0.08

491

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

106

2.21

3.06

7.8

3.8

61.91

47.96

mg/l

0.25

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

432

1.57

3.06

2.1

3.9

51.48

58.46

mg/l

0.15

361

Anorexia (incl.atypical)

384

1.60

3.05

3.7

3.3

38.98

55.81

mg/l

0.52

334

Other and unspecified visual disturbances

189

1464

1.30

3.05

3.7

3.5

38.14

91.67

mg/l

0.83

167

1248

Propionic acid derivatives

520

2227

1.18

3.04

3.5

3.2

59.22

62.56

mg/l

0.10

442

1861

Other and unspecified mononeuropathies of upper limb

324

1.66

3.03

3.2

3.9

34.39

64.75

mg/l

0.92

270

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

215

1692

1.28

3.03

3.1

3.0

38.63

73.97

mg/l

0.56

186

1455

LSIL lesion of the cervix uteri

106

751

1.42

3.02

4.5

3.6

40.83

41.96

mg/l

0.05

647

Melanoma in situ

103

730

1.44

3.01

5.1

3.7

64.83

57.81

mg/l

0.15

636

HSIL lesion of the cervix uteri, vagina or vulva

192

1490

1.29

3.01

2.7

3.1

33.16

39.12

mg/l

0.73

164

1273

Melanoma in situ of other and unspecified parts of face

206

1.87

3.01

3.6

4.2

58.40

85.76

mg/l

0.40

176

Localized scleroderma [morphea]

155

1.99

3.00

2.3

4.2

33.30

74.88

mg/l

0.57

136

Amoebiasis, including avohilmo

2.62

3.00

2.5

3.0

43.47

148.67

mg/l

0.57

Perichondritis of external ear

235

1.79

3.00

5.7

3.5

44.73

79.46

mg/l

0.70

197

Postpartum care and examination

456

0.59

2.98

3.3

2.7

31.63

32.94

mg/l

0.07

387

Endometriosis ASRM stages 1,2

203

1590

1.28

2.98

2.3

3.2

41.54

74.61

mg/l

0.47

171

1361

Epiphora

288

1.70

2.98

4.6

4.2

32.36

72.25

mg/l

1.22

251

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

192

1.88

2.97

2.3

4.2

60.11

85.93

mg/l

0.35

166

Diphtheria

5.97

2.97

4.7

4.8

30.41

38.92

mg/l

—

Toxic liver disease

170

1.93

2.96

1.7

3.4

36.46

75.53

mg/l

0.57

145

Maternal care related to the fetus and amniotic cavity and possible delivery problems

339

2400

0.83

2.96

3.9

3.3

34.44

37.90

mg/l

0.54

302

2035

Tularaemia, including avohilmo

206

1.84

2.96

5.3

4.4

31.34

79.42

mg/l

0.97

175

Other disorders of the genitourinary system

251

2023

1.25

2.95

3.3

231.56

80.42

mg/l

0.38

220

1725

Dermatographic urticaria

631

1.46

2.94

4.4

3.8

37.40

61.62

mg/l

1.36

548

Allergic contact dermatitis due to drugs in contact with skin

244

1.76

2.92

3.1

3.9

53.34

69.56

mg/l

0.25

209

Acute alcohol intoxication

460

3927

1.18

2.92

2.2

3.6

160.04

70.40

mg/l

0.43

360

3333

Pain and other conditions associated with female genital organs and menstrual cycle

225

1491

1.27

2.91

2.6

3.3

31.73

42.00

mg/l

2.02

194

1272

Other and unspecified iridocyclitis

543

1.49

2.91

4.4

3.7

47.37

59.10

mg/l

0.46

467

Other lesions of median nerve

360

1.62

2.90

1.9

3.8

57.09

65.07

mg/l

0.13

307

Car occupant injured in other and unspecified transport accidents

256

2069

1.24

2.89

3.1

3.4

43.35

76.13

mg/l

0.67

221

1762

Benign neoplasm: Tongue

369

1.60

2.87

5.0

4.2

49.38

61.84

mg/l

0.23

315

Obstructed labour due to malposition and malpresentation of fetus

110

1398

0.73

2.85

3.2

3.3

25.95

35.95

mg/l

2.18

1194

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

231

1.77

2.85

3.3

1.3

41.49

40.59

mg/l

0.06

193

Acute epiglottitis

137

2.01

2.84

9.7

4.1

67.55

94.55

mg/l

0.26

123

Carcinoma in situ of colon

442

1.55

2.84

3.8

4.0

138.59

63.67

mg/l

0.43

376

Injury of eye and orbit

206

1628

1.27

2.84

3.0

3.4

62.70

52.39

mg/l

0.41

175

1385

Pustular psoriasis

538

1.49

2.84

3.2

3.8

49.19

65.39

mg/l

0.43

469

Urethritis and urethral syndrome

216

1.79

2.84

2.9

4.1

39.06

73.42

mg/l

0.64

183

Pilonidal cyst

652

1.44

2.84

3.0

3.4

48.32

53.16

mg/l

0.17

555

Subacute thyroiditis

385

1.58

2.84

3.0

3.6

802.09

71.10

mg/l

0.46

340

Infective bursitis

370

1.60

2.83

4.2

4.0

85.71

49.47

mg/l

1.66

301

Tongue abnormality

118

865

1.38

2.83

4.3

3.5

51.33

120.05

mg/l

0.56

103

743

Malignant neoplasm of tongue, including Hilmo

292

1.68

2.83

3.2

1.4

41.85

43.74

mg/l

0.14

245

Malignant melanoma of skin

218

1738

1.26

2.82

4.1

1.5

58.39

48.14

mg/l

0.58

186

1467

Lateral epicondylitis

186

1453

1.29

2.82

2.8

3.6

46.51

48.76

mg/l

0.10

153

1204

Other and unspecified injuries of ankle and foot

354

1.60

2.81

1.9

3.8

30.58

61.10

mg/l

1.07

298

Other and unspecified follicular disorders

442

1.54

2.80

2.5

3.7

48.30

62.69

mg/l

0.45

374

Other retinal artery occlusion

356

1.61

2.80

3.7

3.8

56.76

69.52

mg/l

0.30

305

Prepatellar bursitis

540

1.48

2.79

2.1

3.9

55.26

48.41

mg/l

0.30

438

Muscle strain

324

1.63

2.78

2.7

3.8

55.13

50.13

mg/l

0.20

267

Maltreatment syndromes

308

1.64

2.77

3.8

3.3

45.47

60.46

mg/l

0.31

259

Emotional disorders starting during childhood or adolecense, excluding more controls

2.40

2.76

1.2

2.5

25.27

30.72

mg/l

0.28

Endometriosis of ovary

239

1815

1.25

2.75

2.4

3.5

58.75

43.68

mg/l

0.43

208

1539

Other noninflammatory disorders of vulva and perineum

136

1022

1.34

2.75

2.6

3.4

36.11

46.53

mg/l

1.20

115

861

HSIL lesion of the cervix uteri

156

1194

1.31

2.75

2.5

3.3

32.92

40.18

mg/l

0.75

132

1021

Malignant neoplasm of tonsil, including Hilmo

182

1.86

2.74

5.6

1.3

49.32

46.39

mg/l

0.13

151

Other strabismus

300

2470

1.22

2.74

3.2

3.3

39.52

70.23

mg/l

0.78

246

2105

Chalazion

184

1443

1.28

2.73

5.0

3.5

65.85

55.09

mg/l

0.41

163

1234

Disturbance of activity and attention

432

1.52

2.73

1.4

2.4

27.71

32.48

mg/l

0.58

364

Benign neoplasm: Skin of other and unspecified parts of face

204

1623

1.27

2.71

3.7

3.3

69.05

90.43

mg/l

0.24

175

1389

Open wound of shoulder and upper arm

212

1.78

2.71

1.5

3.6

38.03

71.22

mg/l

0.61

180

Congenital malformations of the respiratory system, including avohilmo

168

1.88

2.70

2.7

4.1

33.00

79.48

mg/l

0.72

147

Malignant neoplasm of oral cavity

406

1.55

2.70

2.2

1.5

59.34

43.91

mg/l

0.45

337

Pustulosis palmaris et plantaris

495

1.50

2.70

3.3

3.9

50.79

66.48

mg/l

0.37

430

Ulcer of vagina/vulva

273

1.67

2.68

2.9

3.8

30.04

41.87

mg/l

1.27

234

Other deformities of toe(s)

399

1.55

2.67

2.9

3.6

32.56

183.93

mg/l

0.62

355

Diphtheria, including avohilmo

5.08

2.67

4.7

5.8

30.41

37.79

mg/l

—

Allergic contact dermatitis

184

1447

1.28

2.67

2.5

3.5

41.56

86.65

mg/l

0.64

151

1241

Procreative management

422

2963

1.18

2.66

3.1

3.3

40.54

63.26

mg/l

0.66

359

2513

Excessive vomiting in pregnancy

553

1.46

2.65

2.7

3.7

29.91

44.97

mg/l

1.16

481

Contact with heat and hot substances

521

1.47

2.65

2.4

3.7

51.62

62.82

mg/l

0.37

440

Calculus of lower urinary tract

114

842

1.37

2.65

3.2

3.9

52.09

60.38

mg/l

0.41

701

ILD medications: pirfenidone

149

1.95

2.64

2.4

1.9

70.14

84.08

mg/l

0.14

134

Mixed conductive and sensorineural hearing loss

251

2052

1.23

2.63

3.8

3.4

71.66

81.23

mg/l

0.11

217

1759

Degenerative macular diseases

262

2152

1.23

2.63

2.4

3.3

59.58

82.81

mg/l

0.42

211

1821

Other orthopaedic follow-up care

647

1.42

2.62

2.2

2.9

48.73

51.33

mg/l

0.10

559

Other benign neoplasms of connective and other soft tissue

163

1267

1.30

2.62

4.3

3.5

42.74

54.29

mg/l

0.83

144

1090

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

477

3386

1.16

2.62

2.7

1.6

50.44

48.41

mg/l

0.28

383

2852

Burn and corrosion of ankle and foot

156

1.91

2.62

2.5

3.4

63.77

88.57

mg/l

0.27

133

Granulomatous disorders of skin and subcutaneous tissue

260

1.68

2.61

3.3

3.6

57.50

69.29

mg/l

0.18

225

Any prescribed medicine buy

6.94

2.60

1.7

3.8

45.98

55.14

mg/l

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

269

1.68

2.60

2.9

4.0

77.45

78.03

mg/l

0.01

224

Congenital malformations of the respiratory system

149

1.92

2.59

2.9

4.4

33.96

87.10

mg/l

0.72

128

Amoebiasis

2.83

2.59

2.9

3.5

45.09

198.49

mg/l

0.58

Benign neoplasm of eye and adnexa

201

1607

1.26

2.58

3.3

3.5

282.78

86.46

mg/l

0.39

173

1366

MS-disease / Multiple Sclerosis

582

1.44

2.57

3.0

3.6

33.45

60.27

mg/l

1.32

499

Malignant neoplasm of head and neck

144

1104

1.32

2.57

2.4

1.5

48.07

50.56

mg/l

0.13

124

934

Uterine polyps

449

2248

1.17

2.57

3.1

3.4

36.76

58.44

mg/l

0.96

388

1907

Dislocation, sprain and strain of joints and ligaments of thorax

387

1.55

2.57

4.5

3.9

54.20

60.86

mg/l

0.13

330

Other neurotic disorders

592

1.44

2.56

1.6

3.8

46.72

59.90

mg/l

0.61

503

Pigmented purpuric dermatosis

129

2.00

2.56

3.3

5.0

34.13

107.16

mg/l

0.91

110

Carcinoma in situ of rectum

187

1.82

2.56

2.0

4.7

57.69

87.83

mg/l

0.42

159

Ulcerative proctitis

609

1.43

2.54

2.5

3.7

41.62

58.16

mg/l

0.84

518

Astigmatism

608

1.43

2.54

2.8

3.8

45.59

57.38

mg/l

0.47

515

Malignant neoplasm of nasal cavity and sinuses

2.40

2.54

6.0

1.2

25.69

46.15

mg/l

2.00

Generalized epilepsy

324

1.59

2.53

3.2

3.7

47.63

65.08

mg/l

0.40

273

Certain zoonotic bacterial diseases, including avohilmo

373

1.55

2.52

4.4

3.8

41.83

63.24

mg/l

0.67

317

Other contact dermatitis

119

890

1.35

2.52

2.1

3.7

108.64

56.05

mg/l

0.35

780

Glaucoma suspect

785

7027

1.12

2.52

3.1

3.4

51.59

66.39

mg/l

0.91

621

5984

Unspecified event, undetermined intent

232

1.71

2.52

3.4

4.0

30.11

73.49

mg/l

1.01

200

Pleural plaque without asbestos

655

1.42

2.51

2.6

3.7

46.21

64.66

mg/l

1.17

560

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

548

4153

1.15

2.51

3.0

3.5

41.61

52.57

mg/l

0.38

473

3549

Melanocytic naevi of upper limb, including shoulder

249

1.68

2.47

4.8

3.7

63.52

71.45

mg/l

0.11

214

Vulvovaginal ulceration/inflammation in other diseases

488

1.47

2.45

3.7

37.44

46.30

mg/l

0.31

429

Hereditary angioödema type 1

7.00

2.45

9.2

6.4

180.72

37.63

mg/l

—

Striae atrophicae

2.22

2.44

1.9

5.4

25.87

37.12

mg/l

—

Injury of other and unspecified intrathoracic organs

117

879

1.35

2.44

3.0

3.4

59.74

55.26

mg/l

0.20

747

Certain zoonotic bacterial diseases

212

1.74

2.44

4.7

3.6

35.58

77.50

mg/l

0.80

177

Colorectal cancer

465

3872

1.16

2.43

3.1

1.6

72.67

47.37

mg/l

1.24

403

3246

Mental disorders, not otherwise specified

656

1.40

2.43

3.3

3.5

450.12

60.25

mg/l

0.46

564

Arthropathy in hypersensitivity reactions classified elsewhere

6.79

2.43

1.4

6.4

31.48

33.39

mg/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

146

1.89

2.41

1.3

2.7

55.22

35.94

mg/l

1.41

113

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

146

1.89

2.41

1.3

2.7

55.22

35.94

mg/l

1.41

113

Melanocytic naevi of lower limb, including hip

483

1.47

2.41

5.4

3.7

61.57

58.74

mg/l

0.04

415

Small cell lung cancer, helper endpoint

386

0.51

2.40

1.5

3.6

59.38

72.26

mg/l

0.28

331

Other appendicitis

129

985

1.32

2.40

3.9

3.8

36.87

58.24

mg/l

2.07

110

837

Malignant neoplasm of small intestine, including Hilmo

370

1.54

2.39

4.9

1.5

56.56

42.38

mg/l

0.87

314

Noninflammatory disorders of female genital tract

535

2340

1.15

2.39

3.2

3.3

150.18

57.05

mg/l

0.44

453

1986

Malignant neoplasm of pancreas

1009

0.70

2.39

1.7

1.5

46.70

48.42

mg/l

0.09

852

Thyrotoxicosis with diffuse goitre

204

1649

1.24

2.38

3.4

3.1

39.39

52.79

mg/l

1.41

166

1388

Perioral dermatitis

183

1.77

2.38

1.7

3.6

27.68

69.27

mg/l

0.69

155

Traction detachment of retina

2.16

2.38

1.5

2.7

86.49

123.87

mg/l

0.24

Myopia

145

1125

1.30

2.37

2.8

3.5

46.68

53.01

mg/l

0.31

110

959

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

583

1.42

2.37

3.4

3.9

63.28

50.00

mg/l

0.33

498

Acute laryngitis and tracheitis

105

765

1.36

2.37

3.3

3.0

39.20

57.19

mg/l

1.10

654

Perforation of tympanic membrane

167

1321

1.27

2.37

3.6

3.5

65.71

95.18

mg/l

0.27

149

1126

Arthropod-borne viral fevers and viral haemorrhagic fevers

160

1260

1.28

2.36

4.9

3.7

44.93

56.02

mg/l

0.92

129

1071

Examination and encounter for administrative purposes

149

1163

1.29

2.36

4.0

3.2

74.59

56.77

mg/l

0.26

137

890

Sequelae of infectious and parasitic diseases

117

884

1.34

2.35

3.1

3.3

48.72

54.79

mg/l

0.32

753

Pneumothorax

127

972

1.32

2.34

3.6

3.5

78.61

57.18

mg/l

0.33

104

830

Abscess of Bartholin gland

199

1.73

2.34

3.7

29.89

35.59

mg/l

0.60

172

Salpingitis and oophoritis

259

2151

1.21

2.33

2.6

3.6

43.71

68.65

mg/l

0.49

213

1843

Benign neoplasm of bone and articular cartilage

120

911

1.33

2.33

3.4

3.7

36.07

57.66

mg/l

1.78

107

780

Other specified disorders of muscle

332

1.56

2.33

2.5

3.6

43.26

49.18

mg/l

0.29

269

Acute nasopharyngitis (common cold)

151

1172

1.29

2.32

3.6

3.2

47.76

55.30

mg/l

0.36

131

999

Ménière disease

177

1415

1.26

2.32

3.0

3.6

41.15

91.87

mg/l

0.73

160

1215

Dystonia

613

1.40

2.31

1.9

4.1

54.56

61.61

mg/l

0.11

533

Malignant neoplasm of other and unspecified parts of tongue

156

1.84

2.30

2.4

1.3

40.26

41.93

mg/l

0.11

132

Persons encountering health services in circumstances related to reproduction

658

4948

0.89

2.28

3.6

3.5

40.25

56.53

mg/l

0.83

575

4183

Hypertrophy of (infrapatellar) fat pad

2.20

2.28

3.7

4.3

31.36

54.82

mg/l

—

Common variable immunodeficiency

2.42

2.26

1.6

3.2

33.30

54.42

mg/l

—

Tuberculosis of other organs, strict, including avohilmo

327

1.56

2.26

2.0

3.7

46.58

70.12

mg/l

0.67

287

Optic neuritis

342

1.54

2.26

3.2

3.7

42.75

61.26

mg/l

0.49

296

Shoulder region

172

1.79

2.25

1.4

4.0

38.24

85.60

mg/l

0.74

147

Follicular adenocarcinoma of thyroid gland, including Hilmo

2.10

2.25

4.8

1.4

37.49

43.75

mg/l

0.32

Medial epicondylitis

375

1.51

2.25

4.1

4.0

36.82

59.71

mg/l

1.09

304

Acne vulgaris

341

1.53

2.25

2.6

2.8

56.23

51.32

mg/l

0.10

294

Respiratory tuberculosis, confirmed, including avohilmo

233

1.66

2.24

1.4

3.9

49.04

83.40

mg/l

0.71

198

Polyp of the female genital tract

461

2269

1.15

2.22

3.3

3.4

37.72

58.27

mg/l

0.91

397

1923

Premature rupture of membranes

935

0.74

2.22

2.7

3.3

36.51

38.33

mg/l

0.08

795

Maternal care for known or suspected abnormality of pelvic organs

138

1193

0.78

2.21

4.2

3.5

28.07

38.30

mg/l

1.52

114

1021

Other menopausal disorders

315

2070

0.84

2.21

3.5

36.82

44.90

mg/l

1.16

279

1761

Tuberculosis of other organs, strict

321

1.56

2.21

2.0

3.7

44.49

70.67

mg/l

0.76

281

Acne, including avohilmo

145

917

1.28

2.19

2.2

2.9

48.89

51.26

mg/l

0.10

123

770

Oesophageal obstruction

536

1.42

2.19

3.3

4.0

59.46

51.89

mg/l

0.23

456

Malignant neoplasm of tonsil and base of tongue, including Hilmo

258

1.62

2.18

5.1

1.4

47.69

48.41

mg/l

0.03

214

Hypertrophic scar

460

1.45

2.17

2.8

3.7

39.54

67.14

mg/l

1.04

400

Calcific tendinitis of shoulder

637

1.38

2.17

3.8

3.9

42.74

52.98

mg/l

0.44

521

Other disorders of optic disc

137

1.86

2.17

4.4

4.0

30.75

89.57

mg/l

0.78

122

Other forms of systemic lupus erythematosus

2.16

2.17

1.8

5.1

36.03

38.88

mg/l

0.19

Disorder of external ear, unspecified

420

1.47

2.16

3.8

3.9

62.41

62.05

mg/l

0.01

355

Other vitreous opacities

562

1.41

2.16

4.0

3.8

59.94

66.70

mg/l

0.17

488

109

1424

0.76

2.16

1.6

3.6

77.88

57.01

mg/l

1.33

1196

Sequelae of infectious and parasitic diseases, including avohilmo

119

914

1.31

2.16

3.1

3.3

49.18

54.50

mg/l

0.28

779

Postpartum hemorraghe, parous women as controls

122

1319

0.77

2.15

3.4

3.5

31.55

37.72

mg/l

0.59

1127

Malignant neoplasm of small intestine

267

1.60

2.15

4.4

1.5

54.56

43.94

mg/l

0.44

229

Dislocation, sprain and strain of joints and ligaments of head

330

1.53

2.15

3.6

3.2

41.23

57.37

mg/l

0.41

285

Anankastic personality disorder

290

1.57

2.15

2.3

4.2

25.09

59.14

mg/l

1.03

252

Malignant neoplasm of colon

292

2474

1.19

2.15

3.2

1.5

79.39

47.55

mg/l

0.91

254

2070

Ankylosing spondylitis, strict definition

371

1.50

2.14

2.0

4.0

44.52

58.38

mg/l

0.36

308

Disorders of refraction and accommodation

379

3263

1.16

2.14

3.2

3.3

47.47

65.95

mg/l

0.54

288

2787

Other congenital malformations of the digestive system

393

1.48

2.13

3.4

3.8

726.11

63.61

mg/l

0.48

331

Supervision of normal pregnancy

115

857

0.76

2.12

3.9

3.3

32.07

38.74

mg/l

0.42

106

730

Respiratory tuberculosis, confirmed

229

1.65

2.12

1.4

3.6

49.83

83.73

mg/l

0.67

194

Separation of retinal layers (serosa)

505

1.42

2.12

2.5

3.8

50.33

61.11

mg/l

0.35

426

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

4.44

2.11

3.7

1.3

30.20

38.85

mg/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

531

1.41

2.11

3.9

3.7

45.93

59.22

mg/l

0.50

451

Hypertrophic disorders of skin

513

1.42

2.11

2.7

3.7

39.00

63.71

mg/l

1.04

447

Anogenital herpesviral [herpes simplex] infection

405

1.47

2.10

3.6

3.5

26.52

62.73

mg/l

1.35

342

Postprocedural disorders of nervous system

505

1.42

2.09

4.0

3.3

24.43

62.89

mg/l

2.03

429

Postpartum hemorraghe, all women as controls

122

1529

0.78

2.09

3.4

3.2

31.55

37.47

mg/l

0.59

1302

Acute appendicitis, with complications

329

2822

1.17

2.09

3.5

3.4

48.21

73.34

mg/l

0.67

275

2396

Burns and corrosions

187

1524

1.23

2.07

2.8

3.5

272.78

53.64

mg/l

0.49

159

1293

Tuberculosis of other organs

278

1.58

2.07

2.0

4.0

45.49

75.71

mg/l

0.75

241

Endometriosis ASRM stages 3,4

312

2666

1.18

2.07

2.4

3.2

54.19

64.79

mg/l

0.18

266

2275

Benign neoplasm: Other and unspecified parts of mouth

441

1.45

2.07

5.2

4.0

38.74

62.02

mg/l

0.94

381

Trigeminal neuralgia

712

1.35

2.06

3.4

3.6

39.70

59.40

mg/l

1.08

616

Benign neoplasm: Skin of ear and external auricular canal

559

1.40

2.06

2.0

3.6

50.76

61.10

mg/l

0.36

485

Benign neoplasm: Long bones of lower limb

302

1.54

2.05

2.0

3.6

33.89

64.41

mg/l

0.84

258

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

424

1.45

2.04

1.6

3.5

39.95

42.27

mg/l

0.08

367

Other superficial mycoses

200

1.67

2.04

3.7

4.1

42.02

76.82

mg/l

0.58

172

Disorders of globe

344

1.51

2.03

3.6

3.8

48.62

66.63

mg/l

0.48

300

Intermittent heterotropia

416

1.45

2.02

4.2

3.6

39.85

66.91

mg/l

0.80

356

Peritonsillar abscess

266

2249

1.19

2.01

3.8

3.4

49.98

74.98

mg/l

0.49

219

1907

Aphakia

163

1.75

2.01

4.0

3.1

75.46

78.22

mg/l

0.02

144

malignant neoplasm of female genital organs

257

2121

1.19

2.00

2.6

1.5

39.28

38.81

mg/l

0.05

216

1790

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Kappa light chains.free [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS